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Abstract
Childhood obesity has been increasing rapidly. Previous work investigating body 
composition in obese children and adolescents has relied primarily on body mass index 
(BMI), or on measures that assume constant properties of fat-free mass (FFM). This 
limits our understanding of the effect of treatment.
My PhD is divided into three aims. First, I explored differences in body composition 
between obese and non-obese children using multi-component models. Second, I 
investigated the effectiveness of two weight-loss programmes (a randomised controlled 
trial adopting the traffic-light program (TLP), and a pilot study evaluating treatment 
using Metformin). Third, I evaluated a bio-electrical impedance analysis (BIA) machine 
(TANITA BC-418 MA) as a clinical tool for assessing body composition in obese 
children.
Aim 1: obese children had greater hydration of FFM; this limits the accuracy of using 
techniques that assume constant FFM properties. Taking this into account, obese 
children had increased fat mass (FM) and FFM, particularly FM in the abdomen region
Aim 2: analyses from the TLP revealed that treatment and control groups significantly 
lost 0.1 BMI SDS during the trial; but did not significantly differ for any of the body 
composition outcomes. A further analysis revealed that there was a significant reduction 
in BMI SDS and FM but an increase in FFM in the period when obese children were 
treated versus an increase in BMI SDS and FM in the period when they were left. 
Results from the Metformin programme revealed no significant change in body 
composition following 6 months or 1 year treatment.
Aim 3: Using a manufacturer’s equations, TANITA was not accurate at assessing body 
composition or its change over time. My new equations had no systematic bias in 
relation to body fatness, although an error of the FFM estimate of 2.2 kg, and may be 
used to guide management in clinical practice.
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Chapter 1 : Introduction
The prevalence of childhood obesity in the UK has been increasing at a very rapid rate 
over the past few decades; most recent estimates report that approximately 16% of 
children are obese as defined by National UK cut-offs (Health Survey for England, 
2008). This is a concern because childhood obesity is associated with a number of 
different consequences such as health risks during childhood (Figueroa-Colon et a l 
1997; Lauer et a l 1997) and adulthood (Reilly et a l 2003), psychosocial problems 
(Strauss, 2000) and huge economic costs (House of Commons, 2004).
There is growing interest in the need to measure body composition in children. 
Assessing body composition is important in understanding the aetiology of childhood 
obesity, and in evaluating the success of different treatment programmes.
It has proven difficult to estimate body composition accurately in children for three 
main reasons. First we cannot use body composition techniques that are considered 
reliable in adults because children’s body composition has not yet reached maturity, and 
equations used to estimate body composition in adults would not be suitable to use in 
children. Second, simple, rapid and non-invasive techniques that are suitable to use in 
children such as body mass index (BMI) do not give information on where fat is 
distributed in the body, or on the different body components such as fat and lean mass. 
Third, there are several methods that estimate the amount of fat and lean tissue, such as 
imaging techniques and deuterium oxide dilution (D2 O); but most of these techniques 
are expensive, require a great degree of subject compliance and are usually only 
available in special research centres.
There has been surprisingly limited research looking both at body composition 
differences between obese and non-obese children, and the effectiveness of different 
treatment strategies in children and adolescents. In addition, most of the research 
conducted has relied primarily on surrogate measures such as BMI to assess body 
fatness. However, BMI has been previously shown to be an inaccurate measure of 
obesity; individuals with the same BMI levels may have very different percentage body 
fat levels (Wells, 2000).
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The aim of this thesis is to investigate the effects of obesity on body composition in 
obese children and adolescents, to evaluate the effect of two different weight-loss 
treatment programmes on body composition, and to validate a simple technique to 
measure body composition in obese children and adolescents.
This thesis is divided into 8 chapters, and the following topics are discussed in each 
chapter: Chapter 2 includes background information on my research outlining the 
definition and classification of childhood obesity, the prevalence of obesity in the UK, 
the various effects obesity has, how obesity develops, and the different treatments 
attempted. The chapter also considers previous findings concerning body composition 
in obese children and adolescents. Chapter 3 is a review of the different available 
techniques used to measure obesity, outlining their advantages and disadvantages in 
assessing body composition in children, particularly the overweight and obese. Chapter 
4 states the three hypotheses for the research and the methodology used to test them. 
Chapters 5, 6 & 7 describe each aim separately stating the research question, giving 
information on the sample size and recruitment, statistical analyses used, reporting the 
results obtained, followed by discussion and study limitations. Finally chapter 8 outlines 
the conclusion of the research giving a summary of all the findings, as well as possible 
implications for future research and clinical practice.
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Chapter 2: Background information on chiidhood
obesity
This chapter will include a review of the different aspects of obesity, giving a brief 
description of the definition and classification of obesity, followed by discussion of the 
prevalence of obesity in the UK and the aetiology of obesity. A description of some of 
the consequences of obesity and the different ways proposed to treat it are also 
discussed.
2.1 Growth and body composition in obese chiidren
Growth is a dynamic process that is characterised by physiological changes occurring 
during life; it is genetically predetermined and significantly affected by hormonal, 
nutritional, and environmental factors (Bechard and Puig, 2003). Assessment of growth 
is essential for defining health and nutritional status, and for preventing and detecting 
diseases by recognising deviations from the normal pattern. Growth monitoring is also 
useful to assess response to interventions such as weight-loss programmes.
The process of growth occurs during four different stages of human life: gestation, 
infancy, childhood and adolescence. For the purpose of this thesis, it is most relevant to 
focus on the process of growth in childhood and adolescence, looking in more detail at 
obese children and adolescents.
During the first year of life, percentage body fat is increased largely by means of 
increased volume of the fat cells. Body fat percentage then decreases slowly as the child 
gets older until puberty. During the pubertal period, body fat increases again largely 
through an increase in the number of fat cells without significant change in the volume 
of fat cells; females showing a bigger increase than males (Baumgartner and Roche, 
1988; Poissonnet et al. 1988) (refer to Figure 2-1). In addition, gender differences in 
the regional distribution of fat become more apparent after puberty where boys tend to 
accumulate more fat around their abdomen, and girls around their hips. This tendency 
can be attributed to hormonal changes that occur during puberty; oestrogen and 
progesterone increase the number and volume of fat cells around the hips for girls 
whereas androgens reduce them (Poissonnet et al. 1988). Before describing and
15
assessing growth and body composition in obese children, one needs to define and 
classify obesity.
Male
â  ^
1 2 3 6 9 12 ia 25 45 65 ISBirth
Ag#
Figure 2-1 Percentage body fat against age of children and adults 
Source: (Lobstein et al. 2004)
2.2 Definition of obesity
A typical medical dictionary defines obesity as an increase in body weight beyond the 
limitation of skeletal and physical requirements, as the result of excessive accumulation 
of body fat (Borland's Medical Dictionary, 2007).
Similarly, the World Health Organisation (WHO) defines obesity as an increase in body 
weight beyond skeletal and physical standards as the result of an excessive 
accumulation of fat in the body (World Health Organization, 2008). They also state that 
overweight and obesity are defined as abnormal or excessive fat accumulation that may 
impair health.
According to the UK Public Health Association and Faculty of Public Health, obesity is 
defined as an excess of body fat frequently resulting in a significant impairment of 
health and longevity (United Kingdom public health association and faculty of public 
health, 2003).
16
2.3 Classification of obesity
For many years, obesity has been classified using charts or cut-offs based on 
measurements from weight and height.
Body mass index (BMI), calculated as body weight in kilograms divided by the square 
of height in metres, has been the most common way to define obesity. For adults, BMI 
categories are: underweight < 18.5, ideal 18.5 - 24.9, pre-obese or over-weight 25.0 - 
29.9, obese class I 30.0 - 34.9, obese class II 35.0 - 39.9; and obese class III > 40 
kg/m^ (James et al. 1988; G arrow and Webster, 1985).
However, these cut-offs cannot be used in children. First, BMI values are much lower in 
children than in adults, and second BMI changes with age due to differences in the 
timing of growth in height and weight (Guo et al. 1997). For these reasons BMI cut­
offs applied in adults are not applicable in children, and, BMI needs to be adjusted for 
age so that comparisons can be made between children of different ages.
The Child Growth Foundation published BMI growth charts for girls and boys that can 
be used from birth to 20 years (Cole et al. 1995). These charts include nine percentile 
curves based on divisions of two thirds of a standard deviation (ranging from 0.4^  ^ -  
9 9 . percentile), where the two extremes identify the heaviest and lightest four per 
1000 of the population. The charts were created by combining several UK surveys 
conducted in 1980 - 1990 and covering almost 15,000 children (Cole et al. 1995). The 
charts were derived using Cole’s LMS method, which summarises data in terms of three 
smooth age-specific curves called L (lambda), M (mu), and S (sigma) (Cole and Green, 
1992). The M curve corresponds to the median and the S curve corresponds to the 
coefficient of variation of BMI at each age and gender. The L curve, based on the Box- 
Cox power, allows for the substantial age-dependent skewness in the distribution of 
BMI. Hence the LMS method adjusts the BMI distribution for differing degrees of 
skewness at different ages, and allows BMI in individual subjects to be expressed as an 
exact centile or standard deviation score (SDS) (Cole et al. 1995). The formula used to 
calculate SD score for BMI is:
Z-score = [BMI / M 1^  — 1 Equation 2-1
LS
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Where BMI is calculated as weight/height^, and L, M and S are values specific to the 
child’s age and gender (Cole et a l 1995).
These charts are currently widely used in clinical practice, and they are less affected by 
differences in the timing of puberty than simple height and weight charts. Figure 2-2 
shows BMI percentiles of the UK population.
However, degree of overweight reported as percentage BMI (% BMI) is another 
common way to diagnose overweight and obesity in many weight management clinics 
in the UK. % BMI is calculated as (BMI - median BMI)/median BMI * 100 (median
BMI = BMI at 50^  ^percentile). % BMI is the percentage above the 50^ " percentile BMIth
for the appropriate age and gender; 50^  ^percentile is ideal, 85^ " percentile is overweightth
and 95^  ^percentile is obese (Paluch et a l 2007; Jelliffe, 1966)
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Figure 2-2 BMI percentiles of the UK population 
Source: Child Growth Foundation; (Cole et al. 1995)
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More recently in April 2006, the WHO produced BMI-for-age growth charts for boys 
and girls spanning from birth to five years (WHO, 2006). A total of 1,737 children were 
measured between 1997 and 2003 from the following countries; Brazil, Oman, Ghana, 
India, Norway and the US. These charts were generated for assessing the growth and 
development of young children all over the world. Figure 2-3 shows BMI-for age 
growth charts for boys and girls.
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Figure 2-3 BMI-for age growth charts for boys (top) and girls (bottom) 
Source: The WHO Growth Standards, 2006 (WHO, 2006)
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The cut-off levels of overweight and obesity in childhood and adolescence and the best 
definitions to use have been debated. There are several different reference BMI cut-off 
values that are currently used. Must et al (1991) developed a set of reference BMI 
values based on the first National Health and Nutrition Examination Survey (NHANES 
1) providing sex-specific BMI values for within the ages 6 - 1 9  years (Must et al. 
1991). In May 2000, another more recent set of reference BMI values were produces by 
the Centres for Disease Control and Prevention growth charts based on the US national 
survey (CDC-US) growth charts (Kuczmarski et al. 2000). These are the revised 
National Centre for Health Statistics (NCHS) growth charts including ages 2 - 2 0  years, 
intended to be used for US children and adolescents (refer to Figure 2-4).
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Figure 2-4 BMI-for age growth charts for 2-20 years old boys (top) and girls (bottom) 
Source: (National Centre for Health Statistics, 2000)
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More recently, the International Obesity Task Force (lOTF) led by Cole and colleagues 
(2000) produced BMI cut-offs for international use (Cole et al. 2000). The data were 
produced by averaging BMI percentiles of large national cross sectional surveys from 
six countries including: Brazil, US, Great Britain, Netherlands, Hong Kong and 
Singapore covering the age range 2 - 1 8  years. The percentiles were chosen to match 
BMI cut-offs used in the adult reference population. An international definition of 
overweight and obesity in children is desirable to be able to monitor trends over time 
and to be able to compare levels between different populations.
The current recommended cut-offs to diagnose clinical obesity in the UK are as follows: 
children and adolescents with BMI > 85^  ^ percentile (equivalent to BMI-SDS > 1.04) 
are defined as overweight and BMI > 95^  ^ percentile (equivalent to BMI-SDS > 1.64) 
are defined as obese (Barlow and Dietz, 1998). In this thesis, these are the cut-offs used 
to define overweight and obesity. Table 2-1 summarises BMI cut-offs for children and 
adolescents from different references.
Table 2-1 BMI cut-offs for males and females from various references
Definition of overweight Definition of obese
lOTF Males: BMI-SDS >1.3 
Females BMI-SDS >1.19
Males: BMI-SDS > 2.37 
Females BMI-SDS >2.25
WHO BMI >85**^  percentile 
BMI SDS > 1.04
BMI > 95^ '^  percentile 
BMI SDS >1.64
Must et al (1991) BMI > 85^  ^percentile 
BMI SDS >1.04
BMI > 95^  ^percentile 
BMI SDS > 1.64
Barlow & Dietz (1998) BMI > 85‘^  percentile 
BMI SDS >1.04
BMI > 95^ *^  percentile 
BMI SDS >1.64
Cole et al (1995) BMI > 9U^  percentile BMI > 98^ "^  percentile
Abbreviations: BMI= body mass index; SDS= standard deviation score; IOTF= International Obesity 
Taskforce; WHO= World Health Organisation
International age and sex specific BMI percentile curves that at age 18 years pass through BMI cut-offs 
for adult overweight and obesity o f  25 and 30kg/m^ respectively
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2.4 Prevalence of obesity in children in the UK
There is a need to estimate the prevalence of obesity among children and adolescents in 
order to assess different preventive measures, monitor secular trends and identify high 
risk population groups.
A survey in the UK studying a total of 15,000 children aged 4 - 1 1  years found that 
there was little overall change in the prevalence of overweight or obesity (defined by 
lOTF) between 1974 and 1984 (Cole et al. 2000). Nevertheless from 1984 to 1994 
overweight substantially increased from 5.4% to 9% in boys, and 9.3% to 13.5% in 
girls; and obesity increased from 0.6% to 1.7% in boys and 1.3% to 2.6% in girls (data 
from White, English 4-11 year old children; overweight and obesity defined by lOTF) 
(Chinn and Rona, 2001). The Department of Health reported that between 1995 and
2004 the frequency of obesity (defined using national UK cut-offs) in children aged 2- 
15 years increased from 11% to 19% in boys and from 12% to 18% in girls (Health 
Survey for England, 2005). More recent data from the Health Survey for England in 
2006 suggest that obesity rates (defined using national UK cut-offs) in 2-15 year olds 
were 17% in boys and 15% in girls; a slight decrease from obesity rates reported in
2005 (Health Survey for England, 2008).
Figure 2-5 shows the prevalence of obesity amongst 2-15 year old children in the UK, 
between 1995 and 2006.
A representative cross-sectional survey measuring children aged 2 - 5  years, and 11-16 
years in 1977, 1987 and 1997 reported that waist circumference (WC) has increased 
over that period; particularly in girls (McCarthy et a l 2003; McCarthy et al. 2005). 
Trends in increased WC exceeded those in BMI.
These findings show that there has been a remarkable trend towards increased obesity, 
especially central obesity, in the UK. Even though the prevalence of obesity in children 
is still high, recent data suggest that these rates, especially in girls, are now slightly 
lower than five years ago but still much higher than a few decades ago.
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Figure 2-5 Prevalence of obesity among 2 - 15  year old children in England, 1984 to 
2006
Source: (Health Survey for England, 2005; Health Survey for England, 2008)
25
2.5 Consequences of obesity
Overweight and obesity during childhood and adolescence may have significant short­
term as well as long-term effects (Reilly et al. 2003). The following section discusses a 
few of the important consequences obesity has including cardiovascular problems, 
psychological effects, its impact on adult health and the costs of treating it.
2.5.1 Cardiovascular risk factors
There is a strong association between obesity and cardiovascular risk factors such as 
high blood pressure, dyslipidemia and insulin resistance (Reilly et al. 2003). In 2003, 
the British Heart Foundation estimated that in the UK around 5% and 6% of deaths 
from coronary heart disease in men and women respectively are due to obesity (defined 
as BMI > 30 kg/m^) (British Heart Foundation, 2004). Obese children tend to have 
significantly higher systolic and diastolic blood pressure, higher plasma triglycerides 
and lower HDL-cholesterol levels than non-obese children (Figueroa-Colon et al. 1997; 
Lauer et al. 1997; Reilly et al. 2003). Data from a longitudinal study in Muscantine 
showed that adult blood pressure was correlated with childhood blood pressure (Lauer 
et al. 1997). Similarly data from the Bogalusa study indicate that overweight 
adolescents are 8.5-fold more likely to have elevated blood pressure as adults compared 
with lean adolescents (Srinivasan et al. 1996). In addition, children who maintained a 
high blood pressure into adulthood were found to be taller, heavier and more obese 
compared to those who had lower blood pressure; indicating that the level at which 
blood pressure tracks during childhood is related to growth and obesity (Lauer et al. 
1984). One study found that over half of the subjects with persistent blood pressure 
elevations were obese (defined as BMI > 95^ percentile) during childhood (Rames et al. 
1978).
Insulin-resistance syndrome is developing in growing numbers of obese children. 
Acanthosis nigricans (AN), a skin disorder characterized by hyper-pigmentation or 
darkening of the skin, is a clinical marker that has been linked to surrogate markers of 
insulin resistance not only in adults but also in children and adolescents (Sinha and 
Schwartz, 2007). AN is most common in areas with body folds such as the neck and 
armpits (refer to Figure 2-6). Obese children with insulin resistance during childhood 
are at a greater risk of developing health problems during adulthood; indicating that 
obesity in childhood may cause complications in adulthood and is a risk factor for both
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child and adult diseases such as type II diabetes (Aggoun, 2007). Therefore there is a 
need for primary prevention early in life in order to avoid such complications in future.
Figure 2-6 Examples of acanthosis nigricans in the neck and armpits 
Source: (McMahon et al. 2004)
2.5.2 Psychological effects
Not only does obesity impact on physical health, it also impacts on mental health. 
Obese children are more likely to experience psychological or psychiatric problems, low 
self esteem and behavioural problems compared to non-obese children (Reilly et al. 
2003). For example, Strauss found that 34% of obese girls and 14% of obese boys had 
low self-esteem compared to only 8% and 9% of those who were not obese respectively 
(obesity defined as BMI > 95^ percentile) (Strauss, 2000). Furthermore, gender 
differences in general self esteem have been reported where overweight and obese girls 
have lower self-esteem than overweight and obese boys (Israel and Ivanova, 2002; 
Reilly et al. 2003). In addition, age was found to be associated with risk of 
psychological morbidity in those obese children; the risk increasing from childhood 
through adolescence (Reilly et al. 2003; Israel and Ivanova, 2002).
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2.5.3 Impact of childhood obesity on health in aduithood
The persistence of obesity present in childhood and adolescence into adulthood
represents another significant consequence of early obesity (Reilly et a l 2003). One 
study found approximately 85% of individuals who were obese in childhood, remained 
obese in adulthood (Must et a l 1992). Data from the Pels longitudinal study revealed 
that overweight or obese adults at the age of 35 years had significantly higher BMI 
values in childhood and adolescence compared to those who were not overweight or 
obese (Guo et a l 2002). In addition, childhood obesity seems to increase the risk of 
subsequent morbidity and mortality (Reilly et a l 2003; Gunnell et a l 1998). In a 
cohort from the Boyd Orr study in Britain, children who had a BMI > 75^ percentile 
had twice the risk of death from heart disease compared to those whose BMI was 
between the 25^ and 49^ percentiles (Gunnell et a l 1998). In a meta-analysis 
reviewing longitudinal studies that examined the risk of becoming an obese adult, the 
proportion of obese children who became obese adults ranged from 26 - 41% for pre­
school children and 42 - 63% for school aged children (Serdula et a l 1993).
Most of the available evidence on the persistence of childhood obesity was based on 
older studies when the prevalence of obesity was much lower. Therefore the magnitude 
of the consequences of childhood obesity is likely to be much greater now following the 
epidemic of childhood obesity.
2.5.4 Cost
Because of the rise in the prevalence of obesity and the consequences obesity brings to 
health both physically and mentally, the costs associated with obesity have become an 
extremely important public health issue. In 2006, according to the WHO, obesity 
accounted for 2 - 6% of total health care costs in many developed countries (World 
Health Organization, 2006). The true costs would probably be much greater as not all 
obesity-related conditions were included in the calculations.
The National Audit Office estimated that the cost of treating obesity in England in 1998 
was 9.5 million pounds, and in 2002 this figure increased to 45.8-49 million pounds. 
The estimated total costs of treating obesity and its consequences in England in 1998, 
including indirect costs such as loss of earnings due to sickness, was 2.1 billion pounds 
(British Heart Foundation, 2004). England’s chief medical officer reported that the
28
direct cost of obesity to the NHS in 2003 was 0.5 billion pounds, while the indirect cost 
to the UK economy was at least 2 billion pounds (Vlad, 2003). This shows that the 
financial burden of obesity has increased drastically over the past decade and this trend 
is continuing to increase.
2.6 Aetiology of obesity
There is considerable debate around possible mechanisms underlying the increasing 
prevalence of overweight and obesity amongst children and adolescents. Determining 
the causes of obesity is important in order to find solutions for tackling it. Obesity is a 
multi-factorial disease; in that there is no single factor that can explain its aetiology. 
Many genetic, medical and environmental factors have been reported to contribute to 
the incidence of obesity. These will be discussed separately below.
2.6.1 Medical conditions
Obesity can develop due to a number of specific medical disorders. These include 
hormonal disorders such as hypothyroidism, hyper-cortisolism and hyper-insulinism 
and leptin deficiency (Zametkin et al. 2004; Montague et al. 1997). These disorders 
can increase the likelihood of the child becoming obese. However, such conditions are a 
relatively rare cause of childhood obesity; in that less than 10% of obese children are 
thought to be affected (Moran, 1999).
Other medical effects that can increase the child’s likelihood of developing obesity start 
before the child is bom i.e. during the fetal period. The quality of the environment 
during which the offspring is developing may lead to adverse effects on the child’s 
health in future (Wells, 2007). This may occur when the offspring is exposed to 
different factors during pregnancy such as toxins (through maternal smoking) and poor 
metabolic control (through gestational diabetes). It has been reported that offspring of 
mothers with gestational diabetes are 50% more likely to become obese children (Styne, 
2001).
2.6.2 Genetic factors
It is well known that genetic factors contribute to the development of obesity. However 
there is inconsistency between studies regarding the variability in adiposity that is 
inherited due to genes rather than derived from environmental factors.
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There is increasing evidence that there is a relationship between the weight status of 
parents and their offspring. Children from families in which one or both parents are 
overweight or obese were found to have a substantially higher risk of becoming obese 
than did children whose parents are not overweight or obese (Lake et a l 1997). Data 
from the Health Survey for England showed that when both parents were classified as 
obese or overweight, around 20% of children aged 2 - 1 9  years were obese compared 
with just 7% of children where neither of the parents was obese or overweight (Jotangia 
et a l 2005). Similarly, in a retrospective cohort study, it was reported that parental 
obesity more than doubles the risk of adult obesity among both obese and non-obese 
children below 10 years of age (Whitaker et a l 1997). Some studies found a stronger 
correlation between child and parental BMI in mother and child compared to father and 
child (Wada and Ueda, 1990; Sorensen et a l 1992; Lake et a l 1997); whilst other 
studies found no such relationship (Ayatollahi, 1992). A possible reason for the 
differences in findings is the inadequacy of self-reported parental weight and height 
data.
The limitation in investigating the relationship between parental fatness and childhood 
fatness is that similarity in fatness may not only be due to genes but could also be due to 
inherited lifestyle behaviours. It could also be that environmental factors affect the 
expression of certain genes which could alter the susceptibility to obesity (Dolinoy et a l
2006) Therefore, adoption and twin studies are better for predicting genetic influences 
on fatness because they have greater capacity to differentiate between genetic and 
environmental effects.
Twin studies suggest that at least 25% of the tendency to become overweight or obese is 
inherited (Bouchard, 1991). Brook and colleagues (1975) measured skin-fold 
thicknesses in a group of twins aged 3 - 1 5  years (Brook et a l 1975). They found that 
heritability was higher in children over the age of 10 years; whereas environmental 
factors exerted a stronger effect on fatness in the younger group of children. A plausible 
reason for this stronger effect is that children over 10 years are able to make their own 
decisions and they are more likely to be affected by their peers and other surrounding 
lifestyle behaviours, which in turn may influence their responses to diet and physical 
activity and allow genetic effects to emerge.
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Several adoption studies explored the contributions of genetic factors and family 
environment to human fatness by assessing adoptees, their biological mothers and 
fathers and their adoptive mothers and fathers (Sorensen et al. 1992; Stunkard et a l 
1986; Vogler et al. 1995). Their results showed a strong relation between the weight 
and BMI of the adoptees and their biological parents. However no relation was found 
when the adoptee’s weight and BMI were compared against those of adoptive parents. 
This represents strong evidence for genetic effects; whereas no apparent effect of the 
family environment was revealed.
2.6.3 Environmental factors
Obesity develops when a disruption to the energy balance equation occurs. Based on the 
law of thermodynamics, obesity develops when energy intake (amount of food and 
drink consumed measured in calories or kilojoules) exceeds energy expenditure (energy 
used for physical activity and other metabolic processes in the body) (Helmholtz, 1847). 
The body is said to be in an ‘energy positive state’ and this extra energy tends to be 
stored in the body as fat. There are multiple factors influencing this imbalance; however 
diet and physical activity seem to play a major role in the rising prevalence of obesity.
It has been hypothesized that there is an association between dietary composition and 
body fat percentage. Tucker and colleagues (1997) examined the relationship between 
diet composition and adiposity in a large sample of children (Tucker et al. 1997). They 
found that total energy intake and dietary fat intake were positively related to obesity 
independent of gender, physical activity and parental BMI. Similar findings were 
observed in Maffeis and colleague’s study (1996) whereby obese children were found to 
have higher intakes of fat than non-obese children, and this increased fat intake was 
assumed to be responsible for the increased fat mass (Maffeis et al. 1996a).
Between 2001 and 2004, British children aged 5 - 1 5  years ate less than half the 
recommended portions of fruits and vegetables a day (Health Survey for England,
2005). The Health Survey for England showed that the proportion of adults that 
consumed more than five portions a day of fruits and vegetables between 2001 and 
2004 has increased by around 2%; however no changes were observed in the mean 
number of portions of fruits and vegetables consumed by children (Health Survey for 
England, 2005). In addition, no significant differences in the levels of obesity were 
observed between children who consumed different numbers of portions of fruits and
31
vegetables a day (Jotangia et al. 2005). However, between 2005 and 2006, there was a 
significant increase in the consumption of fruits and vegetables among children aged 5 - 
15 years; girls were more likely than boys to consume five or more portions of fruits 
and vegetables (Health Survey for England, 2008). At the same time, the prevalence of 
obesity in children between 2005 and 2006 decreased. Caution is advised when 
interpreting results obtained from questions involving food consumption. Since parents 
of obese children are more likely to be overweight or obese themselves, portion sizes 
may be underestimated and ‘good food’ consumption over-reported whilst consumption 
of ‘bad foods’ may be under-reported (Schoeller et al. 1990).
The rising prevalence of obesity has also been linked in part to the increased 
consumption of high sugar drinks (Health Survey for England, 2005). These drinks 
provide little or no nutritional value beyond energy, and they provide a large amount of 
added sugars in children’s diets. There is evidence that children who consume sugar- 
sweetened beverages regularly between the ages of 2 and 5 are three times more likely 
to be overweight compared to non-consuming children (Dubois et al. 2007; Welsh et 
al. 2005). In a prospective analysis, Ludwig and colleagues (2001) found that for each 
additional serving of sugar-sweetened drink consumed in children (average age of 12 
years), both BMI and the odds of becoming obese increased by approximately 0.24 
kg/m^ over the follow-up of 19 months, after adjusting for dietary and lifestyle factors 
(Ludwig et al. 2001).
Over the past two decades, there has been a remarkable increase in portion size of foods 
paralleling the rising obesity epidemic, which suggests that large portion sizes may play 
a role in the increase of body weight amongst children and adolescents. Items at fast 
food chains are 2 - 5 times larger now than 20 years ago. Studies have shown that when 
children were provided with larger portions, they ate more (McConahy et al. 2002).
It is widely believed that reduced physical activity and increasing sedentary behaviour is 
implicated in the aetiology of childhood obesity (Reilly and Dorosty, 1999; Reilly et al.
2003). Even though the prevalence of obesity in children increased between 2002 and 
2006, physical activity levels (i.e. number of hours of activity; assessed using 
questionnaires) in British boys and girls did not change significantly (Health Survey for 
England, 2008). However, there was a tendency for obesity rates to rise inversely in 
association with children’s level of physical activity; obesity rates in children aged 2-11
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years were 14.8% versus 17.4% in highly active versus sedentary respectively (Health 
Survey for England, 2005).
A review by Spear and colleagues in 2007 reported inconsistent findings on the 
association of physical activity and BMI in children and adolescents (Spear et a l
2007). The lack of validated questionnaires to assess activity levels accurately makes it 
difficult to interpret and compare results from different studies. Also, the majority of 
studies used BMI to assess adiposity. BMI however does not give separate information 
on fat and lean mass, and physical activity promotes the growth of lean tissue (Torun 
and Viteri, 1994); this can therefore be overlooked when indices such as BMI are used 
to assess adiposity levels.
There is increasing evidence that watching television in childhood is an important 
contributing factor to the current cause of childhood obesity. In a longitudinal study 
assessing the impact of childhood television viewing on BMI, watching television was 
significantly associated with increased BMI (Hancox and Poulton, 2006). This 
association tended to be stronger in girls, particularly during adolescence, than in boys. 
A similar longitudinal study showed that each additional hour of television watched on 
weekends at five years of age increased the risk of developing obesity in adulthood by 
around 7% (Viner and Cole, 2005). The Framingham Children’s Study showed that by 
age 11, children who watched 3 hours or more of television per day had increased body 
fat compared with those who watched less that 1.75 hours per day (Proctor et a l 2003).
It can be argued that the time one spends television viewing displaces the time one can 
be physically active instead. Moreover, those that view television are exposed to food 
advertising which may encourage unhealthy eating behaviours such as snacking and 
oversized meals. Salmon et al (2006) showed that children who watched television for 
more than two hours a day were more likely to have high energy drinks and snacks, and 
less likely to have fruit compared to those who watched less than two hours of 
television a day (Salmon et a l 2006). A potential limitation of such studies is that they 
rely on the parents’ and children’s reporting of diet and physical activity.
The obesity epidemic has also been accompanied by a parallel trend in sleep deprivation 
(Patel and Hu, 2008). Whereas dietary intake and level of physical activity each alter 
one side of the energy balance equation, recent research suggest that sleep alters both
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sides of this energy equation therefore affecting energy balance more strongly (Taheri,
2006). A systematic review on sleep duration and weight gain in adults and children 
supported the evidence that short sleep duration is strongly associated with increased 
weight and obesity risk; the relationship weakened with age (Patel and Hu, 2008). In 
obese children, short sleep duration was also found to be associated with greater insulin 
resistance and impaired glucose tolerance compared to obese children with normal sleep 
duration (Flint et al. 2007). Several mechanisms linking short sleep duration with 
obesity have been suggested. These include increased energy intake due to altered 
hormone levels, reduced physical activity levels due to being tired, decreased body 
temperature impacting energy expenditure through thermo-regulation and altered 
hormones such as cortisol predisposing to insulin resistance (Flint et al. 2007; Patel and 
Hu, 2008; Taheri, 2006).
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2.7 Factors associated with obesity
2.7.1 Socio-economic status (SES)
Recently, increased evidence for the influence of SES on later fatness in children has 
been found (Stamatakis et al. 2005). SES is often measured using one of three 
indicators: income, education or occupational status; the latter being the most 
commonly used marker of SES in adults. In children parental SES is used as an 
indicator of children’s SES.
The Health Survey for England reported that the levels of obesity in children aged 2-11 
years were highest among those with lower social class (17.1%) compared to those with 
parents in managerial or professional occupations (12.1%) (Health Survey for England,
2005). A British birth cohort followed up from birth to 43 years showed that lower 
childhood social class was associated with increased BMI in adult life (Hardy et al.
2000). In another cohort investigating the rate of childhood obesity in 5 -  11 year old 
children in Plymouth, the prevalence of obesity was higher in those of lower SES (Kinra 
et al. 2000b). This was also observed in other Western countries (Wardle and Griffith, 
2001; Wardle et al. 2002; Laitinen et al. 2001; Stamatakis et al. 2005; Kinra et al. 
2000a). In Finland for example, data from the 1966 birth cohort showed that the 
family’s social class during childhood had a long-term influence on BMI; where obesity 
was found to be most common in the lowest social class group (Laitinen et al. 2001).
Gender differences in the effect of social class on fatness were also observed. Higher 
occupational status was associated with a lower risk of obesity in women, but not in 
men (Wardle et al. 2002; Langenberg et al. 2003). Lower social class occupations, 
such as manual occupations, tend to be more physically demanding especially for men. 
This higher level of physical activity might be partly responsible for the prevention of 
overweight and obesity risk in lower SES occupations among men compared to women.
Different attitudes and practices relative to weight control might be a possible factor 
contributing to SES differences in fatness. It has been found that those from lower SES 
are less likely to feel overweight and so are less likely to try to control their weight 
compared to those from higher SES group who are more likely to perceive themselves 
as overweight (Wardle and Griffith, 2001). The role of stigma associated with 
overweight and obesity, and discrimination against people who are overweight or obese.
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especially in the higher SES group of people, may be another reason why those from 
higher SES have lower risk of obesity. Higher SES individuals place greater emphasis 
on healthy weight and are more rejecting of overweight, particularly women, and show 
higher levels of dieting (Gortmaker et a l 1993). These differences may account for the 
results obtained.
2.7.2 Birth weight
A high birth weight has been associated with an increased risk of later obesity 
(measured by BMI) (Dietz, 1994; Parsons et a l 1999). However, there is evidence that 
a high birth weight programs lower susceptibility to cardiovascular disease (Barker et 
al 1993; Barker, 1995). Since BMI is strongly correlated with both fat and lean mass, 
the high birth weight might be due to increased lean mass rather than fat mass. On the 
other hand, low birth weight is associated with programming of greater abdominal or 
central fat. Malina and colleagues (1996) reported that as birth weight decreased, more 
subcutaneous fat (measured using skin-fold thickness) was accumulated within the 
trunk than within the extremities, especially in girls (Malina et a l 1996). Similar 
observations were reported by Koziel and Jankowska (2002) who found that 14 year old 
girls with low birth weight accumulated increased abdominal fat (assessed using waist- 
hip ratio) (Koziel and Jankowska, 2002). A suggested reason for this is that babies who 
have low birth weight lack muscle and so will have a high ratio of fat to lean mass if 
they become overweight or obese in the future; thus increasing the risk of coronary 
heart disease. Conversely, a high BMI associated with a high birth weight may reflect 
increased lean tissue.
Studies have shown inconsistent relationships between birth weight and body 
composition in later life. Singhal and colleagues (2003) showed that a high birth weight 
was associated with greater PPM but not with greater PM (assessed using skin-fold 
measurements) in children and adolescents aged 13-16 years; an increase in 1 SD score 
of birth weight was significantly associated with an increase in 0.9-1.4 kg (2 -3%) of 
lean mass (Singhal et a l 2003). Similar findings were observed in the New Delhi birth 
cohort where birth weight was strongly correlated with adult lean mass (assessed using 
skin-fold thickness) (Sachdev et a l 2005). Their study however showed a gender 
difference where higher birth weight only in females was also related to increased 
adiposity. A similar sex difference was also observed in the Guatemalan Longitudinal 
Study where the effect of growth during early childhood on adult fatness (predicted
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using equations from hydrostatic weighing) was much greater in women than in men (Li 
et a l 2003). Eriksson and colleagues (2001) observed a positive correlation between 
birth weight and later obesity (defined as BMI > 30 kg/m^); however this association 
was only significant among males (Eriksson et al. 2001). A possible reason behind the 
differences in outcomes between the studies might be due to the different methods used 
to assess obesity; Eriksson relied only on BMI whilst the others used skin-fold 
measurements and circumferences as well.
2.7.3 Gastro-intestinal bacteria
Very recent research suggests that there might be a link between obesity and the type 
and proportion of bacteria in the digestive tract. The human gut is predominantly 
composed of two types of beneficial bacteria: the Bacteroidetes and the Firmicutes. A 
study in mice showed that the introduction of certain gut microbiota from normal mice 
into germ-free mice produced a rapid increase in body fat despite a reduction in food 
consumption (Backhed et a l 2004). In humans, Ley and colleagues (2006) showed that 
the relative proportion of the Bacteroidetes is decreased in obese compared to leaner 
people, and this proportion increased after weight-loss (Ley et al. 2006). This indicates 
that manipulation of bacteria in the gut could be another approach in the treatment of 
obesity. However, more research is needed before this can be confirmed.
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2.8 The biology of obesity
Using a simplistic approach, obesity is fundamentally a result of a problem with energy 
balance: when energy intake is in excess of energy expenditure, the difference in input 
and output results in changes in fat stores (Helmholtz, 1847). 
However, not only does obesity encompasses mechanisms of energy balance, it is a 
multidimensional condition which also includes a biological basis for the development 
of obesity such as the contribution of genes, appetite and physiological adaptations 
(Trayhum, 2005). This makes the basis of treatment strategies of obesity extremely 
difficult. Figure 2-7 summarises the different factors that may affect the energy balance 
equation, therefore affecting body composition; hence offering various targets for 
treatment. Even though other factors are associated with childhood obesity (as described 
previously), for the purpose of this thesis, I will focus on diet, activity, drugs, and 
behaviour.
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Figure 2-7 The mechanisms affecting energy intake and energy expenditure and the point of impact of different treatments.
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2.9 Treatment of obesity
Uncertainty over the exact aetiology of obesity remains one of the chief barriers to 
designing effective strategies for its prevention and treatment. Because obesity is a 
multi-factorial condition, numerous treatment strategies have been attempted. These 
include weight loss programmes based on dietary restriction, exercise, behaviour 
modification, pharmacotherapy or a combination of these approaches.
2.9.1 Diet
It is important that a child has a healthy diet as this is a crucial period for growth and 
bone development. Experts do not recommend that moderately overweight or obese 
children are put on a restricted diet to lose weight; instead it is recommended that they 
maintain their weight and try to grow into it (Lobstein et al. 2004). Changing unhealthy 
eating habits is recommended, not only to the overweight and obese but to all children 
irrespective of their weight. However, weight loss is recommended in extremely 
severely obese cases such as children with congenital leptin deficiency whereby 
treatment with leptin results in decreased energy intake and hence weight reduction 
(Farooqi et al. 1999).
In view of the evidence on various aspects of diet in relation to the risk of overweight 
and obesity, it is encouraged that young children limit their intake of sugar sweetened 
beverages, by consuming mineral water instead. It has also been recommended by 
nutritionists and dieticians that parents watch the portion size they give their children 
during meal times, and to limit eating out. The energy density of foods is another 
variable that can affect food intake. Energy density simply refers to the amount of 
energy in food per unit weight (kilojoules per gram). Water increases the weight of food 
but not energy density, whereas fat increases the energy density more than carbohydrate 
and protein. Foods that are high in energy density have been shown to increase total 
energy intake while foods that are low in energy density decrease energy intake (Ello- 
Martin et al. 2005). Therefore one strategy to reduce energy intake is to provide 
children with low-energy dense foods such as fruits and vegetables.
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2.9.2 Activity
‘Lack of physical activity is a major underlying cause of death, disease and disability, 
and is one of the ten leading global causes of death and disability’ (World Health 
Organization, 2002).
Physical activity is the only readily modifiable component of the energy expenditure 
component of the energy balance equation. Consequently, increasing physical activity 
has the potential to improve weight loss and maintenance. Not only does physical 
activity play a role in preventing or reducing weight gain, it has also been shown to 
improve insulin sensitivity and promote the growth of lean tissue and increase bone 
strength in young adolescents (Carrel et al. 2005).
The time and intensity of physical activity has been shown to correlate with a reduction 
in fat level in children and adolescents. In a large cross sectional study of 9 -10 year old 
European children, Ekelund and colleagues (2004) reported that those who spent less 
than one hour of physical activity a day were significantly fatter (measured by skin-fold 
thickness) than those who were active more than two hours a day (Ekelund et a l 2004). 
A systematic review of controlled trials of interventions to prevent childhood obesity 
and overweight concluded that trials involving compulsory rather than voluntary 
physical aerobic activity were more effective in reducing adiposity in children 
(Connelly er a/. 2007).
Accurate measurement of physical activity is difficult, some researchers relying on self- 
reported data from parents or children whilst others use activity monitors. Also, studies 
might be limited in the methods used to assess body composition. This makes 
comparisons between studies difficult, and data concerning the relative and absolute 
contribution of sedentary behaviour to obesity are difficult to interpret.
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2.9.3 Psychological management
A systematic review conducted by McLean and colleagues (2003) suggested that weight 
loss interventions targeting food intake and physical activity might be more effective if 
they incorporate a psychological and educational approach (McLean et al. 2003). Also, 
there has been substantial research on whether to involve family members in the 
treatment programme. Inconsistent findings were reported, however a recent meta­
analysis of family based behavioural programs for children indicated that including the 
parents in the treatment of childhood obesity may be more beneficial than treating the 
child alone (Young et al. 2007). Such benefits may be due to parents having more 
control over the purchase of food and its preparation, and their lifestyle behaviour, 
consequently affecting the child’s behavioural choices and level of physical activity.
A number of studies investigating the effectiveness of treating childhood obesity with 
behavioural management have been conducted. I have chosen to discuss only the recent 
few that were either randomised control trials (RCT) or those that used the traffic light 
diet (a family-based behavioural program). These are summarised in Table 2-2.
A two year family based behavioural program based on the traffic light diet was 
conducted on obese children (mean age 13 years) in China (obesity defined as weight- 
for-height > 120% of Chinese reference) (Jiang et al. 2005). Children were randomised 
to either a treatment group (n = 33) or a control group (n = 35); whereby children were 
assessed every six months using conventional weight and height measurements. At the 
end of the program, those in the treatment arm had a significant reduction in BMI and 
BMI SDS compared to the control arm; BMI reduction of 2.6 kg/m^ versus 0.1 kg/m^, 
and BMI-SDS reduction of approximately 1.8 versus 0.5 SDS in the treatment arm 
versus the control arm respectively. The programme was successful in decreasing the 
degree of obesity.
Similarly, a 10 week behavioural trial in the US investigated the effect of the traffic 
light program on obese children (obesity defined by CDC cut-offs) compared to those 
that had usual clinic treatment (Johnston and Steele, 2007). At the end of the trial, those 
on the program demonstrated significantly greater reduction in BMI SDS compared to 
controls.
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A one year RCT compared the effects of the ‘Bright Bodies’ family behavioural 
treatment in a group of 8-16 year old obese children (obesity defined as BMI > 95^ 
percentile based on the CDC growth chart) (Savoye et al. 2007). Families met biweekly 
the first six months, and bimonthly after; also incorporating a session of exercise in the 
program. At the end of the trial, Bright Bodies was found to significantly decrease BMI 
and % fat (assessed by a bio-electrical impedance device: TANITA TBF-300) in the 
treatment group whilst significantly increasing these parameters in the control group; 
the treatment group (n = 75) significantly lost an average of 4% body fat and 1.7 kg/m^ 
BMI whereas the control group (n = 44) significantly gained an average of 2% body fat 
and 1.6 kg/m^ BMI.
In a one year family behavioural treatment in Spain, obese children (% BMI > 120%) 
significantly lost 0.67 BMI SDS after six months and maintained this loss at one year 
follow-up (Bermudez de la Vega et al. 2007). There were no controls in this study; 
therefore conclusions drawn from this study may not be reliable.
A 12 week RCT LEAP (live, eat and play) behavioural trial in Australia investigated the 
effect of a 12 week program on overweight and obese (lOTF cut-off) children aged 
between 5 - 1 0  years (McCallum et al. 2007). The family attended four consultations 
with their GP where they were provided with information targeting healthier lifestyle 
goals. No significant reduction in BMI was observed between the treatment and control 
groups at follow-up.
Differences in outcome between the different studies may be due to the participants 
differing in relation to ethnicity, sample size, the criteria used to define obesity, and the 
method and duration of the treatment programme. The majority of the studies used 
conventional BMI to assess the effectiveness of the programme. BMI cannot 
differentiate between the fat and lean component of total body weight. For this reason, 
the results obtained and conclusions drawn should be interpreted with caution especially 
when exercise is incorporated into the programme. Therefore, there is a need to assess 
body composition in more detail before any judgments on the success of behavioural 
programmes can be concluded.
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Author
country
year
Inclusion/Exclusion Age
(years)
Sam ple size Duration Follow-up M easures Results
Johnston & Steele
US
2007
BMI > 85^ percentile 
CDC cut-off
6 - 1 8 treatment n = 41 
control n = 41
10 weeks NO W T & H T BMI SDS decreased significantly more in 
treatment versus controls, but by an 
unspecified magnitude (p<0.05)
McCallum et al 
Australia 2007
BMI SDS > 3 excluded 
lOTF cut-off
5 - 10 treatment n = 82 
control n= 81
12 weeks 9 months 
15 months
W T & H T 9m onths (BM I SDS):
Treatment changed from 2.0 to 1.96 
Controls changed from 1 9  to 1.93 
Treatment-control = 0.04 (p -  0.6) 
15 m onths (BM I SDS):
Treatment did not change 
Controls changed from 1.9 to 1.92 
Treatment-control = 0.08 (p =  0.4)
Savoye et al
US
2007
BMI > 95**’ percentile 
CDC cut-off
8 - 1 6 treatment n = 44 
control n= 75
1 year 6 months 
12 months
W T & H T  
% fat (by 
TANITA- 
300)
6 m onths (% fat):
Treatment lost 3.2% fat 
Controls gained 2% fat. 
Treatment-control= 5.2% (p < 0.001) 
12 m onths  (% fat):
Treatment lost 4% fat
Controls gained 6% fat
Treatment -control 6.0% (p < 0.001)
Bermudez et al
Spain
2007
weight-for-height > 120% 
(Spanish reference)
6 - 1 3 treatment n = 50 
no control
1 year 6 months 
12 months
W T & H T 6 months:
BMI SDS changed from 4.77 to 4.13
(p=0.002)
/  vear: no significant further change
Jiang et al
China
2005
weight-for-height >120%  
(Chinese reference)
13 treatment n = 33 
control n = 35
2 years every 6 
months for 2 
years
W T & H T At 2 years BM I SDS:
Treatment: changed from 4 to 2.2 
Control: changed from 4 to 3.5 
Treatment -control = 1.3 to < 0.0011
A bbreviations:
obesity task force
number per group; BM I= body mass index; CDC= centre for disease control; SDS= standard deviation score, WT= weight; HT= height; IOTF= international
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2.9.4 Drug therapy
Some drugs are used in the management of obesity in adults, however great care should 
be taken when anti-obesity medications are used in children. It should not be assumed 
that the risks and benefits associated with drugs used in adults are the same in children 
and adolescents. Most of these drugs have not yet been adequately studied with respect 
to efficacy, safety and long-term effects in children and adolescents. At present, there 
are only a few drugs approved by the Food and Drug Administration (FDA) for the 
treatment of adult obesity; these include Orlistat (Xenical, Roche) and Sibutramine 
(Meridia, Abbott Laboratories). Other drugs such as Rimonobant (Acconplia) and 
Metformin (Glucophage) are usually recommended for obese patients with high insulin 
levels or at risk of developing diabetes. All drugs are usually prescribed in combination 
with a program of diet, exercise and behaviour modification. A summary of the drugs, 
the mechanisms by which they function, their side effects and evidence in obese 
children and adolescents is shown in Table 2-3.
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2.9.4.1 Orlistat
Orlistat is a gastric and pancreatic lipase inhibitor that works by binding to 
gastrointestinal lipases causing a partial inhibition of fat absorption from the gut. It has 
been shown to reduce the absorption of dietary fat by approximately 30% in adults (Zhi 
et al. 1994), and approximately 27% in obese adolescents (Zhi et a l 2003); whereby 
ingested fat is excreted in the faeces. Orlistat is usually given at the standard dose of 
120 mg three times daily taken before meals. Major adverse side effects that have been 
previously reported in those taking Orlistat are predominantly gastrointestinal and 
include increased defecations and increased incidence of fatty or oily stools. These 
effects have limited their usefulness in almost one in three adolescents (Ozkan et a l
2004).
In adults, 6 months of Orlistat treatment was shown to produce significant weight loss: 
4.2%, 5.5% 6.2% in obese patients with type II diabetes, hyper-cholesterolaemia and 
hypertension respectively (Guy-Grand et al 2004). Similar results were also observed 
when obese adolescents were treated with Orlistat; mean decreases in weight, BMI and 
waist circumference which were highly correlated with a decrease in FM (assessed by 
DXA or ADP) (Chanoine et a l 2005; Chanoine et a l 2005; McDuffie et a l  2002b). 
Only one pilot study by Norgren and colleagues (2003) investigated the effects of 
Orlistat treatment in obese pre-pubertal children (Norgren et a l 2003). They found that 
12 weeks of taking Orlistat caused a weight-loss of approximately 4 kg and was highly 
correlated with a decrease in fat mass (assessed by DXA), with no major negative side- 
effects reported.
Orlistat not only affects body weight and body composition, but has also been shown to 
have some effects on blood lipid and glucose measurements. It significantly decreases 
low density lipoprotein cholesterol concentrations, lowers leptin concentrations and 
improves indicators of glycémie control, decreasing fasting glucose and insulin levels in 
adults (Hsieh et al. 2005; Guy-Grand et al. 2004) and adolescents (Chanoine et al. 
2005; McDuffie et al. 2002b). Therefore, Orlistat appears to have anti-diabetic and 
anti-atherogenic properties and may help prevent risk factors for the metabolic 
syndrome in people who are overweight and obese.
46
Since Orlistat limits fat absorption, it is necessary to determine whether deficiencies of 
mineral and fat soluble vitamins occur due to treatment. Previous studies showed no 
significant changes in serum levels of vitamins A, E and K between those on treatment 
compared to those on placebo; however impairments of vitamin D absorption were 
found in both adults and adolescents (Chanoine et al. 2005; McDuffie et al. 2002a). 
This can cause problems in terms of bone formation; particularly in adolescents and 
children who are still growing. No changes in bone mass or density were seen after one 
year treatment with Orlistat apart from those explained from the weight loss itself in 
adults (Gotfredsen et al. 2001) and children (Chanoine et al. 2005). Moreover, it has 
been demonstrated that no significant effects on mineral absorption or mineral balance 
were observed in those on Orlistat treatment (Zhi et al. 2003). Nevertheless, it remains 
unknown whether there would be any significant effects on bone formation with long­
term use of Orlistat.
2.9.4.2 Sibutramine
Sibutramine is a serotonin nor-epinephrine reuptake inhibitor which causes a centrally 
mediated increase in satiety (feeling of fullness) and energy expenditure. It is usually 
given at a low dose at the start of treatment (5 mg/day) and increases gradually to 15 
mg/day; taken as one single dose in the morning. Adverse effects that have been 
previously reported in those taking Sibutramine include increased blood pressure and 
heart palpitations in both adults (Wadden et al. 2005) and adolescents (Berkowitz et al. 
2003).
Several studies have shown that Sibutramine used in combination with an appropriate 
diet and exercise program in obese adults is effective in terms of weight maintenance 
and reduction. Mathus-Vliegen (2005) showed that weight loss was more effectively 
maintained in adult obese patients using Sibutramine compared to those only on low 
calorie diets (Mathus-Vliegen, 2005). Similarly, Wadden and colleagues (2005) showed 
that those on combined therapy of Sibutramine plus diet and exercise over one year 
showed a weight loss of 12.1 ± 9.8 kg, whereas those treated by lifestyle modification 
alone lost only 6.7 ± 7.9 kg (Wadden et al. 2005).
Similar to studies of adults, the addition of Sibutramine with a behavioural program 
induced significantly greater weight loss in obese adolescents compared with those on 
placebo (Berkowitz et al. 2003). They also reported significant reductions in hunger.
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Moreover, high-density lipoprotein cholesterol increased by around 8% in the 
Sibutramine group; which suggests a reduced risk of developing insulin resistance, heart 
disease and type II diabetes mellitus. In a large randomised multi-centre European 
study (STORM trial) of weight loss and long-term weight maintenance in a group of 
obese people aged 1 7 - 6 5  years, the Sibutramine-treated group continuously had 
significantly lower body weight compared to the placebo-treated group, and weight 
maintenance was positively influenced by continued Sibutramine treatment (van Baak et 
al. 2003).
2.9.4.3 Metformin
Metformin, a dimethyl biguanide, acts by suppression of endogenous glucose 
production in the liver, but may also have an insulin sensitising effect in peripheral 
tissues through an effect on the key intracellular enzyme AMP kinase (Hundal and 
Inzucchi, 2003). It is usually prescribed at a starting dose of 500 mg/day and then 
increased up to 1,000 mg/day for those weighing < 50 kg, 1,500 mg/day for those 
weighing 50 - 75 kg and 2,000 mg/day for those weighing > 75 kg. Metformin is 
generally taken with meals to minimise gastrointestinal side effects such as abdominal 
pain, nausea, vomiting and diarrhoea.
Metformin has been traditionally used as an anti-diabetic agent to reduce hyper- 
insulinaemia and hyperglycaemia in adults with type II diabetes mellitus. It has also 
been effective in reducing weight gain in tightly treated type II diabetes. One 
randomised clinical trial showed that type II diabetic patients taking Metformin for 6 
weeks showed a reduction in insulin requirements and improvements in glycémie 
control with no weight gain (Janssen et al. 1991). Jones and colleagues (2002) 
conducted a multi-centre double-blind placebo controlled trial whereby paediatric 
patients with type II diabetes were randomised to take Metformin or placebo for one 
year (Jones et al. 2002). Similar to the trial by Janssen and colleagues (1991), they 
reported improved glycémie control in the Metformin group; mean glycosylated 
haemoglobin (HbAlc) was significantly lower in the Metformin group compared with 
placebo (7.5% versus 8.6%), indicating a reduction in blood glucose levels.
Metformin has also been used in adjunct to insulin therapy in patients with type I 
diabetes. In adolescents, two short-term randomised controlled trials have investigated 
the effectiveness of Metformin on insulin sensitivity and metabolic control in type I 
diabetes. Hamilton and colleagues (2003) reported that in 27 adolescents treated for
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three months, Metformin in addition to insulin resulted in minimal reduction in fasting 
glucose but a significant reduction in BMI compared with placebo (Hamilton et al.
2003). Similarly, Samblad and colleagues (2003) reported that 26 adolescents treated 
with metformin for 3 months showed improved HbAlc and insulin-induced glucose 
uptake compared with controls; no significant changes in BMI, weight and waist 
circumference were observed (Samblad et al. 2003). Both trials demonstrated that 
Metformin improves metabolic control and Metformin was generally well tolerated in 
adolescents with type I diabetes.
Metformin seems to have positive effects on patients with diabetes; however it may also 
be used in obese non-diabetics to help lose weight. Paolisso et al (1998) found that 
administration of Metformin for 15 days reduced food intake, body weight and body fat 
in a group of obese adults (Paolisso et al. 1998). The weight loss effect has also been 
confirmed in the BIGPRO study whereby administration of Metformin for one year 
induced a significant weight loss and a reduction in blood glucose and plasma insulin 
levels in a group of obese middle-aged subjects (Fontbonne et al. 1996). Giving 
Metformin to obese adolescents with family history of type 2 diabetes caused similar 
effects (Freemark and Bursey, 2001; Kay et al. 2001). Those on Metformin showed a 
significant reduction in plasma leptin levels and weight loss which was primarily due to 
fat (assessed by using bio-electrical impedance).
2.9.4.4 Rimonabant
Rimonabant (Acomplia) is currently recommended for adult obese patients with a risk 
of developing diabetes or cardiovascular disease. It was first developed when scientists 
noticed that cannabis smokers experienced an increase in appetite, and worked on the 
idea of blocking cannabinoid receptors in the brain to reduce the increase in appetite. 
The drug was approved by the FDA in 2006, however due to its side effect of severe 
depression; there has been extreme caution in prescribing it. Other reported side effects 
include mood disorders, anxiety, nausea and dizziness (Despres et al. 2005; Scheen et 
al. 2006). Rimonabant is usually taken as a daily dose of 20 mg in the morning.
Rimonabant works by blocking receptors in the part of the brain that regulate food 
intake and the body's ability to break down sugars and fats in the blood, therefore acting 
on the central nervous system to decrease appetite and on the gastrointestinal tract to
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diminish fat absorption. It mimics the effects of both Orlistat and Sibutramine by acting 
on both the central and peripheral systems.
Two randomised-controlled studies investigating the effectiveness of taking 
Rimonabant for one year showed promising results (Scheen et al. 2006; Despres et a l
2005). 18 - 70 year old obese adults with type II diabetes and untreated dyslipidemia 
were randomised to either placebo, 5 mg of Rimonabant or 20 mg of Rimonabant, in 
conjunction with a hypo-caloric diet. Weight loss was greater in both groups receiving 
Rimonabant compared to placebo with average loss of approximately 4 kg. Also, those 
on the larger dose lost on average 4cm from their waist and showed improvement in a 
number of cardiovascular and metabolic risk factors (Despres et al. 2005; Scheen et al.
2006). Those with dyslipidemia showed improvement in their lipid profiles (Despres et 
al 2005).
To date there are no studies looking at the effectiveness of using Rimonabant in obese 
children and adolescents.
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Table 2-3 Drugs used for treating obesity
Drug Mechanism Side Effects Evidence in obese children and 
adolescents
Orlistat Gastrointestinal lipase inhibitor loose stools, oily discharge, 
deficiency of fat-soluble 
vitamins particularly 
vitamin D
Decreases: WT, BMI, WC, LDL, 
leptin, glucose & insulin
Sibutramine Appetite suppressant High blood pressure & 
heart rate
Decreases: WT 
Increases: HDL
Metformin Endogenous glucose suppressant & 
increases insulin sensitivity
abdominal pain, nausea, 
diarrhoea
Decreases: WT, fat (by BIA), 
leptin, glucose & insulin
Rimonabant Gastric lipase inhibitor & 
appetite suppressant
depression, mood disorders, 
anxiety, nausea, dizziness
None
Abbreviations: WT: weight; BMI; body mass index; WC; waist circumference; LDL: low density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol; BIA; bio­
electrical impedance analysis.
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2.9.5 Surgery
Bariatric surgery can be divided into three main categories. Mal-absorptive surgery, the 
most common of the three categories, bypasses part of the gastrointestinal tract to limit 
the absorption of food. Restrictive surgery reduces the size of the stomach whereby the 
feeling of fullness is accomplished with lower food intake. Finally mixed surgery as the 
name implies uses a combination of the first two techniques. Costs of bariatric surgery 
are approximately in the range of £5,500 per procedure.
The National Institute of Health (NIH) Consensus Development Panel concluded that 
surgery is an appropriate treatment for adults with a BMI greater than 40 kg/m^ or 
greater than 35 kg/m^ if co-morbid conditions were present (National Institute of Health,
1991). According to The National Institute for Clinical Excellence (NICE) criteria, 
bariatric surgery is not recommended for those under 18 years, and surgery should not 
be performed in adults unless there is sufficient evidence that all other weight-loss 
measures have been adequately tried but have failed to achieve long-term weight 
maintenance.
A recent study looking at the effects of bariatric surgery in 68 adolescents followed-up 
over a period of 30 years found excellent weight loss results and the long-term mortality 
rate was very low (4%) (Papadia et al. 2007). Side effects reported after bariatric 
surgery was performed in adolescents include: gastro-intestinal bleeding, bowel 
obstruction and nutrient deficiencies in addition to nausea, vomiting and constipation 
(Strauss e/fl/. 2001).
Bariatric surgery seems to be well tolerated in adolescents; however due to the number 
of side effects reported, this procedure should remain the last option for treatment. 
Adolescents should be given the opportunity to lose weight using less invasive methods 
such as family-based behavioural programs and diet modifications. To date, there are no 
data on the use of bariatric surgery in children under 12 years old, and more extensive 
research is necessary for weighing the risks and benefits of surgical intervention in 
obese children and adolescents.
52
2.9.6 Available treatment In the UK
Compared to the many weight-loss programmes available for adults, there are very few 
weight-management programmes available for children and adolescents in the UK. 
These include weight-management clinics, weight-loss camps and government 
initiatives and plans incorporating school-based interventions. Each of these strategies is 
described in detail below.
2.9.6.1 Weight-management clinics
There are a few weight-management clinics available in different hospitals around 
London such as Great Ormond Street Hospital (GOSH), University College Hospital 
(UCH) and Royal Free Hospital. The clinics accept overweight and obese children and 
young adolescents who are referred to the specialised weight-management out-patient 
clinics by their GPs. They tend to include a multi-disciplinary team of dieticians, 
psychologists and doctors who follow up the children over time giving them advice on 
healthy eating, setting goals and assessing their growth to check their progress. These 
clinics can be quite useful as families learn about ‘good foods’ and ‘bad foods’, and 
setting targets and milestones is usually a good way to keep the children motivated. 
However, there are not enough clinics around the UK and some families may live far 
away and may not be able to come frequently to appointments due to time constraints 
and travel expenses.
2.9.6.2 Weight-loss camps
There are two main weight loss summer camps available in the UK. Wellspring UK is a 
12 week residential program based in the Lake District, where 12 - 17 year old 
overweight adolescents are invited to register for the programme. The programme aims 
to teach participants about healthy eating and nutrition and incorporates various sports 
and outdoor activities. Carnegie International camp is another weight loss camp 
developed at Leeds Metropolitan University based at Woodhouse Grove Boarding 
school in Apperley Bridge. Similarly, it works under the same objectives as Wellspring 
UK whereby 1 1 - 1 7  year olds take part in different activities and are placed on a 
healthy eating regime. 12 weeks is the maximum duration of the programme; however 
participants can chose to stay for any duration during the summer holiday. In a group of 
57 obese adolescents that took part in the programme, adolescents lost an average of 5.6 
kg and showed a reduction in BMI SDS of 0.28, indicating that the programme is
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effective in managing obese children and adolescents during their stay (average stay = 4 
weeks) (Walker et a l 2003). However, there is not enough information on whether 
these changes remain after the children finish the programme, or on the long term 
effects of the intervention. A disadvantage of these camps is that they are very 
expensive; the monthly fee is in the region of £3,000. Even though these summer 
programmes may look promising, not many people can afford to register their children.
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2. lOGovernment initiatives and plans
Stopping the rising trend in the prevalence of childhood obesity is now considered to be 
a public health priority. The NHS plan intends to tackle child obesity by promoting 
healthy eating and physical activity. There are now a number of government plans and 
initiatives specifically targeting schools and school children.
The Healthy School Programme includes the National School Fruit Scheme and Safe 
Active Travel to School (Department of Health, 2000). The National School Fruit 
Scheme aims to promote healthier eating in nurseries where every child aged 4 - 6 years 
will be entitled to a free piece of fruit each school day (Department of Health, 2000). 
Evidence from the National Diet and Nutrition Survey shows that school pupils in 
England consume an average of 3.4 portions of fruit and vegetables a day; with only 
27% achieving the recommended intake of five a day. Safe Active Travel to School is a 
strategy aimed to reduce car journeys to school; hence promoting walking or cycling 
whenever possible. These programs tend to target all pupils instead of those who are 
already obese; to avoid increasing stigmatisation of overweight children at school. The 
Healthy Schools initiatives also aim to provide healthy tuck shops and vending 
machines to influence the choice of food available. Crisps, chocolate and fizzy drinks 
are the main items sold in tuck shops and vending machines; therefore providing 
healthy alternatives such as fhiits may be useful especially if schools have adopted 
teaching the pupils about healthy eating and unhealthy foods.
The Active Programming Promoting Lifestyle Education in Schools (APPLES) 
programme consists of teacher training, modifications of school meals, and the 
development and implementation of school action plans designed to promote healthy 
eating and physical activity over one academic year (Sahota et al. 2001). APPLES is a 
randomised controlled trial (RCT) which included a total of 634 children aged 7 - 1 1  
years from ten primary schools in the UK, randomised to either receive a school-based 
intervention or act as controls. There was no difference in change in BMI SDS between 
the two groups, and the programme had little effect on children’s eating behaviour other 
than a modest increase in the consumption of vegetables. Results from APPLES were 
disappointing however one can argue that one year was not enough for a ‘lifestyle’ 
intervention to show any results, and it is possible that investigating a longer duration of 
APPLES may yield promising results.
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‘Eat smart, play smart’ is a Food Standards Agency teaching resource developed for 
primary school teachers throughout the UK to use with children aged 5 - 7  years. The 
program was originally launched in 2004 in Australia and was developed to help 
children understand about the need for healthy diets and encourage them to be more 
active. A one year evaluation of the program reported no significant changes in 
overweight and obesity (assessed using BMI and skin-fold thickness); however 
consumption of fruit and vegetables increased significantly (Warren et al. 2003)
The Department of Health stated that physical activity levels in England are declining 
(Health Survey for England, 2005). Current recommendations suggest that adults should 
accumulate at least 30 minutes of moderate activity on most days of the week, and 
children should accumulate at least one hour of moderate activity on most days of the 
week. In view of the rapid increase in childhood obesity, and the declining levels of 
physical activity, the Prime Minister recently announced a £100 million campaign to 
increase school children’s activity to five hours of sport every week, two hours of which 
are included in the curriculum; equivalent to one hour of sport every day of the school 
week (Department for children, 2007). The aim of introducing this campaign is not only 
to counteract obesity but also to increase bone strength.
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Chapter 3: Body composition techniques for 
measuring obese children and adolescents
3.1 Introduction
There has been considerable interest in the need to measure body composition in 
children. Due to the rise in the prevalence of childhood obesity, assessing body 
composition is important in understanding the aetiology of childhood obesity, and in 
evaluating the success of different treatment programmes. As mentioned earlier, body 
composition is extremely difficult to measure in young children and adolescents for two 
main reasons. Firstly, accurate techniques tend to be more expensive, time consuming 
and are usually only available in specialized research centres. Secondly, measuring 
children is notoriously challenging as it can be difficult to make them comply with 
measurement protocols.
The body can be divided into five levels of body composition with increasing 
complexity: atomic I, molecular II, cellular III, tissue IV and whole body V (Wang et al.
1992) (refer to Figure 3-1). The gold standard for measuring body composition with 
optimum accuracy is through cadaver analysis. Therefore because this is not possible, a 
number of other techniques; mainly at the molecular level, have been used to estimate 
and predict body composition.
This chapter includes a review of the different techniques used to assess body 
composition in children and adolescents, giving details on the advantages and 
disadvantages regarding their use with children and adolescents, specifically the obese.
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Figure 3-1 The five-level model of human body composition 
Source: (Wang et al. 1992)
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3.2 Anthropometry
3.3.1 Weight, height and body mass index
Although from a medical perspective obesity is defined as an excess of body fat and not 
an excess of body weight, it is usually classified on the basis of weight relative to 
height. At present, routine measures including weight, height and BMI are often used 
for monitoring growth and nutritional status. These have been used because they are 
very easy to calculate, quick to measure and non-invasive.
Many studies have reported a high correlation between BMI and percentage body fat in 
childhood (Pietrobelli et al. 1998; Ellis et al. 1999); this gives the impression that BMI 
is a good index of body fatness. Nevertheless, BMI has numerous limitations making it 
a poor index of body composition. First, compared to adults, children and adolescents 
vary in their growth rates and level of maturity. It has been reported that during growth, 
children tend to increase in the lean more than fat component of BMI (Maynard et al.
2001). Second, BMI correlates with both the lean and fat content of the body, and so it 
cannot differentiate between the two components and hence may give misleading 
information on body fat growth in children and adolescents (Wells, 2000). Third, BMI 
gives no information on where the fat is distributed in the body. Previous studies have 
shown that fat located around the abdomen area increases the risk of developing 
cardiovascular diseases in both adults and children independent of their body weight or 
BMI levels (Larsson et al. 1984).
Certain ethnic groups display a different relationship between BMI and percent body fat 
to that described for Caucasians. For example on average Asians tend to have a 
significantly greater proportion of fat mass for the same BMI value compared to 
Caucasians (Dudeja et al. 2001). The reverse is true for the average black population; a 
study showed that for the same level of body fat, age and gender American blacks have
1.3 kg/m^ higher BMI compared to Caucasians (Deurenberg et al. 1998). These 
differences in fat levels have public health implications for the definition of BMI cut­
offs for obesity, which would need to be population-specific. For example, the WHO 
suggested that obesity related diseases among Asian populations increase above a BMI 
of 23 kg/m^, as opposed above 25 kg/m^ in Caucasians (World Health Organization,
2004).
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In specific population groups such as athletes, estimation of body fat from BMI is 
likewise problematic since they have a higher proportion of lean mass than non-athletes. 
Also, using BMI as a measure of body fat in various weight loss programmes may give 
false results. Weight loss does not equal fat loss as on average approximately 22-30% of 
the weight is lost as lean tissue and the remaining 70-78% is fat loss, and this may also 
vary between individuals (Webster et a l 1984). In addition, many recent weight-loss 
programmes are incorporating exercise as part of their regime. Physical activity may 
lead to increase in limb muscle mass as it has been shown to be a stimulant of muscle 
growth in children; therefore changing body composition but not necessarily weight 
(Torun and Viteri, 1994). Hence, weight maintenance or even slight weight gain may be 
experienced during exercise interventions, and this change may be overlooked if BMI is 
used as the outcome.
In addition there can be big differences in fat and lean levels within the same BMI level 
even within a group of children of the same age, sex and ethnicity. Wells (2000) 
measured a group of 64 children and estimated their FM and FFM (by D2 O) (Wells, 
2000). Figure 3-2 shows a graph of FM versus FFM, both adjusted for height, indicating 
variability in percentage fat that can occur for a given BMI value. FFMI and FMI add 
up to BMI, so there are lines of constant BMI value decreasing across the graph. It is 
also possible to add non-parallel lines of constant percentage fat (Hattori et a l  1997). 
For example, girls A and B on the graph are both eight years old and they both have a 
BMI of 18 kg/m^; however A has double the fat compared to B. This graph clearly 
shows that BMI is not a good indicator of fat in young children and can give misleading 
information on the amount of fat and lean in populations with similar BMI values.
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Figure 3-2 A Hattori chart of FFMI and FMI in 64 children aged 8-12 years. 
Fat mass index (FMI) = FM/HT^; fat free mass index (FFMI) = FFM/HT^
Source: (Wells, 2000)
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3.3.2 Waist circumference (WC)
Measuring WC is another common way for assessing obesity in adults and children 
because it is fairly simple, fast and non-invasive.
An android fat distribution with excess fat in the upper areas of the body, especially in 
the abdomen, has been associated with an increased risk of developing coronary artery 
disease compared to the gynoid pattern which relates to fat distributed in the lower parts 
of the body, particularly in the hips and thighs (Daniels et al. 1999). Measuring WC has 
proved to be a useful tool for assessing risk for obesity-related diseases such as 
cardiovascular disease (Lemieux et al. 2000). Inconsistent relationship on the 
association between WC and abdominal fat has been reported, some finding no 
significant relationship (De Ridder et al. 1992; Wells and Fewtrell, 2006) On the other 
band, some studies have shown that WC correlates well with intra-abdominal adipose 
tissue (measured by MRI or CT) in adults and children; with correlations in the range of
0.5 to 0.8 (Taylor et al. 1998; Fox et al. 1993; Lobstein et al. 2004; Owens et al.
1999). Measuring body fat distribution may be more important than measuring total 
adiposity for assessing risk of developing metabolic complications.
The criteria for selection of cut-off points for waist circumference in adults are as 
follows: action level 1: men, > 94 cm, women, > 80 cm; and action level 2: men, > 
102 cm, women, > 88 cm for diagnosis of abdominal obesity which are based on data 
derived from adult Caucasians (Lean et al. 1995). These WC cut-off points were based 
on high sensitivity and specificity profiles against cut-off values of BMI (25 kg/m^ for 
action level 1 and 30 kg/m^ for action level 2) and waist-to-hip circumference ratio 
(0.95 for men and 0.80 for women for both action levels) in adult Caucasians. A similar 
indicator was used in the WHO report where an increased risk of developing 
complications is present when WC exceeds 94 cm in men and 80 cm in women (World 
Health Organization, 2000). However, these cut-offs were derived from Caucasian 
populations, and several studies have shown that they are inappropriate in other ethnic 
populations (Wildman et al. 2004; Zhu et al. 2005; Wildman et al. 2004; Misra et al. 
2006). For example, compared to White populations, Asians have been shown to have 
greater WC for the same BMI leading to a greater prevalence of cardio-vascular risk 
factors at lower BMI levels (Wildman et al. 2004). Therefore revised ethnic specific 
cut-off points for WC have been proposed for males and females (refer to Table 3-1).
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Waist circumference to height ratio (WHTR) is another index used to assess the risk of 
disease related to central fatness in both adults and children; cut-off WHTR = 0.5 
(McCarthy and Ashwell, 2006).
Moreover, adult WC cut-offs cannot be used for children, instead age- and gender- 
specific reference data are available for WC in children and adolescents. Similar to BMI 
measurements, raw WC measurements can also be converted to SDS using UK 
reference data for children aged 5 - 16.9 years collected in 1988 (McCarthy et a l 
2001).
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Table 3-1 Waist circumference cut-offs corresponding to established BMI cut-offs for 
adults from different ethnic groups
WC cut-offs corresponding to BMI cut-offs (cm)
BMI cut-o& 
(kg/m^ )
White Black Mexican
American
Indian
Asians
Chinese
Men 25 94 86.4 88.7 78*
80§30 102 98.8 101.2 90**
Women 25 80 83.5 83.1 72*
80§30 88 93.9 93.6 80**
Abbreviations: WC: waist circumference; BMI: body mass index 
* at BMI cut-off > 21; ** at BMI cut-off > 25; § at BMI cut-off of 24 
Source: (Wildman et al. 2004; Misra et al. 2006; Zhu et al. 2005)
3.3.3 Skin-fold thickness
Skin-fold thickness measurements are another popular traditional technique that can be 
applied to infants and children. This method measures subcutaneous fat at several sites 
of the body by “pinching” the skin with callipers. Even though measuring skin-fold 
thickness is non-invasive, easily performed and inexpensive it has many disadvantages. 
First, it measure only subcutaneous fat, and hence assumes that subcutaneous fat is 
proportional to the person’s total body fatness. This proportion actually varies widely 
and is highly dependant on gender, age and ethnicity (Deurenberg et al. 1990). Some 
people have a greater proportion of their total body fat situated internally rather than 
subcutaneously; hence measurements obtained using skin-fold callipers may not be 
representative. Second, relative skin-fold data only refer to measures of fatness but not 
lean mass; hence only one index on body composition is considered. Third, the 
equations that convert skin-fold measurements to measures of body fat are inaccurate, 
with a prediction error of about 3-5%; being highest in pre-pubertal children; and the 
data obtained cannot be considered to be reliable (Deurenberg et al. 1990; Reilly et al. 
1995). Finally, skin-folds are also very difficult to measure in the obese, the callipers 
cannot grasp the wide fold of the skin; therefore underestimating measures of 
subcutaneous fat.
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The best way of using skin-fold thickness data is by using the raw data because they are 
relatively reliable indices of regional fatness (Wells and Fewtrell, 2006). These can be 
converted into SDS using UK reference data for infants (Paul et a l 1998) and children 
(Davies et a l 1993). The children’s reference data however are very old (Tanner and 
Whitehouse, 1975) and therefore a revised standard for skin-fold thicknesses for healthy 
children is needed.
BMI, WC and skin-fold measurements are the most widely used tools of assessing body 
composition because to date they are the only existing outcomes with reference data; 
but only BMI and WC are practical in those obese.
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3.3 Two-component model (2C)
Various different models can be used to estimate body composition; the simplest is the 
2C model which divides total body weight into the components FFM and FM. This 
model assumes constant properties of FFM, like constant density or hydration. In those 
cases, the accuracy of the results obtained by the 2C model will depend on the validity 
of the assumptions made about the different components of FFM. A summary of the 
different equations used to estimate percentage fat by the 2C model is shown in Table 3-
2 .
Generally, three main factors introduce variations in the properties of FFM. First, 
properties are not constant even between healthy subjects of a given age and sex (Wells 
et al. 1999). Second, properties change significantly during growth due to the process 
of chemical maturation (Fomon et al. 1982). Third, different diseases states may 
involve a variety of conditions such as: over hydration, under hydration, muscle 
wasting, tumour growth, mineral loss or oedema, each of which exerts effects on the 
properties of FFM. All these sources of errors reduce the validity of the 2C models of 
body composition (Wells and Fewtrell, 2006).
For the rest of this section, I have selected a number of the various techniques that use 
the 2C model for calculating body composition, and I will describe each method in 
detail separately.
66
3.3.1 Isotope dilution
Deuterium oxide (D2 O) dilution has been used to measure TBW because it can be safely 
administered in humans and because deuterium (^H) weighs approximately twice as 
much as hydrogen (^H); and can thus be detected using a mass spectrometer. D2 O is a 
stable, non-toxic, non-radioactive isotope of water It is naturally occurring but
heavier than normal water ^H2 ^ ^ 0  because the hydrogen part of the water has one extra 
neutron, giving its other name ‘heavy water’. Hydrogen atoms in the body water pool 
are fully exchangeable with isotopic water by substituting the hydrogen (^H) with 
deuterium (^H) (Culebras and Moore, 1977). is another isotope that can be used to 
measure TBW. D2 O is used more than H2*^0 as the latter isotope is substantially more 
expensive. TBW values calculated from and are highly correlated (Schoeller et 
a/. 1980).
The principal of using isotopic tracers to calculate body water is that if a quantity of 
tracer is added to the body water pool, measurement of the concentration of tracer in 
body fluids will allow the size of the body water pool to be calculated (Culebras and 
Moore, 1977). The tracer isotope is assumed to have reached an equilibration with the 
body water pool by a specified time after administration of the dose.
There are three ways of measuring isotopic enrichment in the body: by taking samples 
from saliva, urine or blood. Blood is too invasive to use in healthy paediatric 
populations; whereas saliva samples and urine samples are preferable to use in children 
and infants respectively (Schoeller et al. 1980). The time needed for the isotope to 
equilibrate in the body is longer when a urine sample is taken instead of a saliva sample; 
4 - 6  hours compared to 3 - 4 hours respectively (Schoeller et al. 1982).
The limitation of using isotope dilution to calculate TBW is that during the time taken 
for the isotope to equilibrate with the body water pool, some of the isotope may be lost 
from the body by sweating or voiding and also may be diluted by additional fluid 
intake. However, losses in expired air and urine are negligible because of the long half- 
life of isotopic hydrogen in the body. On the other hand, any fluid consumed during the 
equilibration period should be taken into account during TBW calculation otherwise the 
concentration of the isotope at the time of equilibration will be lower than predicted by 
the model, and TBW will be overestimated (see below).
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The equation used to calculate TBW is:
N = TA * (Ea -Et) (Halliday and Miller, 1977) Equation 3-1
a (Es -Ep)
where N is the dilution space in ml, A is the dose given in grams, T is the amount of tap 
water in which the dose sample was diluted before analysis, a is the portion of the dose 
in grams diluted for spectrometer analysis, Ea is the isotopic enrichment of the dosing 
portion. Et is the isotopic enrichment of the tap water. Es is the post dose enrichment 
and Ep is the pre dose enrichment. Ea, Et, Es and Ep are measured in delta units which 
express isotopic enrichment relative to a standard, in this case International Standard 
Vienna Standard Mean Ocean Water.
Values of N are converted into values for TBW by dividing by 1.044 when using D2 O 
technique, but only by 1.01 when using H2^^0, as there is more non-aqueous H 
compared to O in the body (Racette et al. 1994).
TBW = N (D?0) approximately equal to N (Hi^^O) Equation 3-2 
1.044 1.01
Furthermore, any fluid consumed during the equilibration period should be subtracted 
from the raw TBW values calculated, as they would increase the dilution space volume; 
thus yielding overestimated results.
FFM can be calculated from TBW by using assumed FFM hydration values. However, 
due to the process of chemical maturation during growth, the relative proportions of 
water, protein and mineral change with age and puberty; whereby there is a non-linear 
decrease in Hffm (Fomon et al. 1982). Therefore a constant used for adults may not 
hold true for children. Also obese children were found to have a significantly increased 
Hffm compared to non-obese children (Bray et al. 2001 ; Haroun et al. 2005). Therefore 
constants used in normal-weight children may not be applicable in the obese.
FFM = TBW Equation 3-3
Hffm
FM can then be calculated by subtracting FFM from total body weight.
FM = WT - FFM Equation 3-4
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3.3.2 Body density and volume measurements
3.3.2.1 Under-water weighing/hydro-densitometry (UWW)
Hydro-densitometry (see Figure 3-3) is based on the principle of Archimedes which
states that the volume of an object is equal to the object’s loss of weight in water. This 
method measures whole body density (calculated as body mass/body volume) by 
measuring body weight and body volume and predicting body composition by assuming 
constant densities of FM and FFM (Siri, 1961). Since fat is homogenous, it is relatively 
reasonable to assume that the density of fat is constant (FIDANZA et al. 1953). 
However because of the heterogeneous nature of the FFM components (mainly water, 
mineral and protein), the validity of the constant density of FFM poses one limitation to 
using this method. FFM composition can be influenced by age, gender and ethnicity in 
addition to changes due to growth, sexual maturation and the effect of various diseases 
(Fomon et al. 1982; Bray et al. 2001 ; Haroun et al. 2005).
One limitation to using hydro-densitometry as a measurement tool to evaluate body 
composition is that the method requires the subject to be completely submerged in water 
(refer to Figure 3-3) (Fields and Goran, 2000). Hence this technique is generally not 
recommended for sick patients, those scared of water and for the majority of the 
paediatric population.
s
Figure 3-3 Under-water weighing machine 
Source: www.mhhe.com
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3.3.2.2 Air-displacement plethysmography (ADP)
This technique is based on the same principle as underwater weighing but instead of 
using water it uses air displacement to determine the subject’s body volume. An 
advantage of this technique over hydro-densitometry is that the subject does not have to 
be submerged in water making it more favourable and feasible in many (Dewit et al.
2000). Also child-specific equations have been recently developed to predict lung 
volume for children over five years old; hence reducing the error in estimating % body 
fat (Fields et a l 2004).
ADP has been evaluated to examine the reliability of body volume measurement by 
BODPOD relative to UWW. Strong correlations between ADP and UWW have been 
reported in normal weight adults and children, and also in overweight and obese adults, 
with correlations in the range of 0.7 - 0.9 (Fields et al, 2001; Ginde et al, 2005) 
However, compared to hydro-densitometry, ADP has been shown to have a better 
precision in measuring body volume and calculating FM and FFM in both adults and 
children (Wells and Fuller, 2001; Dewit et al. 2000; Fields et al. 2002).
ADP requires the subjects to sit still in a chamber for a couple of minutes; therefore 
those who are claustrophobic or are very young might not be able to comply with the 
measurement protocol. The other disadvantage of using such a technique is the time 
needed to calibrate the machine (40 minutes) before the measurement is performed. 
Also due to the size of the equipment, ADP is not suitable for field studies and most 
routine clinics.
The other consideration that needs to be taken into account when estimating body 
volume is the amount of air left in the lungs, also called residual lung volume which can 
either be estimated or measured. Even though lung volume can be measured, it is 
usually estimated using predicted equations because the procedure involves the subject 
exhaling air into a tube which can be very difficult for young children.
Using Siri’s equation (Siri, 1956), % fat can be calculated from density using the 
following equation:
% fat = (495 / Db) -  450 Equation 3-5
where Db is body density calculated by dividing weight by volume.
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3.3.3 Dual X-ray Absorptiometry (DXA)
DXA was originally designed to assess bone mineral density as a screening and 
diagnostic test for osteoporosis. However over the last decade DXA has been 
increasingly used to measure body composition as it also provides information on FM, 
FFM and their distribution in the trunk and upper and lower limbs (Mazess et al. 1990). 
This is because it is fairly quick, a whole body scan lasts about 10 minutes, and it can be 
used in young children. The DXA scanner emits two distinct low energy x-ray beams 
with different energy levels, and bone mineral is then calculated from the differential 
absorption of the two energies after taking into account soft tissue. In current 
instruments the radiation dose is very low (< 3 pSv per scan), which is lower than a 
day’s background radiation in the UK. The precision of soft tissue body composition by 
Lunar DPX-L was established by repeated measurements on 20 adults over four days 
(Kiebzak et a l 2000). A variation of 0.6%, 2% and 1% for BMC, FM and FFM 
respectively was reported; regional measurements were less precise than total body 
measurements. For ethical reasons, repeated measures have not been performed on 
children.
Caution is required when using DXA for body composition measurements. First, DXA 
scanner software assumes a hydration constant of 73% for FFM. This constant might be 
appropriate for healthy adults but would not be appropriate for children or adolescents 
where the hydration status changes during growth, or in disease states that might alter 
the hydration of FFM. Second, a recent study comparing DXA with the 4C model in a 
wide group of patients showed that the precision of using DXA (Lunar Prodigy) varies 
according to gender, size, fatness and disease (Williams et al. 2006). Similar findings 
by Wong and colleagues (2002) comparing DXA (Hologic QDR-2000W model) with 
the 4C model in a group of young girls reported that an individual’s FM can be 28% 
under or over-reported relative to the 4C model (Wong et al. 2002). This implies that 
DXA is not a very reliable tool for measuring body composition in case-control studies 
and for longitudinal studies assessing changes in body composition such as weight loss 
programmes. Moreover, the DXA scanner has a weight limit of 115 kg and a limited 
width area. Hence, it is not suitable to use in morbidly obese children and adolescents. 
Another limitation of the DXA scanner is that it only estimates the proportion of fat and 
lean tissue in pixels containing no bone; therefore the composition of fat and lean in the 
trunk is less accurate than in the limbs due to the greater amount of bone in the trunk
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including ribs, pelvis and spine. Even though the radiation is low, it would be 
unfavourable to use in short term longitudinal studies or routine clinical assessments 
such as weight management clinics. Finally, having a DXA scan is expensive (current 
costs in the range of £100 per scan), and due to its large size it is not made easily 
available in clinics and hence has some limitations for use as a routine body 
composition assessment tool.
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3.3.4 Bio-electrical impedance analysis (BIA)
BIA is a simple, non-invasive, inexpensive technique that needs very little maintenance 
and minimal operator training. BIA machines, for example TANITA machines, work 
by sending a low, safe electrical signal through the body. BIA is based on the fact that 
lean tissue, such as muscle and blood, contains high levels of water and electrolytes and 
therefore acts as a conductor of an electrical signal. Fat tissue is comparatively 
anhydrous and acts as a resistor to the flow of an electrical signal. The machine 
therefore relies on the assumption that body conductivity is proportional to TBW. The 
only direct measurement BIA machines make is impedance; all other values such as 
FM, FFM and TBW are calculated using in-built equations predicting TBW from data 
on impedance and height and in some cases other terms such as weight, age and sex.
BIA measures resistance of a body to an electric current (refer to
Figure 3-4). Based on the theory that the body is a cylinder of a certain length, the 
resistance (R) of the cylinder is given by:
R = K * HT/A Equation 3-6
where R is resistance, K is a constant known as resistivity, HT: is the length of the 
cylinder, and A is the cross/sectional area. If the equation is re-arranged:
A = K * HT/R Equation 3-7
Multiplying both sides of the equation by length gives:
Ht*A = K* HTVr  Equation 3-8
Ht*A = Volume (V) Equation 3-9
V = K * HT /R Equation 3-10
Therefore, the volume of the cylinder/body can be determined by measuring its length 
and resistance. The volume of the body is the volume of the conducting material i.e. 
TBW. Hence V can be replaced with TBW and the equation becomes:
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TBW = K * HT^/R Equation 3-11
One limitation of using BIA is that the human body is not a uniform cylinder of 
constant ionic properties. Therefore, BIA predicts rather than measures TBW. Another 
limitation of using BIA to predict TBW is that this method assumes that the hydration 
status of FFM is constant. However, physiological and pathological factors such as 
pregnancy, obesity, disease states and ethnicity may interfere with the hydration status. 
We have previously shown that the hydration of FFM was significantly higher in obese 
children compared to lean children matched for age and gender (Haroun et al. 2005). 
Therefore more research is needed in order to determine the validity of BIA in obese 
individuals.
HT
Resistance
Whole
body
Figure 3-4 A diagram illustrating the theory behind whole body impedance
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3.3.5 Magnetic resonance Imaging (MRI)
MRI (see Figure 3-5) works by creating a strong magnetic field around the body 
causing hydrogen nuclei located either in water or fat to align with or against the 
magnetic field. The absorption and emission of energy by these nuclei are then analysed 
hence producing multiple cross-sectional images of the body which are then combined 
by computer software to calculate regional tissue volumes. This method therefore 
estimates the volume of adipose tissue.
MRI can differentiate between subcutaneous and visceral fat. Subcutaneous fat is 
located underneath the skin while visceral fat is located internally within the abdomen 
and surrounding the organs. There is growing interest in looking at visceral fat rather 
than total body fat as a risk factor for metabolic conditions associated with obesity in 
children and adolescents as it is more metabolically active (Taksali et al. 2007).
One problem with using MRI is the assumption made on the density of fat and the fat 
content of adipose tissue. As mentioned earlier the density of fat is relatively constant 
but the fat content of adipose tissue is not (Thomas, 1962). The other problem with 
using MRI is that it only estimates fat present in the adipose tissue, which is different to 
total fat estimated using other techniques; therefore posing a problem when converting 
adipose tissue to total fat.
MRI is safe because it does not use radiation. However its use is limited primarily 
because of the high cost of the equipment (approximately £350 per scan) and also 
because of the time needed for scanning and analysis -  a typical whole body scan takes 
approximately 10 minutes. Also some subjects, particularly very young children, may 
not be able to keep still for the scan and so movement artefacts may result. In addition, 
the scan is performed in an enclosed area while lying on a hed; hence those who are 
claustrophobic might not be able to perform the scan.
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Figure 3-5 MRI scanner 
Source: www.mritodav.net
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3.3.6 Computerized tomography (CT)
A CT scan (see Figure 3-6) uses three-dimensional x-rays to take cross-sectional 
pictures of the body. Like the MRI scanner, CT is limited by the high equipment cost 
and time; the procedure takes between 20 minutes and one hour. Another limitation to 
using a CT scanner is exposure to high doses of radiation (approximately 10 mSv); 
making it unfavourable to use particularly in healthy young children and adolescents.
Mitsiopoulos and colleagues (1998) reported that both MRI and CT estimates of 
skeletal muscle and adipose tissue were highly correlated, and were in agreement with 
those obtained from cadaver analyses (Mitsiopoulos et al. 1998).
Figure 3-6 CT scanner 
Source: www.cancerhelp.org
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3.4 Multi-component models
Multi-component models are considered to be the most accurate method to estimate 
whole-body composition in-vivo because they minimize the assumptions made about 
the composition of FFM (Wells and Fewtrell, 2006). In the multi-component models the 
different properties of FFM such as hydration, density and bone mineral content (BMC) 
are actually measured rather than assumed as in the 2C models.
A summary of the different equations that can be used to calculate body composition 
using the 2C, 3C and 4C models of body composition is given in Table 3-2.
The equations and models differ regarding assumptions made concerning the 
relationships and densities of the various components of FFM. In this thesis, the 
equations used for calculating body composition in children and adolescents using the 
3C and 4C models were those derived from Fuller and colleagues (1992) (Fuller et al. 
1992).
The three component (3C) model divides total body weight into FM, water and 
remaining fat-free dry tissue, assuming constant densities of these three components 
(Brozek et at. 1963), and an assumed ratio of protein to mineral. It is advantageous 
compared to using the 2C model in that it avoids the assumption that the water content 
of FFM is constant between individuals of a given age and gender. It can also provide 
an estimate of the hydration and density of FFM. The measurements required for this 
model are WT, TBW and BV. The following equation is used to calculate FM:
FM (kg) = [2.22] BV -  [0.764] TBW -  [1.465] WT Equation 3-12
Where BV is measured in litres; TBW in litres; WT in kg (Fuller et al. 1992)
The four component (4C) model divides body WT into fat, water, protein and mineral, 
thereby avoiding the assumption that the ratio of protein to mineral in FFM is constant. 
However, the model assumes a constant ratio of osseous (bone mineral) to non-osseous 
mineral (total body mineral). This model requires the same measurements used for the 
3C model in addition to BMC measurement (by DXA). The equation is as follows:
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FM (kg) = (2.747) BV -  (0.71) TBW + (1.46) BMC -  (2.05) WT Equation 3-13
where BMC is measured in kg (Fuller et a l 1992)
The reliability of estimating body fat in children using the multi-component models was 
tested by Wells and colleagues (1999) (Wells et a l 1999), The propagated errors 
(whereby the total error is a function of the independent and additive technical errors) 
for calculating FM and FFM for the 2C, 3C and 4C models are shown in Table 3-3. It is 
clear that the precision of estimating body composition when using multi-component 
models is not invalidated by the sum of errors associated with performing multiple 
measurements. On the contrary, using multi-component models was shown to improve 
accuracy because assumptions made concerning the different components of FFM are 
minimized.
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Table 3-2 Equations for estimating body composition based on 2C, 3C and 4C models
Model Equations Reference
2C FM = (4.95)BV -  4.50WT for adults 
FM = (4.57)BV- 4.142WT for adults
(Siri, 1956)
(Brozek et al. 1963)
FM = (5.27)8V -  4.85WT for children (Wells et a/. 1999)
3C FM -  (2.118)8V -  (0.78T8W) -  1.354WT (Siri, 1961)
FM = (6.386)8V -  (3.96M) -  6.09WT (Lohman, 1986)
FM (kg) = (2.22) BV -  (0.764) TBW -  (1.465) WT (Fuller et a/. 1992)
FM (kg) = (2.15)BV -  (0.771)TBW -  (1.390)WT * 
FM (kg) = (2.106)BV -  (0.776)TBW -  (1.339)WT **
(Haroun et al. 2005)
4C FM = (2.747)BV -  (0.714)TBW + (1.146)M -  2.0503WT (Selinger, 1977)
FM = (2.7474)BV -  (0.7137)TBW + (1.1471)M -  2.0503WT # (Baumgartner et al. 1991)
FM = (2.559)BV -  (0.734)TBW + (0.983)BMC -  1.841WT (Friedletu/. 1992)
FM (kg) = (2.747)8V- (0.71)TBW + (1.46)BMC -  (2.05)WT (Fuller et a/. 1992)
FM = (2.5126)BV -  (0.7389)TBW + (0.947)BMC -  1.7896WT (Heymsfield et al. 1996)
Abbreviations: WT= weight (kg); M= minerai (osseous and non-osseous) (kg); FM= fat mass (kg); BV= body volume (1); TBW= total body water (1); BMC= bone mineral content 
(kg) *Equation to be used in control children (-2 < BMI SDS < 1.64) aged 7 - 14 yeas 
**Equation to be used in obese children (BMI SDS > 1.64) aged 7 - 1 4  years 
# Equation to be used in White adults aged 65 - 94 years
Table 3-3 Propagation of methodological error on FM and FFM values obtained by the different models
Error calculating FM/FFM (kg) % of FFM %of FM
4C model* 022 0.5 3.1
3C model ** 020 0.5 2.8
2C models:
D2 O 027 1.3 3.8
uww 1.00 3.8 13.8
BOPDPOD 0.3 1.1 5.2
DXA 0.2 - 0.4 1.5 3
* measurements involved BODPOD, D%0 and DXA 
** measurements involved BODPOD and D2 O
Source: (Wells et al. 1999) & (Wells and Fuller, 2001): error estimated from 30 children aged 5 - 1 6  years; average weight assumed to be 48.7 kg 
(41.5 kg FM and 7.2 kg FFM)
Abbreviations: FM= fat mass; FFM= fat-free mass; DzO^ deuterium oxide dilution; UWW= under-water weighing; DXA= dual x-ray absorptiometry.
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3.5 Summary
When assessing body composition in a cross-sectional study, it is important that the 
technique used to measure body composition is accurate. However when assessing body 
composition in a longitudinal study, the accuracy of the measurements is not the only 
relevant issue and the precision of the measurements will also contribute to the ability to 
accurately detect significant changes.
Different factors can affect the different body components such as fat and lean mass; 
especially during growth. Therefore adult constants and equations should not be applied 
to children when assessing body composition as these may yield false results. Also 
obesity may alter the different components on FFM such as hydration or density (Bray 
et al. 2001; Haroun et al. 2005); therefore this aspect should be considered when 
assessing body composition in obese children or adolescents.
Multi-component models are the most accurate to estimate whole body composition, 
especially when a disease state has an effect on the various components of lean mass. 
On the other hand, the best technique to use when regional body composition is required 
is MRI as it provides information on the regional distribution of fat and also gives 
separate information on subcutaneous versus visceral fat. Measuring regional fat may be 
more appropriate in ranking individuals according to risk of developing cardiovascular 
diseases.
Multi-component techniques require the use of several methods to measure body 
composition; and these methods tend to be expensive and are only available in big 
research centres. Therefore it is important to find a simple technique that can be used to 
detect change in body composition without bias, by validating it against the gold 
standard in vivo which is the multi-component model. This technique can then be used 
easily by paediatricians in clinics to look at body composition changes in different 
disease states such as obesity.
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Chapter 4: Hypotheses, recruitment, methods used, 
ethical considerations and study pian
This chapter outlines the different hypotheses I proposed to test in this thesis, a brief 
description of where subjects were recruited from, the methodology used and finally an 
overview of the study plan along with the ethical considerations.
4.1 Hypotheses
This study is divided into three main hypotheses; each of these hypotheses will be 
described in detail in chapters 5, 6 and 7 including details on study design, sample size 
calculation and statistical analyses.
The first hypothesis tested:
1. Body composition differs between obese and non-obese children and adolescents
The different components of the body, such as fat-free mass (FFM) and fat mass (FM) 
in addition to the various components of FFM such as hydration (Hffm) and density 
( D f f m ) ,  were compared between normal weight and obese children and adolescents.
The second hypothesis tested:
2. Body composition o f obese children and adolescents on different weight-loss 
programmes changes over a period o f 6 months and 1 year.
For this part of the study, two different weight-loss programmes available at Great 
Ormond Street Hospital (GOSH) were investigated: the Traffic Light Program (TLP) 
and Metformin program. Details of the two programmes are described in detail in 
chapter 6. Body composition was assessed at baseline, six months and one year after 
taking part in the program, to investigate and evaluate the success of the programmes in 
changing body composition i.e. detecting a change in FM or FFM and their distribution.
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Finally, the third hypothesis tested:
3. A new BIA machine, TANITA BC-418 MA, can accurately measure body 
composition, and change in body compositions in obese children and adolescents 
compared to the multi-component model.
For this part of the study, body composition measurements from the impedance machine 
were compared against those obtained from the 3C and 4C models. TBW or FFM 
(estimated from D2 O and the 3C or 4C model respectively) was compared to height^/R 
(measured by TANITA BC-418 MA). Validating the TANITA machine enables the 
construction of equations that can be used to estimate body composition specifically for 
a group of obese individuals within a specific age range. These equations were then 
tested in a sub-group of obese children that had longitudinal measures of body 
composition to assess the accuracy of the machine in estimating body composition 
changes over time.
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4.2 Recruitment
Participants were recruited over a period of four years, between January 2004 and 
January 2008, from four different sources:
1. Paediatric outpatient weight management clinic based at GOSH, run by Dr. 
Russell Viner
2. Weight management clinic based at UCH, run by Dr. Russell Viner and Dr.
Terry Segal
3. Traffic light programme (TLP) based at GOSH, run by Prof. Jane Wardle, Helen 
Croker and Dr. Russell Viner
4. Lifestyle, Eating, Activity and Fitness (LEAF) weight management clinic in 
Chichester, run by Dr. David Candy
5. On-going body composition research project based at ICH/GOSH, run by Jane 
Williams
Obese patients presenting to the weight management clinics at GOSH and UCH were 
initially referred though their local hospital. General Practitioners (GPs), paediatricians, 
school nurses and dieticians.
Non-obese subjects (used as controls) in addition to a few obese subjects were also 
recruited via an on-going body composition research project. This group of subjects 
were recruited via the media: leaflets and posters were distributed in different places in 
London including hospitals, universities and sports centres, and details of the study 
were also published in the Metro and Evening Standard newspapers a number of times 
during the study period.
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4.3 Methods
4.3.1 Anthropometry
Body weight was measured with minimum clothing to the nearest 0.01 kg using the 
electronic weighing scale integral to the BODPOD machine (described later). The 
accuracy of the scale was determined by using two weights, each weighing 10 kg. 
Standing height was measured to the nearest millimetre using a wall-mounted 
stadiometer (Holtain, Dyfed, UK). BMI was calculated as weight (kg)/ height (m)
Circumferences of the head, mid-upper arm (MUAC), waist (WC), hips, calf and thigh 
were also measured using a non-stretchable flexible measuring tape and recorded to the 
nearest 0.1 cm. WC was measured midway between the tenth rib and the top of the iliac 
crest (World Health Organization, 1995), whilst hip circumference was measured at the 
widest girth. All measurements were done on the left hand side of the body while the 
subject was standing; in accordance with the Anthropometric Standardization Reference 
Manual (Callaway et al. 1988).
Height, weight, BMI and WC were converted into SDS using current 1990 UK 
reference data calculated using the LMS Growth program (Cole et al. 1995; McCarthy 
et al. 2001).
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4.3.2 Deuterium oxide dilution (D2O)
Total body water (TBW) was determined by, using an oral dose equivalent to 0.05 g 
^HzO/kg of body weight (99.9 atom % excess, Sigma Chemical Co. Chemicals, Poole, 
UK). Saliva samples were collected using absorbent salivettes (Starstedt, Rommelsdorf, 
Germany) prior to administration of the dose to determine the natural background 
concentrations of the isotopes in the body. Further saliva samples were collected at four 
hours (for non-obese subjects or controls) or five hours (for obese subjects) 
(unpublished data) after dosing to give enough time for the isotope to equilibrate fully 
with the body water pool. Subjects were asked to refrain from introducing any food or 
liquid at least 30 minutes before the saliva sample was collected. Saliva samples were 
spun using a centrifuge, frozen at -80”C and then analysed using the equilibration 
method (Scrimgeour et al. 1993). 0.5 ml of saliva sample along with a platinum-on- 
alumina catalyst rod was placed in a sealed vial and flushed using 2% Hydrogen in 
Helium gas for approximately seven minutes. The samples were then left to equilibrate 
at room temperature for at least eight hours before analysis. Isotopic enrichment of the 
dose and the saliva samples was then determined in duplicate using isotope ratio mass 
spectrometry (Geo 20-20; Europa Scientific, Crewe, UK or Delta Plus, XP, Thermo- 
Fisher, Germany). The accuracy of the analyses was checked by measuring water 
standards at the beginning, middle and end within each batch of samples analysed. The 
mean SD of deuterium analyses is less than 2.5%.
Subjects were asked to record amount of fluid consumed during the equilibration 
period, and were given a pre-paid padded envelope to send the second saliva sample 
along with the instruction sheet for taking saliva sample (refer to Appendix 7). Raw 
TBW was corrected for any drinks consumed during the equilibration period by 
subtracting the amount of fluid consumed during that period.
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4.3.3 Air-displacement plethysmography (ADP)
Body volume (BV) was measured by ADP using the BODPOD instrumentation (Life 
Measurement Instruments, Concord, California, USA) following the manufacturer’s 
instructions and recommendations (see Figure 4-1). Briefly, the machine was warmed 
up for at least 30 minutes and calibrated with and without a 50 litre metal cylinder until 
acceptable criteria were met (SD < 75 ml and mean volume is < 0.1 litres different from 
actual volume of the cylinder). The subjects were asked to wear tight fitting swimming 
costumes and swimming caps and to remain seated in the fibreglass chamber during the 
measurement. Subjects sit in the anterior chamber (450 litres) which is connected to a 
rear measuring chamber (300 litres) via oscillating diaphragms used to induce pressure 
changes in the anterior chamber. In each test, duplicate measures of body volume are 
performed, each lasting about 50 seconds. If the two measurements differed by more 
than 150 ml, the system required that a third measurement be performed. The final 
result reported by the BODPOD instrumentation is the average of the duplicate raw 
volume measurements or the average of the closest two if three measurements were 
performed. Two complete tests (i.e. a minimum of four raw volume measurements) 
were performed on each child. If the densities of the two measurements differed by 
more than 0.007kg/l, a third test was performed to ensure precision (Wells and Fuller,
2001). Corrections were made for lung volume (Rosenthal et al. 1993) and surface area 
artefact (Dewit et al. 2000) using children’s equations to obtain actual body volume. 
This value was then used in subsequent calculations using the multi-component model 
to calculate FM and FFM.
Figure 4-1 BODPOD machine 
Source: Nutrition Unit, Institute o f  Child Health
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4.3.4 Dual X-ray absorptiometry (DXA)
Bone mineral content (BMC) was measured using DXA (Lunar Progidy, GE Medical 
Systems, Madison, Wisconsin, USA) (see Figure 4-2). The scanner was calibrated daily 
according to the manufacturer’s recommendations using a spine phantom, and all scans 
were performed and analysed by a licensed radiographer. The scan was performed with 
the subjects wearing light indoor clothing containing no metal, and they were required 
to lie in the supine position with arm and legs at their sides during the whole scan. The 
typical scan duration is approximately 1 0 - 1 5  minutes, depending on the weight and 
height of the subject. The radiation exposure per scan is estimated to be 2.2 pSv, which 
is lower than the total daily background radiation exposure in the UK; estimated to be 7 
pSv.
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Figure 4-2 DXA machine (top); example of DXA whole body scan print-out (bottom) 
Source: Radiology department, Great Ormond Street Hospital
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4.3.5 TANITA body fat analyser
Whole body BIA was measured using the TANITA machine (BC-418 MA), which 
provides a printout for weight, BMI, % fat, FM, FFM, TBW and desirable body fat 
ranges (see Figure 4-3).
The subject’s age, gender and height were entered manually into the machine, and then 
the subject was asked to stand in bare feet on the metal foot plates of the machine for 
approximately 30 seconds whilst holding the arm grips.
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4.4 Outcome measures
The different outcome measures obtained from the measurements above include:
1. WT
2. BV from BODPOD
3. TBW from D2 O
4. BMC obtained from DEXA
5. R from TANITA (BC-418 MA)
Using the 4C model, FM was calculated using the following equation:
FM (kg) = (2.747) BV -  (0.71) TBW + (1.46) BMC -  (2.05) WT Equation 4-1
(Fuller e / <3 / .  1992)
There is a weight limit of 115 kg on the DXA machine. Therefore, because 
approximately 5% of the obese subjects weighed more than 115 kg, they could not be 
scanned. Instead, the 3C model was used for calculating FM which is calculated using 
the following formula:
FM (kg) = (2.22) BV -  (0.764) TBW -  (1.465) WT
(Fuller e /ûf/. 1992)
Equation 4-2
FFM can then be calculated as the difference of FM from total body weight:
FFM (kg) = WT — FM Equation 4-3
Hffm can be calculated as the ratio of TBW to FFM: 
Hffm=TBW/FFM Equation 4-4
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4.5 Assessment of confounding factors
Factors that might confound results obtained from this study were assessed using 
questionnaires (refer to Appendix 5). These include:
4.5.1 Age
The participating subject’s age was collected and was precisely calculated using the 
following equation:
Age = (date of birth - date of measurement)/365.25 Equation 4-5
4.5.2 Social data
Social data which included ethnic origin and parent’s educational attainments and 
occupation were collected in order to establish an overview of social class of the 
subjects being measured. Social class was defined on the basis of the primary earner’s 
occupation according to the registrar general’s classification which consisted of six 
categories: I professional, II intermediate, IIINM skilled non-manual, HIM skilled 
manual, IV semi-skilled, V unskilled (Office of Population Censuses and Surveys, 
1991). Those with no occupation were not classified in this scheme, but for analysis 
were given a social code of greater than V. Socio-economic status (SES) was also 
expressed as an index of over-crowding based on the ratio of number of people per 
room of the house.
4.5.3 Medical history
For each child participating in the study a brief medical history was obtained from the 
parent or guardian. The information collected included:
• Details of any fractures
• Medical illnesses during childhood such as asthma, diabetes, epilepsy etc.
• Long-term medications or currently on any medications such as bronchodilators,
steroids, hormones etc.
• Supplements such as multivitamins, minerals, fish oils etc.
• Family history of diseases including high cholesterol, heart disease, 
osteoporosis, hypertension and diabetes
• Details of any surgery during childhood
• Parent’s weight and height
• Gestation and birth weight
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4.5.4 Physical activity
Level of physical activity was assessed using a special questionnaire. The child was 
asked how many physical education (PE) lessons he or she had a week and the number 
of hours they spent on activities outside PE classes. The child’s inactivity level was also 
assessed by asking how many hours they spend sitting around watching television and 
videos and playing on the computer. The total number of hours was reported on a usual 
school day and on a usual weekend day. In addition, the parent’s opinion of the child’s 
physical activity compared to their peers of the same age and gender was asked. This 
was answered on a five-point scale ranging from “much less active” to “much more 
active”.
4.5.5 Pubertal status
Sexual maturation was assessed according to the Marshall and Tanner classification. 
Children over the age of nine years were given self assessment pictures (breast 
development and pubic hair in females; genitalia and pubic hair in males) (refer to 
Appendix 6). Each child was asked to indicate which picture mostly resembled their 
current appearance. The categories include: pre-pubertal boys with pubic hair stage and 
gonadal stage I and girls with pubic hair stage and breast stage I; pubertal boys with 
pubic hair and gonadal stage II to III and girls with pubic hair stage and breast stage II 
to III; late pubertal/post-pubertal boys with pubic hair and gonadal stage IV to V and 
girls with pubic hair stage and breast stage IV to V. It has been previously 
demonstrated that there is a good agreement between self-assessment stages of puberty 
and those assessed by a physician (Duke et al. 1980).
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4.6 Ethical considerations and study plan
Ethical approval was granted by GOSH for Children NHS Trust/ Institute of Child 
Health Research (ICH) Ethics Committee. Ethical approval was also obtained from 
University College Hospital (UCH) (refer to Appendix 1)
The project was also registered with the Data Protection Act at ICH/GOSH. Only those 
involved in the research and a representative from the research ethics committee have 
access to the data collected in the study. Each participant was given a unique study 
number. Names and addresses along with the consent forms were not computerized; 
they were stored in a filing cabinet separate to the measurements data files. Data on my 
computer is password protected at ICH. Data storage and all other procedures are 
compliant with the Data Protection Act.
Children were recruited from the outpatients clinics at GOSH and UCH, and through a 
weight-management clinic at Chichester: lifestyle, eating, activity and fitness (LEAF) 
clinic, and also through the media. The study was verbally explained to both the parents 
and children. If they expressed interest in taking part, a parent information sheet (refer 
to Appendix 2a) and child information sheet (refer to Appendix 2b) was then given or 
sent to them. At this point their contact details including address and telephone number 
were collected. They were contacted after approximately one week to ensure that 
enough time was given to read and understand the information regarding the project. A 
suitable appointment was then made and an appointment letter was sent (refer to 
Appendix 3).
For the TLP, children were recruited through their general practitioners (GPs)
After explaining the study and before proceeding with the measurements, both written 
parental consent (refer to Appendix 4a) and child assent (refer to Appendix 4b) were 
obtained. Subjects over 16 years did not require parental consent and were given 
participant consent forms (refer to Appendix 4c). These forms were signed by the 
parents and participants first, and then by myself before commencing.
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Travel expenses were reimbursed, and all subjects received a print-out copy of their 
whole body skeleton (obtained from the DXA scanner) in addition to a £5 voucher from 
WH Smith as a token of appreciation.
The study took place at GOSH in the body composition suite situated in the Radiology 
Department. Participating subjects were asked to report to X-ray reception on the day of 
the study. The suite consisted of two rooms: the first contained the DXA scanner, and 
the second contained the BODPOD and TANITA BC-418 MA. The study took almost 
one and a half hours; half an hour was spent in the DXA room and the remainder of the 
time was spent in the second room. The appointment was considerably shorter for 
follow-up visits; especially third visits where DXA scans were not performed.
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Chapter 5: Body composition in obese children and 
adolescents
5.1 Introduction
There has been substantial research investigating body composition in obese children. 
However, the majority of these studies have been limited by the methods used to assess 
body composition with many using BMI as the main outcome. However, children’s 
body composition development is not stable: the process of growth and maturation 
alters their body composition making theoretical approaches suitable for use in adults 
inappropriate for children. In order to estimate body composition with optimum 
accuracy in young children and adolescents, it is necessary to use methods that 
minimize assumptions made about the various body components. This study uses the 
most accurate technique, also known as the ‘gold standard’ (the 4C model) to 
investigate body composition differences between obese and non-obese children and 
adolescents.
5.2 Hypothesis
Body composition differs between obese and non-obese children and adolescents
This hypothesis can be subdivided into the following four objectives:
1. Compare differences in size between obese and non-obese children
2. Compare gross tissue masses, the fat and lean tissues, between obese and non- 
obese children
3. Compare the composition of FFM, specifically hydration and density, between 
obese and non-obese children and adolescents.
4. Compare regional distribution of fat and lean mass between obese and non- 
obese children and adolescents.
Furthermore, for all the main objectives above, this study will additionally test for 
gender differences in obese and non-obese children, and whether differences between 
obese and controls vary by gender. The effect of age on body composition will also be 
described in obese and non-obese children.
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5.3 Study design
These hypotheses were investigated in a cross-sectional study looking at all the obese 
children, and comparing their body composition outcomes with those of non-obese 
children after matching them for age (to within one year) and gender. If obese children 
were recruited as part of a treatment programme, only their baseline data were used in 
this analysis.
5.4 inclusion and exclusion criteria
To be eligible to take part in this part of the study, obese children were > 4 years old, 
with BMI > 95^  ^ percentile equivalent to BMI SDS > 1.64 as defined by the 1990 UK 
reference cut-offs (Cole et al. 1995). Because different ethnic groups vary in body 
composition, only those from White ethnic origin were included in this part of the 
analysis.
Controls had BMI-SDS between -1 and 1, to ensure that obese children were not 
compared to overweight or underweight children. They were required to be healthy i.e. 
not taking any kind of medication or having a condition that could affect their growth or 
nutritional status, and they should have been bom >37 weeks gestation.
5.5 Recruitment
Obese children were recruited from weight-managements clinics based at GOSH and 
UCH, and from the LEAF clinic in Chichester. Both obese and control children were 
also recruited from an ongoing body composition research project for healthy children 
and adolescents at ICH/GOSH. Thus, some obese children and adolescents were not 
recruited as patients.
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5.6 Sample size
The conventional formula for a paired sample t-test used to determine the number of 
children required to detect a difference between two case-control matched groups is:
N = 8 (SDVD^) Equation 5-1
Where N is the number per group, SD is the standard deviation, D is the difference 
between groups. This provides 80% power and significance cut-off of 0.05 (p < 0.05). 
This formula allows you to calculate for a given SD of a trait what magnitude and
difference you can detect for a given sample size, or how many subjects you need per
group to detect a given difference. Hence, very few subjects (N) are needed to detect a 
big effect (D) and vice versa. Most biological factors create relatively small effects and 
there is no consensus on the cut-off point for excess fatness of overweight or obesity in 
children and adolescents; hence the difference (D) is best expressed in SD score (SDS) 
format. This simplifies the formula to:
N = 8/D  ^ Equation 5-2
The sample size included in the analysis is a total of 106 pairs. Based on the above 
equation, a difference of 0.27 SDS can be detected.
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5.7 Methods
The 4C model was used to estimate body composition. This model uses a combination 
of measurements including volume (from BODPOD), TBW (from D2 O) and BMC 
(from DXA); details of each of these measurements were explained in chapter 4. 
Estimates of body composition were also derived using the 3C model and compared 
against those obtained from the 4C model in both the obese and control groups.
Different factors that might confound the results such as pubertal status, socio-economic 
status (SES), activity levels, parental BMI and birth weight were assessed using 
questionnaires; details can be found in chapter 4.
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5.8 Statistical analysis
All statistical analyses were performed using the program Statistical Package for Social 
Science (SPSS v.l5 for Windows).
Correlations were used to associate age with size (including BMI), gross tissue masses 
(including FM and FFM) and Hffm in obese and control children and adolescents.
Paired sample t-tests were used to compare the different body composition outcomes, 
such as FM, FFM and Hffm between matched obese and non-obese children and 
adolescents. Paired sample t-tests were also used to compare outcomes from the 3C 
model versus the 4C model in 99 children and adolescents with data from both models.
Independent sample t-tests were used to investigate gender differences in body 
composition for the obese and non-obese; gender being the independent variable.
Chi-Square tests were used to test for differences between obese and non-obese, and 
between genders in non-interval variables such as: SES, physical activity level and 
pubertal status.
General linear models were used to test for body composition differences between obese 
and controls after adjusting for potential confounding factors such as SES, birth weight, 
pubertal status, maternal and paternal BMI, and to investigate what proportion of the 
crude difference these confounders account for. In each model, the dependant variable 
was the outcome such as FM and FFM, the fixed factors included non-continuous 
factors such as sex, status (obese or control) or physical activity level, and the co­
variants were confounding factors such as height or gestation. In this study, two models 
were generated. These will be explained in detail later on.
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5.9 Results
5.9.1 Background characteristics of the sample
A total of 186 obese children and adolescents were measured although some had to be 
excluded from the analyses because they did not fulfil the inclusion criteria for this part 
of the study, or they did not have complete required measurements (see Table 5-1 for 
details). Therefore, the sample size consisted of 112 obese children and adolescents; 45 
males and 67 females, ages ranging between 4.6 - 21.7 years. A breakdown of where the 
obese sample was recruited from can be seen in Table 5-2.
Of the final sample of 112 eligible obese children and adolescents, a total of 106 (45 
males; 61 females) were matched with controls due to lack of available controls for 
some ages required. No significant differences were seen between the non-matched 
obese sample and the remaining obese sample for any of the background or physical 
characteristics. Therefore the final sample included in the analyses was 106 matched 
pairs of obese and control children and adolescents. The maximum age difference 
between matched obese and controls was 0.95 years, however 91.5% of the sample were 
matched to within 0.5 years.
The background characteristics of the matched obese and control children and 
adolescents are given for boys and girls in Table 5-3 and Table 5-4 and respectively. 
Data are presented as mean, standard deviation (SD) and range. There was no 
significant difference in age between obese and pair-matched control children and 
adolescents (average difference = 0.2 years; p = 0.5; range = 0 - 0 . 9  years). No 
significant differences were found for SES, pubertal status and birth weight in obese 
versus controls matched for age, gender and ethnicity. No significant difference in 
gestational age was found between obese and control girls, however obese boys were on 
average bom significantly earlier than control boys (mean difference = 0.8 ± 0.3 weeks;
p = 0.01).
Even though there were no significant differences in the number of hours of physical 
activity reported between obese and controls, a significant difference was apparent 
when the rating of physical activity compared to peers was used (this is when parents 
ranked their children on a scale of 1-5 of how active or inactive they perceived them to 
be); whereby obese were significantly less active compared to controls (p = 0.002 for
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boys; p = 0.03 for girls). Also, obese children had significantly heavier parents 
compared to controls. Mothers and fathers of obese boys had on average 4.0 kg/m^ (p = 
0.003), and 3.3 kg/m^ (p = 0.004) higher BMI values respectively, and those of obese 
girls were 6.5 kg/m^ (p = 0.002), and 2.3 kg/m^ (p = 0.03) respectively heavier.
Table 5-1 A list of the sample excluded from the analyses
Number excluded Reason
1 Hffm outside the normal range; defined by 
68-84%
2 no BODPOD measurement
13 unknown ethnicity (missing)
58
21
15
2
20
non-white
Black
Asian
Chinese
other ethnic backgrounds
Table 5-2 Description o f  where the final sample was recruited from
Number Recruitment
3 LEAF clinic in Chichester
3 UGH clinic
23 Metformin trial at UGH
25 “Traffic Light Program” at GOSH
52 Reference study
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5.9.2 Effect of age
In both obese and non-obese children and adolescents, age was found to be positively 
associated with BMI; and this was highly significant (p < 0.001) (refer to Figure 5-1).
In terms of gross tissue masses, age was found to be positively and significantly 
associated with FM and FFM in both groups of children (p < 0.001). However, after 
adjusting FM and FFM for height, age was no longer associated with FM in obese 
children (p = 0.2), but the association with FFM remained significant. A scatter-plot 
demonstrating these associations are shown in Figure 5-2 and Figure 5-3.
Looking at the composition of FFM, it can be shown from Figure 5-4 that there is a 
negative association between age and Hffm in both obese and controls. Correlations 
showed that this association was borderline significant in obese (p = 0.07), but highly 
significant in controls (p < 0.001).
These findings support my approach of matching for age when comparing obese and 
non-obese children and adolescents.
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Figure 5-1 A scatter-plot dem onstrating the association between age and BM I in obese and control 
children and adolescents
Obese: r = 0.44, p < 0.001; Controls: r = 0.81, p < 0.001
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Figure 5-2 A scatter-plot dem onstrating the association between age and FM (top) and FM I 
(bottom) in obese and control children and adolescents
FM: obese: r = 0.46, p < 0.001; controls: r = 0.61, p < 0.001 
FMI: obese: r = 0.15, p = 0.2; controls: r = 0.30, p = 0.002
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Figure 5-3 A scatter-plot demonstrating the association between age and FFM 
(top) and FFMI (bottom) in obese and control children and adolescents
FFM: obese: r = 0.82; p < 0.001; controls: r = 0.87, p < 0.001 
FFMI: obese: r = 0.63, p < 0.001 ; controls: r = 0.73; p < 0.001
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Figure 5-4 A scatter-plot demonstrating the association between age and Hffm in 
obese and control children and adolescents.
Obese: r = -0.19, p = 0.07; controls: r =-0.34, p < 0.001
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5.9.3 Size differences of the sample
Anthropometry measurements of the matched obese and control children and 
adolescents are reported for each sex in Table 5-5. As intended, obese children were 
substantially heavier than controls; WT SDS difference of 2.4 ± 0.2 (p < 0.001) and 
BMI SDS difference of 2.6 ±0.1 (p < 0.001). Compared to non-obese girls, obese girls 
were on average 3.0 ± 1.2 cm taller (p = 0.01). Obese boys were 2.6 ± 1.5 cm taller than 
non-obese boys; unlike in girls this was not quite significant (p = 0.08). No significant 
gender differences in WT, HT and BMI SDS were found within the obese or the control 
children and adolescents.
Obese children had significantly greater circumferences of the head, arm, calf, thigh, hip 
and waist than controls (p < 0.001). Boys had significantly greater head circumference 
than girls (p = 0.001 in obese; p = 0.05 in controls). Boys also had greater waist 
circumference than girls (p = 0.04 in obese; p = 0.05 in controls); these differences were 
no longer significant when WC SDS was used. There were no significant gender 
differences in the arm, calf, hip and thigh circumferences in the obese or the control 
group.
5.9.4 Body composition differences In the sample
Raw body composition measurements and whole body composition outcomes using the 
3C and 4C model for the matched obese and control sample are described in Table 5-6. 
A comparison of values obtained using the 3C and 4C model in the matched sample that 
had measurements from both models is given in Table 5-7. The latter table shows the 
average differences between matched pairs, whereas the former table only shows the 
average value of each of the measurements. Comparing raw body composition 
measurements between obese and control children and adolescents using paired sample 
t-tests, the former group had significantly higher body volume (BV), total body water 
(TBW) and bone mineral content (BMC) (p < 0.001). There were no gender differences 
in obese or control children and adolescents for measures of BV and BMC. However, 
obese and control boys had significantly greater TBW compared to girls; p = 0.02 and p 
= 0.005 respectively.
Measurements of FM, FFM and % fat levels obtained from both the 3C and 4C models 
were also significantly greater in obese versus matched controls (p < 0.001). Control
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boys had approximately 3.2 kg more FFM (p = 0.006) and 6.7 kg less FM (p < 0.001) 
than control girls, using both the 3C and 4C models. These gender differences remained 
significant when FM index (calculated as FM/ HT^) (FMI) and FFM index (calculated 
as FFM/HT^) (FFMI) were used.
There were no gender differences in FM between obese boys and obese girls. This 
remained when FMI was used. On the other hand, FFM was significantly greater in 
obese boys compared to girls (mean difference of 6.7 kg), but only when the 3C model 
was used (p = 0.03). This difference lost its significance when FFMI was used.
The various components of FFM including water, protein and mineral were then 
investigated. Obese children were found to have significantly greater Hffm compared to 
controls (p < 0.001); with a difference of 1.4% when using the 3C model versus 1.7% 
when the 4C model was used. Not surprisingly, because an increased hydration was 
found in obese children, a significantly lower density of FFM (Dffm) was found in obese 
children using both the 3C (mean difference = -0.007 ± 0.002; p<0.001) and 4C model 
(mean difference = -0.005 ± 0.001; p < 0.001); the former model overestimating the 
difference by 0.002 kg/1. Because DXA was incorporated in the 4C model, only the 4C 
model can provide information about the protein and mineral components of FFM. Both 
of these components were also found to be significantly greater in obese children 
compared to matched controls. The protein to mineral ratio was also significantly lower 
in obese children (p < 0.001). This ratio is assumed to be constant when measurements 
obtained from the 3C model are estimated.
Obese boys had significantly greater Hffm compared to obese girls using the 3C and 4C 
models. Dffm was significantly greater in obese girls compared to obese boys only when 
the 4C model was used (p = 0.02). Gender differences in Hffm and Dffm were not 
observed in controls. Protein mass was found to be significantly greater in control boys 
compared to girls (p = 0.005); but not between obese boys and girls. No gender 
differences were found for mineral mass either in the obese or in the control groups.
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5.9.5 Regional body composition differences of the sample
Regional body composition measured by DXA can be seen for obese and controls
presented separately for each sex in Table 5-8. As expected DXA showed that the 
different body segments including the arms, legs and trunk regions had significantly 
greater amounts of fat, lean and bone in obese children and adolescents compared to 
matched controls (p < 0.001). Except for the significantly greater amount of arm lean in 
obese boys compared to girls (p = 0.04), there were no gender differences in bone, fat or 
lean in the different body components of obese children and adolescents. On the other 
hand, control boys had significantly greater lean mass in the trunk (p = 0.003), legs (p = 
0.001) and arms (p = 0.001) than girls. Control girls had a significantly greater amount 
of fat in the trunk (p = 0.001), legs (p < 0.001) and arms (p < 0.001) than boys. Also, 
control boys had significantly greater BMC in the legs (p = 0.03), but the BMC in the 
trunk and arm region was not significantly different between control boys and girls.
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5.9.6 Effects of confounding variables
After looking at absolute body composition differences between obese and control 
children, the next step was to confirm whether these differences persist after adjusting 
for potential confounding factors. Therefore, general linear models were conducted 
separately for each sex to check whether confounding factors had any effect on the 
results obtained. Table 5-9 and Table 5-10 are divided into three main sections: the first 
section shows the mean differences between matched obese and control children and 
adolescents before any factors were taken into account, the second section incorporates 
age, height, pubertal status and activity level (number of hours and activity level 
compared to peers) into the model, and the third section included everything in section 
two in addition to birth weight SDS, gestation, SES and parental BMI. The second 
model describes factors relating directly to the child, whereas the third model also 
includes factors relating to the family. All models had two additional variables included 
in the model: these were status (dummy variable 1 for being obese versus 0 for being a 
control), and match (where every matched pair had the same corresponding number in 
the match column). Because some data were missing from confounding factors such as 
parental BMI, the sample size after adjustments was lower than before any adjustments 
were made. Therefore, to be confident any differences in outcome were not due to the 
smaller sample size, the same test was performed on the sample that was included in the 
final model (data not presented in the table).
After adjusting for the different factors mentioned above, both obese girls and boys 
remained significantly heavier than controls; however the mean difference in weight 
SDS and BMI SDS decreased by 0.3 and 0.2 for girls and 0.7 and 0.4 for boys 
respectively. Similarly differences in waist circumference between obese and controls 
was also partly due to the various confounders incorporated in the model; the mean 
difference decreased by 6.1 cm for girls versus 7.2 cm for boys.
In terms of whole body composition, the magnitude of the difference in FM and FFM 
between obese and control children and adolescents was reduced after adjusting for 
various confounders but these differences remained significantly different. In obese 
boys for example, approximately 6 kg of FM and 2 kg of FFM can be accounted for the 
mentioned confounders, whereas the remainder of the difference (11kg of FM and 6 kg 
of FFM) was due to their obesity status.
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Looking at the composition of FFM, there was a significant difference in Hffm between 
obese and controls (p < 0.001); and this difference remained significant for boys (p = 
0.02) and borderline significant for girls (p = 0.07) even after taking confounders about 
the child into account (model 1). On the other hand, when all the other confounders 
were added into the model (model 2), this difference was borderline significant for boys 
(p = 0.07) and no longer statistically significant for girls (p = 0.4). In boys, the 
magnitude of the difference did not change whereby obese boys remained 
approximately 2.3% more hydrated compared to controls, however the SE increased 
from 0.5 to 1.2 possibly accounting for the change in significance. In girls the absolute 
difference in Hffm decreased from 1.4% to 0.8% (in model 1) or 0.7% (in model 2). 
Similar to boys, the SE in Hffm in girls increased from 0.3 to 0.8.
Additional analyses were performed specifically on Hffm to check whether there was one 
particular variable confounding the results obtained. Results showed that there was not 
one particular variable causing an effect, and it is possible that because these factors are 
not causing significant changes, when incorporated into a model absolute differences or 
significances change in magnitude. Confounding factors also influence the components 
of lean mass.
Data on regional distribution of fat, bone and lean has also been presented in Table 5-9 
and Table 5-10; however because of the limitations of using DXA on obese children, 
differences between obese and controls may be affected by the nature of the 
measurement and not due to the effect of the various confounders. Broadly, differences 
in regional fat distribution remained significantly different between obese and non- 
obese boys and girls even after adjusting for confounders. Differences in regional 
distribution of lean mass between obese and non-obese girls remained significantly 
different after adjusting for confounding factors. It is apparent from the model that some 
of the differences in lean mass in the trunk and legs were due to activity or puberty 
(model 1). Differences in regional distribution of lean mass between obese and non- 
obese boys decreased but remained significantly different after adjusting for puberty 
and physical activity, but were no longer significant after adjusting for factors about the 
family environment (model 2). This shows that some of the extra lean mass in obese 
children is predicted by the family environment.
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Table 5-3 Background characteristics of boys (obese & controls)
Obese Controls
n mean SD range n mean SD range
Age (years) 44 12.8 3.5 5.0-20.6 44 12.8 3.5 5.0-20.6
Gestation (wks)* 44 39.7 1.4 36-43 44 40.4 1.4 37-42
Birth weight (kg) 43 3.7 0.5 2.5-4.8 43 3.6 0.6 2.5-5.0
Paternal height (cm) 40 176.8 7.0 154.9-190.5 40 177.4 10.1 152.4-198.1
Paternal BMI (kg/m^) ** 36 30.2 4.6 21.5-45.4 36 27.0 3.5 18.8-35.2
Maternal height (cm) 43 164.5 6.5 152.4-175.3 43 164.2 6.4 149.9-177.8
Maternal BMI (kg/m^) ** 42 2&5 5.1 18.6-41.9 42 25.6 5.3 20.1-40.6
Physical activity (hours/wk) 42 7.1 5.1 0-28 42 7.8 5.4 0-24
Physical activity compared
to peers
(n, %) *
Much less active& less active 14 32.6 2 4.7
Same 20 46.5 18 41.9
More active 8 18.6 15 34.9
Much more active 1 2.3 8 18.6
Social Class (n, %)
Class 1 5 11.4 13 2 9 j
Class 2 15 34.1 14 3L8
Class 3 2 4.5 6 13.6
Class 4 or more 22 50.0 11 25.0
Pubertal status (n, %)
Pre-pubertal 9 20L9 8 18.2
Early pubertal 25 58.1 21 47.7
Late pubertal 9 20.9 15 34.9
* Significant difference between groups at p<0.05, ** Significant difference between groups at p<0.005. 
Abbreviations: n= number in group; SD= standard deviation; wks= weeks; BMI= body mass index
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Table 5-4 Background characteristics o f girls (obese & controls)
Obese Controls
n mean SD range n mean SD range
Age (years) 61 12.2 3.7 4.6-21.7 61 12.2 3.6 4.7-21.9
Gestation (wks) 61 40.2 1.2 38-44 61 40.0 1.3 37-42.6
Birth weight (kg) 60 3.5 0.5 2.7-4.6 60 3.4 0.5 2.2-4.7
Paternal height (cm) 51 177.5 7.1 154.9-193.0 51 177.9 8.3 154.9-203.2
Paternal BMI (kg/m^) ** 49 2&8 6.3 18.8-56.4 49 26.4 4.0 20.1-37.1
Maternal height (cm) 52 164.9 6.5 152.4-177.8 52 162.5 6.0 152.4-175.3
Maternal BMI (kg/m^) ** 51 31.0 12.7 19.7-93.2 51 24.5 4.4 16-43.2
Physical activity (hours/wk) 60 5.6 4.8 0-25 60 6.5 4.8 0-20
Physical activity compared
to peers (%) *
Much less & less active 16 26^ 5 8.3
Same 29 47.5 26 433
More active 13 21.3 23 383
Much more active 3 4.9 6 10.0
Social Class (%)
Class 1 4 6.5 10 16.4
Class 2 19 30 6^ 26 42.6
Class 3 9 14.5 10 16.4
Class 4 or more 30 48.4 15 24.6
Pubertal status (%)
Pre-pubertal 9 14.8 20 328
Early pubertal 33 54.1 25 41.0
Late pubertal 20 328 16 26.2
^Significant difference between groups at p<0.05, **Significant difference between groups at p<0.005  
Abbreviations: n= number in group; SD=standard deviation; wks= weeks; BM I= body mass index
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Table 5-5 Anthropometry measurements of the matched sample (obese & controls)
Obese Controls
Boys Girls Boys Girls
n mean SD n mean SD n mean SD n mean SD
Anthropometry
Weight (kg) ’ 44 77.5 333 61 68.4 223 44 45.8 14.7 61 42.3 14.0
Height (cm) ^ 44 157.4 17.0 61 151.4 14.8 44 154.8 17.3 61 148.4 17.6
BMI (kg/m'^) 44 30.1 8.2 61 29^ 6.4 44 18.5 2.2 61 18.5 2.5
Weight SDS ' " 44 2.7 1.1 61 2.6 0.9 44 0.3 0.6 61 0.13 0.7
Height SDS " 44 0.7 1.09 61 0.72 0.92 44 0.37 038 61 032 0.92
BMI SDS 44 2.8 0.8 61 2.6 0.8 44 0.20 0.59 61 0.05 060
MUAC (cm) 42 32.9 6.5 58 32L0 5.1 44 23.1 3.4 58 23.2 3.4
Head C (cm) 42 57.3 2.7 60 55.7 2.0 42 55.1 2.2 60 54.2 2.1
WC (cm) 42 94.0 19.0 60 87.0 14.5 42 66.4 7.5 60 63.6 7.2
Hip C (cm) 42 101.6 16.9 60 100.7 16.3 42 80.4 10.8 60 80.5 12.8
Thigh C (cm) ' 42 58.1 13.7 60 57.8 13.2 42 45.5 6.1 60 45.8 7.0
Calf C (cm) 42 37.9 7.7 60 363 7.4 42 323 9.3 60 303 4.2
WC SDS '■" 36 2.5 0.8 53 3.1 0.8 36 0.5 0.6 53 0.6 0.7
Abbreviations: n= number per group; SD= standard deviation, BMI= body mass index; SDS= SD score, MUAC= mid-upper arm circumference, C -  
circumference, WC= waist circumference
I : significant difference between obese & control boys; p < 0.05 2: significant difference between
3. significant difference between obese boys & obese girls; p <0.05 4: significant difference between
obese & control girls; p < 0.05 
control boys & control girls; p < 0.05
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Table 5-6 Whole body composition measurements o f the matched sample (obese & controls)
Obese Controls
Bovs Girls Bovs Girls
n mean SD n mean SD n mean SD n mean SD
Body volume (1) ' 44 77.4 343 61 68.4 233 44 43.4 13.7 61 40.8 13.7
TBW (1) 44 353 13.9 61 293 7.9 44 28.4 9.6 61 23.4 7.1
3C data
Weight (kg) 44 77.5 333 61 68.4 223 44 45.8 14.7 61 423 14.0
FM (kg) 44 31.5 19.3 61 29.1 13.5 44 7.4 3.2 61 10.6 5.2
FMI (kgW ) 44 12.2 5.8 61 12.3 4.9 44 3.1 1.2 61 4.6 1.6
FFM (ka) 44 46.0 17.7 61 393 10.9 44 38.4 13.4 61 31.7 9.9
FFMI (ke/m-’) 44 17.9 3.7 61 16.4 2.0 44 15.4 2.1 61 13.8 1.5
% Fat 44 39.2 8.8 61 41.1 7.5 44 16.7 5.9 61 243 6.4
D,rm(kg/I)''' 44 1.08 0.02 61 1.08 0.02 44 1.09 0.007 61 1.09 0.006
Ham(%)'"' 44 76.4 2.1 61 75.2 1.7 44 74.2 1.6 61 74.0 1.5
4C data
Weight (kg) 39 683 21.8 60 67.7 21.9 39 43.7 14.0 60 41.9 13.7
BMC (ka) 39 2.0 0.7 60 2.0 0.7 39 1.7 0.7 60 1.6 0.6
FM (ka) 39 263 10.7 60 29.0 13.0 39 7.5 2.9 60 10.8 5.3
FMI (ka/m") 39 10.8 3.7 60 12.3 4.5 39 3.2 1.1 60 4.7 1.7
FFM (kg) 39 42.0 15.0 60 383 10.6 39 363 12.8 60 31.1 9.5
FFMI (ke/m^) 39 16.9 2.7 60 16.7 2.1 39 15.0 2.0 60 13.9 1.5
% Fat 39 38.5 7.9 60 41.6 7.3 39 17.6 5.9 60 24.8 6.6
Dff„(ka/I) 39 1.085 0.010 60 1.091 0.01 39 1.092 0.006 60 1.094 0.006
%m(%) 39 773 2.3 60 76.1 1.8 39 74.9 1.8 60 74.7 1.6
Protein mass(kg) 39 7.0 2.7 60 6.7 1.9 39 7.0 2.9 60 5.9 1.8
Mineral mass (kg) 39 2.6 0.9 60 2.5 0.9 39 23 0.8 60 2.0 0.8
Protein:mineral ratio 39 2.7 0.5 60 2.8 0.5 39 33 0.5 60 3.0 0.4
Abbreviations: n= number per group; SD= standard deviation; TBW = total body water, BM C= bone mineral content, F M - fat mass, FFM= fat-free mass, FMI= fat mass index, 
FFMI= fat-ffee mass index, Dfftn= density o f  FFM, Hffm= hydration o f  FFM. 1; significant difference between obese & control boys 2; significant difference between obese & control 
girls 3 .significant difference between obese boys & obese girls 4; significant difference between control boys & control girls; p <  0.05
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Table 5-7 Differences in body composition for obese versus matched controls for the 3C and 4C models
3C model (n = 99) 4C model (n = 99)
difference SE P difference SE P
FM (kg) 18.3 1.1 <0.001 18.5 1.1 <0.001
FMI (kg/m^) 7.5 0.4 <0.001 7.6 0.4 <0.001
FFM (kg) 7.0 0.8 <0.001 6.8 0.8 <0.001
FFMI (kg/m^) 2.5 0.2 <0.001 2.4 0.2 <0.001
% fat 19.2 1.0 <0.001 18.4 0.9 <0.001
1.4 0.2 <0.001 1.7 0.2 <0.001
Dffm (kg/1) -0.007 0.002 <0.001 -0.005 0.001 <0.001
Protein (kg) &52 0.17 0.003
Mineral (kg) 0.45 0.06 <0.001
Protein: mineral -0.32 0.06 <0.001
Difference= mean difference, calculated as obese-control values
Abbreviations: SE= standard error, FM= fat mass, FFM= fat-free mass, FMI^ fat-mass index, FFMI= fat-free mass index, hydration o f  FFM, density 
o f FFM
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Table 5-8 Regional body composition measurements by DXA o f the matched sample (obese & controls)
Obese (n = 99) Controls (n = 99)
Boys (n = 39) Girls (n = 60) Boys (n = 39) Girls (n = 60)
mean SD mean SD mean SD mean SD
Arm bone (kg) 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.08
Arm fat (kg) 2.7 1.2 2.8 1.2 0.6 0.3 1.0 0.5
Arm lean (kg) 4.2 1.9 3.6 1.0 3.5 1.4 2.7 0.9
Leg bone (kg) 0.8 0.3 0.8 0.3 0.7 0.3 0.6 0.3
Leg fat (kg) 10.6 4.3 11.9 5.6 3.6 1.5 5.0 2.4
Leg lean (kg) 13.5 4.9 12.1 3.5 11.7 4.6 9.6 3.1
Trunk bone (kg) 0.6 0.2 0.6 0.3 0.5 0.2 0.5 0.2
Trunk fat (kg) 13.0 5.5 14.2 6.3 3.0 1.6 4.8 2.8
Trunk lean (kg) 17.8 6.0 16.7 4.7 16.1 5.7 13.5 4.2
Trunk fat: 
whole body fat
0.5 0.05 0.5 0.04 0.4 0.05 0.4 0.05
Abbreviations: n= number per group; SD= standard deviation
1 : significant difference between obese & control boys; p <  0.05 
2: significant difference between obese & control girls; p < 0.05 
3: significant difference between obese boys & obese girls; p < 0.05 
4: significant difference between control boys & control girls; p < 0.05
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no adjustment M odel 1: adjusted for adjusted for age, 
HT, pubertal stage & activity
Model 2; adjusted for age, SES, HT, pubertal 
stage, activity, parental BMI, birth weight SDS 
& gestation
N mean SE P N mean SE P N mean SE P
Weight SDS 122 2.5 0.2 <0.001 120 2.0 0.2 <0.001 105 2.2 0.4 <0.001
BMI SDS 122 2.6 0.1 <0.001 120 2.2 0.2 <0.001 105 2.4 0.4 <0.001
Waist C (cm) 121 23.2 1.6 <0.001 120 17.8 2.2 <0.001 105 16.9 4.6 0.002
Body volume (1) 121 27.7 2.2 <0.001 120 20.9 2.8 <0.001 105 18.2 5.1 0.002
TBW (1) 121 6.1 0.7 <0.001 120 4.9 0.8 <0.001 105 4.2 1.7 0.02
BMC (kg) 121 0.4 0.1 1 moonr 119 0.3 0.1 <0.001 104 0.2 0.1 W\
FM (kg) 121 18.3 1.5 <0.001 119 13.6 2.0 <0.001 104 11.3 3.5 0.005
FFM (kg) 121 7.5 0.9 <0.001 119 6.3 1.0 <0.001 104 6.3 2.0 0.006
% Fat 121 16.8 1.2 <0.001 119 12.2 1.6 <0.001 104 10.8 3.1 0.003
Dffin (kg/1) 121 -0.004 0.001 119 -0.002 0.002 p 104 0.000 0.003
Hffln(%) 121 1.4 0.3 119 0.8 0.4 104 -0.7 0.8
Protein mass(kg) 121 0.8 0.2 <0.001 119 0.8 0.2 <0.001 104 1.5 0.4 0.002
Mineral mass (kg) 121 0.5 0.1 m()oi 119 0.4 0.1 <0.001 104 0.3 0.2 yProteinrmineral 121 -0.2 0.1 8.0011 119 -0.1 0.1 p 104 0.3 0.1 a
Regional (DXA)
Arm bone (kg) 121 0.04 0.01 <0.001 119 0.03 0.01 <0.001 104 0.03 0.01 0.03
Arm fat (kg) 121 1.8 0.1 <0.001 119 1.5 0.2 <0.001 104 1.3 0.3 <0.001
Arm lean (kg) 121 0.8 0.1 <0.001 119 0.8 0.1 <0.001 104 0.9 0.2 <0.001
Leg bone (kg) 121 0.2 0.0 <0.001 119 0.2 0.0 <0.001 104 0.1 0.1 0.05
Leg fat (kg) 121 6.9 0.6 <0.001 119 5.2 0.9 <0.001 104 3.8 1.4 0.02
Leg lean (kg) 121 2.5 0.3 <0.001 119 1.8 0.4 <0.001 104 1.8 0.6 0.009
Trunk bone (kg) 121 0.1 0.0 nm.oQD 119 0.1 0.0 <0.001 104 0.03 0.06
Trunk fat (kg) 121 9.4 0.7 <0.001 119 7.3 0.9 <0.001 104 5.6 1.7 0.005
Trunk lean (kg) 121 3.2 0.4 <0.001 119 2.5 0.5 <0.001 104 3.2 1.1 0.01
T B W - total body water, F M - fat mass; FMI= FM index; FFM= fat-free mass; FFMI= FFM index; Dom= density o f  FFM; Hffm= hydration o f  FFM; DXA= dual x-ray 
absorptiometry. Highlighted p-values refer to those that lost significance in model 2.
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Table 5-10 Differences in size, whole body (by 4C) & regional body composition (by DXA) between obese versus controls boys
no adjustment M odel 1: adjusted for adjusted for age, 
HT, pubertal stage & activity
M odel 2: a 
stage, activ 
& gestation
djusted for age, SES, HT, pubertal 
ity, parental BMI, birth weight SDS
N mean SE P N mean SE P N mean SE P
Weight SDS 88 2.4 0.2 <0.001 84 1.8 0.2 <0.001 76 1.7 0.2 <0.001
BMI SDS 88 2.6 0.1 <0.001 84 2.3 0.2 <0.001 76 2.2 0.3 <0.001
Waist C (cm) 86 27.6 2.5 <0.001 82 19.6 2.9 <0.001 74 17.1 3.8 0.006
Body volume (1) 88 34.0 4.1 <0.001 84 21 3.8 <0.001 76 18.6 2.7 <0.001
TBW (1) 88 6.9 1.4 84 4.5 1.2 0.001 76 3.8 1.9
BMC (kg) 83 0.3 0.1 79 0.2 0.1 0.001 74 0.1 0.1 w
FM (kg) 83 18.9 1.7 <0.001 79 13.0 1.9 <0.001 74 14.7 3.1 0.003
FFM (kg) 83 5.8 1.5 W . Ô 0 1 I 79 4.1 1.2 0.003 74 2.4 1.8 a
% Fat 83 20.9 1.4 <0.001 79 16.9 1.7 <0.001 74 19.9 3.9 0.002
Dffm (kg/1) 83 -0.007 0.002 79 -0.006 0.003 0.06 74 -0.007 0.006
H m J % ) 83 2.3 0.5 to .0 0 1 79 2.0 0.8 0.02 74 2.5 1.2
Protein mass(kg) 83 0.02 0.3 a 79 -0.1 0.4 1 1 “ 74 -0.7 0.6
Mineral mass (kg) 83 0.4 0.1 79 0.3 0.1 0.001 74 0.2 0.1 r i
Proteinrmineral 83 -0.4 0.1 79 -0.4 0.2 0.02 74 -0.5 0.3 u
Reeional(DXA) 74
Arm bone (kg) 83 0.04 0.01 79 0.03 0.01 <0.001 74 0.03 0.02
Arm fat (kg) 83 2.1 0.2 <0.001 79 1.5 0.2 <0.001 74 1.7 0.3 0.001
Arm lean (kg) 83 0.8 0.2 79 0.7 0.2 <0.001 74 0.7 0.3 Tg
Leg bone (kg) 83 0.1 0.0 79 0.1 0.0 0.01 74 0.07 0.06
Leg fat (kg) 83 7.1 0.7 <0.001 79 4.8 0.9 <0.001 74 6.0 1.2 0.003
Leg lean (kg) 83 1.8 0.5 79 1.4 0.5 0.007 74 1.1 0.7
Tmnk bone (kg) 83 0.08 0.03 79 0.08 0.03 0.006 74 0.03 0.05 P
Trunk fat (kg) 83 10.0 0.8 <0.001 79 7.1 0.9 <0.001 74 7.4 1.4 0.002
Trunk lean (kg) 83 1.7 0.6 79 0.9 0.5 74 -0.008 0.7 M .
Abbreviations; N= obese + controls; HT= height; SE= standard error; BMI= body mass index; SDS= standard deviation score; SES= socio-economic status; C= 
circumference; TBW= total body water, FM= fat mass; FMI= FM index; FFM= fat-free mass; FFMI= FFM index; Dnh,= density o f  FFM; Hffm= hydration o f  FFM; DXA= 
dual x-ray absorptiometry. Highlighted p-values refer to those that lost significance in model 2.
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5.10 Discussion
Obese children in this study were found to have heavier parents compared to those that 
were not obese. This is consistent with the findings of previous studies (Lake et al. 
1997; Whitaker et al. 1997). This association may be due to two factors: first obesity is 
partly heritable; therefore obesity tracks from parents to children, and second the 
environment parents live in and their lifestyle behaviour may influence the children’s 
behaviours.
In the sample population studied, obese children were on average 3 cm taller than 
controls after matching for age, gender and ethnicity. This is consistent with the 
findings of previous studies (Kain et al. 1998). There is not sufficient evidence to 
explain why obese children are taller, however two theories may explain the reason 
behind this common finding. First, obese children might have been exposed to a higher 
plane of nutrition early on in life which may have contributed to faster development and 
growth (Bray et al. 2001; Tse et al. 1989; Mills et al. 1986) Reports however have 
shown that even though obese children may be taller as children or young adolescents, 
they are usually found to be stunted when followed up later on in young adulthood (Tse 
et al. 1989). Second, reports have shown that earlier sexual maturation in girls is 
associated with an increase in FM whereas earlier sexual maturation in boys is 
associated with decreased FM (Guo et al. 1997; Wang, 2002). Pubertal status has been 
assessed in this study and obese children remained significantly taller than controls after 
adjusting for pubertal status.
Due to their increased size, obese children had significantly greater body 
circumferences compared to controls. Only about one third of the waist circumference 
in obese children was accounted for by factors such as parental size and activity. 
Regional body composition analyses using DXA confirmed that obese children had 
significantly greater fat and lean mass in their limbs and trunk compared to controls; the 
difference being greatest in trunk fat. Differences in fat remained significant after 
adjusting for pubertal stage and activity. This indicates that obese children are gaining 
weight disproportionately in the abdominal region, which is correlated with an 
increased risk of metabolic complications (Daniels et al. 1999; Taylor et al. 1998).
In terms of gross tissue masses, obese children had greater amounts of both fat and lean 
mass compared to controls. Even though gender differences in these components were
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observed in controls whereby boys have less fat and more lean compared to girls, this 
was not observed in obese children. Also, the association of age with an increase in both 
fat and lean mass after adjusting for height was observed in controls, but only for lean 
mass in the obese. This phenomenon demonstrates that the association of body 
composition with age and gender is lost when a child becomes obese, and obese 
children show a different pattern of growth compared to those who are not obese. This 
aspect should be taken into account when assessing body composition in obese children.
After examining gross tissue composition differences, the next step was to look at 
differences in the composition of FFM, including water (Hffm), mineral and protein. An 
increased Hffm found in obese children has been previously reported in Bray’s study 
(Bray et al, 2001) where fatter children had significantly greater Hffm compared to the 
leaner ones (77.2% versus 74.3%; p < 0.001). Bray and colleagues (2001) found obese 
children to have approximately 3% more Hffm compared to controls, whereas this study 
showed that obese boys and girls had only 2.3% and 1.4% more Hffm respectively (Bray 
et al. 2001). The differences in the absolute percentages between Bray’s finding and 
my finding can be attributed to the difference in methodology used to assess body 
composition. Bray and colleagues calculated Hffm as TBW (measured by isotope 
dilution)/FFM (from DXA), whereas Hffm in this study was calculated as TBW 
(measured by D20)/FFM (from the 4C model). The 4C model has been previously 
shown to be a more reliable predictor of FFM compared to the DXA machine (Williams 
et al. 2006); making the difference in Hffm between obese and controls obtained in this 
study more robust. Another possibility in the differences in outcome is the degree of 
obesity; children in Bray’s study had an average BMI of 22 kg/m^ whereas average 
BMI in my study was 30 kg/m^.
One possibility explaining the increase of Hffm might be an expansion of extra-cellular 
water (ECW) space (Battistini et al. 1995); however this was not measured directly in 
this study. Previous research has shown that in adults this over-hydration persisted even 
after weight reduction was achieved either by dietary modification (Marken Lichtenbelt 
and Fogelholm, 1999) or surgery (Leone et al. 2000). The reason behind an increase in 
ECW space remains poorly understood, and it is possible that obesity causes irreversible 
alterations in hemodynamics and fluid regulation (Marken Lichtenbelt and Fogelholm, 
1999).
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The other part of FFM that was also found to be significantly altered was the mineral 
mass (0.5 kg extra mineral mass in obese children), which is mainly present in bone. 
This is consistent with reports from previous studies where obese children were found 
to have greater absolute BMC (Fischer et a l 2000). Increased weight has been 
associated with earlier bone accumulation due to earlier sexual maturation (Whiting, 
2002). After adjusting for factors such as pubertal status and activity, this increased 
mineralization remained significant. However when other factors such as parental BMI 
and SES were also taken into account, this increased in mineralization found in obese 
children was no longer significant. In relative terms obese children tend to be under 
mineralized for their weight, and have a higher rate of fractures compared to non-obese 
children, indicating that obesity is not protective for bones (Skaggs et a l 2001; 
Goulding et a l 1998). This may be due either to the bone growth taking time to catch 
up with the rapid increase in weight, causing bone fragility (Goulding et a l 1998), or to 
smaller bone dimensions in those obese (Skaggs et a l 2001).
Since the water and mineral components of FFM were higher in obese children, the 
proportion of protein was reduced resulting in lower Dffm and a lower ratio of protein to 
mineral compared to controls. These differences in the composition of FFM are not only 
important health outcomes but they also need to be taken into account when assessing 
body composition with optimum accuracy.
After adjusting for factors that may be associated with obesity, the broad conclusion 
drawn is that some of the differences in body composition between obese and non-obese 
children were not due to obesity per se, but were due to differences in activity or 
puberty or they can be predicted by the family environment, illustrating that obesity 
tracks from parents to children. However, around two thirds of an obese child’s fat can 
be attributed to other factors causing obesity such as their diet whereas only one third is 
due to factors about the child or their family such as parental size or SES.
Data from this study confirmed that when children grow, they increase in both the fat 
and the lean components of weight, and the rate of the growth of these separate tissues 
would be overlooked if simple indices like BMI were used. Also, results from using 
multi-compartment models show that the properties of FFM are not constant; obese 
children have significantly different composition of FFM compared to controls matched 
for age, sex and ethnicity. These differences remained significant even after adjusting
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for factors such as SES, birth weight, gestation Therefore for this group of subjects, 
results from 2C models that assume constant properties of FFM may provide inaccurate 
body composition values. For example using the 2C model to estimate FFM, such as 
D2 O which assumes a constant hydration of FFM, is problematic if the adult constant of 
73% is used. Also, the 3C model assumes a constant ratio of protein to mineral, and this 
ratio was found to be significantly lower in obese children. The 3C model was shown 
to underestimate fat and overestimate FFM, but the absolute differences did not differ 
substantially. Therefore in situations where DXA cannot be used, such as extreme 
obesity, the 3C model is considered a fairly accurate technique in estimating body 
composition.
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5.11 Study limitations
Even though TBW was measured using D2 O, BCW and intra-cellular water were not 
measured in this study. Therefore the reason behind the increased hydration values 
found in obese children can only be speculated on, based on findings from previous 
studies.
Due to the weight limit of 115 kg on the DXA machine, I was unable to scan very large 
children. Therefore I could not use the 4C model to obtain measurements of body 
composition in the heaviest children and only the 3C model was used on this group. 
Also regional analysis of body composition using the DXA should be interpreted with 
caution in the obese population. Due to their large size, some of the obese children were 
scanned with their arms partially tucked underneath their trunk, to fit in the designated 
scanning area. This could lead to misinterpretation of some results in terms of specific 
regional areas measured and analysed, specifically the arms and trunk.
Data on birth weight, physical activity and parental weight and height were estimated 
by the parents. Therefore, the reliability of the data recorded depends on the honesty and 
accuracy of the parental report. In order to minimize such limitations in future studies, it 
is recommended that whenever possible, data required are measured rather than 
estimated: parents’ weight and height should be measured, the child’s activity levels can 
be measured using activity monitors instead of estimating the number of hours they are 
active. This is because the child might be enrolled in an activity such as football, 
however he might be a goal keeper who is standing still most of the time rather than 
running around.
Data on the children’s dietary intake was not collected in this study. Given that the 
quality and quantity of one’s diet may be associated with differences in BMI or fat 
levels between populations (Tucker et al. 1997; Maffeis et al. 1996b), it would have 
been interesting to investigate whether differences in fat between obese and control 
children was confounded by what they ate and the quantity consumed. A food 
frequency questionnaire or a food diary could describe a person’s food habits; however 
the reliability of such data largely depends on the honesty of the children or their 
families, in addition to the accuracy of determining portion sizes. Previous research has 
shown that dietary intake recorded may be extremely biased and not recommended for 
use in obesity research (Schoeller et al. 1990).
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Chapter 6: Evaluation of the success of two 
treatment programmes in obese chiidren
6.1 Introduction
There has been considerable research on the effectiveness of various weight loss 
programmes in adults. However weight loss programmes in adults are very different to 
those in children; successful treatment in adults may not be successful in children and 
adolescents. In addition, most of the research conducted in children has used prediction 
techniques to assess body composition. It is important to measure the different body 
components directly to be confident that the programmes were successful at reducing 
body fatness. For example, programmes involving physical activity may not alter body 
weight per se, but might change the relative proportions of the fat and lean components. 
This aspect can be overlooked if  surrogate measures such as BMI are used.
There are limited available weight management programmes for children and 
adolescents in London. I have chosen the only two available programmes used in 
GOSH and UCH to test whether body composition in children changes after taking part 
in either of the two programmes. The best available technique (multi-component model) 
has been used to assess whole body composition.
Each of the two programmes will be discussed separately in two different sections: the 
first is a psychological program adopting the traffic light system, and the second is a 
pharmacological program using Metformin.
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6.2 Traffic light program (TLP)
6.2.1 Rationale of the study
The first treatment programme is the TLP which is a family-based program used for the 
treatment of paediatric obesity. The programme is based on the ‘stop light dief 
developed and tested by Len Epstein and colleagues in the United States (Epstein et a l 
1985). The program has already been tested in the US; however it still remains to be 
evaluated in the UK clinical setting. A pilot study looking at the effectiveness of a 
family based behavioural treatment in the UK confirmed that it is feasible and 
acceptable to be used in Britain (Edwards et a l 2006). Prof. Jane Wardle is conducting 
the first randomised controlled trial (RCT) in the UK. Therefore the aim was to recruit 
all children taking part in the treatment programme to measure their body composition 
and evaluate the efficacy of the treatment programme.
The program teaches parents and children healthy eating by adopting the ‘traffic lights’ 
system for classification of foods, depending on nutritional value and energy density. 
Green indicates foods which can be eaten without worrying (like vegetables), yellow 
indicates food the child should be cautious about eating (like meat and dairy products), 
and red indicates foods which the child should stop and think about before eating (like 
cakes and biscuits).
The programme consists of regular 1.5 hour meeting sessions over a period of six 
months. The first ten sessions were held weekly, the next three fortnightly and the last 
two monthly. These involved both the child and at least one of their parents meeting 
with a dietician and a psychologist. After the program ended, follow-up meetings were 
conducted every six months for a year. The children’s body composition was measured 
at baseline, 6 months and 1 year.
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The aims of the psychological program are as follows:
1. Halt weight gain instead of aiming at weight loss
2. Provide nutritional education such as having a healthy balanced diet rather than 
calorie counting
3. Provide behaviour change training for both parents and children
4. Create a healthy microenvironment by changing the whole family’s unhealthy 
patterns
5. Encourage maintenance of change
The TLP-RCT consisted of five consecutive treatment arms labelled as: waves 1 to 5. 
On average each wave was six months apart. In wave 1, children were randomised to 
two groups: the first group would start the treatment program immediately whilst the 
second group waited for six months before starting the treatment programme. The latter 
group would then act as controls. At this point, wave 2 would commence including 
wave 2 treatment group and wave 2 control group. Wave 2 treatment group would 
commence treatment with Wave 1 controls, and wave 2 control group waited for six 
months before starting treatment. This process was then repeated for each consecutive 
wave in a similar way. When two siblings from one family participated, they were both 
assigned to the same treatment arm. All participating obese children received the same 
duration of treatment of approximately six months; whether they were part of the 
treatment or control group. The only difference between the groups was that the control 
groups waited for six months before commencing treatment, and when they did become 
treated, they were not counted as part of the RCT treatment program. Refer to Figure 
6-1 and Figure 6-2 for a summary of the trial profile.
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Wave 4 
treatment 
N = 6
Wave 3 
treatment 
N = 4
Wave 5 
treatment 
N = 4
Treated not part of RCT
Treated not part of RCT
Wave 1 
treatment 
N = 7
Wave 2 
treatment 
N = 7
Treated not part of RCT
Treated not part of RCT
Treated not part of RCT
WaveS control 
N =  10
Wave 5 control 
N = 2
Wave 4 control 
N = 8
Wave 2 control 
N = 7
Wave 1 control 
N = 7
Wave 5
N = 6
Wave 4
N =  14
Wave 3
N = 14
Wave 2
N =  14
Wave 1
N =  14
Figure 6-1 A summary of the different waves of the traffic-light program 
Treatment groups started TLP immediately, whilst controls waited for 6 months before joining 
consecutive wave treatment group. When controls get treated after 6 months, they do not become part o f  
the RCT treatment group
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Total Eligible 
(Waves 1- 5)
N = 62
Randomized
Treatment Group
Pre-treatment 
N = 30 #
Control Group
6 months pre-treatment 
N =  32
N - 7
r
Dropped out N = 14
/
6 months post treatment Pre-treatment
N =  23 *
V V
N = 18**
J
N = 6 Dropped out N = 5
1 year post treatment 
N =  17^
6 months post treatment 
N =  13
Dropped out N = 4
1 years post treatment 
N = 9 (S)
Figure 6-2: A summary of the traffic-light program
# 28 (3C), 27 (4C). *18 (3C), 17 (4C). **16 (3C), 16 (4C). ^ 16(3C). ^ 1 3  (3C). @ 9 (3C).
Numbers refer to those with available data for the 3C and 4C models.
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Treatment group Control group
Wait­
listedTreated
Treated
Left
Left
Termination
visit 2 
RCT
Baseline
visit 1 
RCT
Figure 6-3 Different measurement time points (A, B, C, D) for the treatment and 
control groups
RCT treatment group includes time points: A, B & C 
RCT control group includes time-points D, A, B & C 
RCT treatment (B-A) compared with RCT control (A-D)
Treated then left compares: (C-B)-(B-A); wait-listed then treated compares: (B-A) - (A-D)
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6.2.2 Hypothesis
The traffic light program significantly alters body composition in children.
6.2.3 Study design
This was a longitudinal RCT investigating the effects of the TLP on body composition 
in obese children. Children were randomized into two different groups: the treatment 
group and the control/waiting list group. The treatment group were measured before 
starting the treatment programme (baseline pre-treatment measurement) and measured 
again after six months and after one year of being on the program. The control group 
were measured six months before starting treatment (6-months pre-baseline 
measurement), then immediately before starting treatment (baseline measurement) and 
then again after six months and after one year of being on the program.
6.2.4 Recruitment
Children in this part of the study were recruited from the TLP programme at GOSH. 
Children were initially recruited through GPs, paediatricians, school nurses and 
dieticians in London. All referrals were made to an outpatient clinic at GOSH, and those 
who were potentially eligible to participate in the study were given information sheets 
about the study.
6.2.5 Inclusion and exclusion criteria
To be eligible to participate in the TLP, children had to be between 8 and 13 years old 
with a BMI > 95^ percentile, equivalent to BMI SDS > 1.64, using UK 1990 reference 
data (Cole ct al. 1995). The children should not be suffering from any medical or 
psychological condition associated with their obesity and they should not be receiving 
any other medical or psychological treatment. At least one parent or carer was required 
to attend the treatment sessions with the child, and both the child and the parent were 
required to read and understand English.
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6.2.6 Sample size
Several factors were taken into account before calculating the appropriate sample size. 
First, the sample size needs to be large enough so that the research question can be 
answered confidently, and second the sample should be small enough to be practical to 
conduct. Also, there are two types of errors that need to be considered: type I error and 
type II error (Peat and Barton, 2005). Type I error is defined as the probability of 
rejecting the hypothesis when it is true, and type II error is defined as the probability of 
not rejecting the hypothesis when it is false. The former error occurs when a statistical 
significance is found but it is of no clinical importance, and the latter error occurs when 
a difference of clinical importance exists but does not reach statistical significance 
usually because the sample size is small.
Therefore, for the RCT, the conventional formula for a non-paired independent sample 
t-test (n = 16 SD^/D^) was used to calculate an appropriate sample size. For example, 64 
children per group would detect a difference of 0.5 SD score. If there was a 25% drop­
out rate, this difference would increase to 0.8 SD score. However, this particular trial 
was designed to take into account cluster effects, which can occur when subjects are 
recruited in waves, such that those within a certain wave may show a common effect. 
Such cluster effects require an increased sample size in order to accommodate them. 
Previous applications of this obesity treatment in the US showed a 10% change in % 
BMI, as did the pilot study in the UK (Edwards et al. 2006; Epstein et ai. 1985). The 
RCT was therefore powered to be able to detect a 10% difference in change in % BMI, 
taking into account cluster effects. The sample size needed assuming a 30% drop-out, 
would be 24 subjects per group; providing 90% power, and p < 0.05.
A total of 62 obese children were recruited to take part in the trial; 30 in the treatment 
group and 32 in the control group. 7 children dropped out of the treatment arm and 14 
dropped out of the control arm, bringing the sample size down to 23 in the treatment 
group and 18 in the control group. The final sample size can therefore detect a 
difference in change of 0.8 SD score.
6.2.7 Methods
The 4C model was used to estimate body composition (details explained in chapter 4). 
Obese children only had DXA measurements for their first two visits; therefore the 3C
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model was used to estimate body composition for visit 3 and visit 4 measurements. The 
DXA scanner has a weigh limit of 115 kg, therefore subjects beyond that weight were 
not scanned and the 3C model was used to estimate their body composition.
6.2.8 Statistical anaiysis
Independent sample t-tests were used to determine baseline and final differences in 
background data and various body composition outcomes between treatment and 
control groups, with intervention as the independent factor (dummy variable = 1 for the 
control group, and dummy variable = 2 for the treatment group).
Chi square tests were used to compare non-parametric data such as ethnicity, pubertal 
status, physical activity levels and SES between treatment and control groups.
Two different analyses were conducted using paired sample t-tests. First differences in 
change in body composition were investigated between the treatment group versus the 
waiting-list group on the RCT. For the treatment group differences between pre­
treatment and 6-month follow up outcomes were analysed, and for the control group 
differences between 6-months pre-treatment and pre-treatment measurements were 
analysed. A second analysis investigated change in body composition between those 
that were treated first and then left versus those that were left for six months before 
being treated. The first group includes everyone that had complete measurements for 
being treated and then left (this includes those on the treatment group and the control 
group who were subsequently treated but not within the RCT). The second group only 
included those that had 6-months pre-treatment measurements (i.e. only the control 
group). These analyses are described in detail later.
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6.2.9 Results
A total of 62 obese children were recruited for the programme. These were randomised 
to two groups: 30 in the treatment group (22 females; 8 males) versus 32 in the control 
group (22 females; 10 males). Baseline differences in background and body 
composition characteristics in treatment and control groups are summarised in Table 
6-1. The mean age and BMI SDS for both groups was approximately 10 years and 3 
SDS respectively. The treatment group had heavier mothers compared to the control 
group; average BMI difference of 4 kg/m^. This difference however was not statistically 
significant (p = 0.1). There were no other significant differences in any of the baseline 
characteristics between the treatment and control groups.
Of the 62 subjects who were originally recruited and had baseline body composition 
assessments, 21 obese children (14 females; 7 males) dropped out of the trial leaving a 
total of 41 (30 females; 11 males) remaining in the trial. A summary of background and 
body composition characteristics between those that remained in the trial versus those 
that dropped out of the trial are summarised in Table 6-2. In terms of background 
characteristics compared to those who remained in the trial, drop-outs were similar in 
age, ethnicity, maternal and paternal BMI, physical activity, social class and pubertal 
status. However, drop-outs had significantly greater gestational age (mean difference = 
0.9 weeks; p = 0.02) and significantly higher birth weight (mean difference = 0.3 kg; p 
= 0.04). Also, drop-outs were significantly shorter by 0.8 SDS which is equivalent to 7 
cm (p = 0.03), than those who remained in the trial. In terms of body composition, drop­
outs had significantly lower body volume (mean difference = 11.0 litres; p = 0.04) and 
BMC (mean difference = 0.3 kg; p = 0.02) compared to those included in the trial. 
Drop-outs also had on average 6.4 kg lower FFM (by 3C) compared to those included in 
the trial; this difference was statistically significant (p = 0.02). When adjusted for 
height, FFM was no longer different between both groups. No other significant 
differences in body composition were observed between both groups.
Even though a number of obese children dropped out of the treatment trial, some (n = 8) 
agreed to have body composition measurements at time of follow-up. The sample size 
however was too small for meaningful analysis.
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The final sample included in the RCT included 23 (18 females; 5 males) in the 
treatment group and 18 (12 females; 6 males) in the control group. Their background 
characteristics are summarised in Table 6-3.
The mean age of the treatment and control groups was 10.7 and 10.0 years respectively. 
Even though there were no significant differences in any of the background 
characteristics between both groups, children of fatter mothers appear more likely to be 
included in the treatment programme. Maternal BMI was approximately 8 kg/m^ higher 
in the treatment group compared to the control group, but the SD was large hence the 
difference did not achieve significance. In addition, the majority of the sample included 
in the RCT were reported to be less active than peers (assessed by using a 
questionnaire), they came from a lower social class (class 4 or more), and were in 
puberty stages II and III (as assessed by indicating pictures that resembled their status at 
time of measurement). The treatment and control groups were very similar in baseline 
body composition characteristics, with no significant differences for any of the 
measurements (refer to Table 6-4).
Change in body composition was then assessed for the treatment and control groups. 
The average time elapsed between the two measurements was 7 months; minimum 
difference = 5 months and maximum difference = 10 months, which was similar in both 
groups. For the treatment group, change in body composition was calculated as the 
difference between baseline and follow-up measurements (i.e. before and after being on 
the TLP), calculated as 6-months post treatment -  pre-treatment (B -  A). For the control 
group, change in body composition was calculated as the difference between two 
baseline measurements, one 6 months before treatment date and another just before they 
commenced the treatment, calculated as (A -  D). Refer to Figure 6-3.
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Table 6-5 shows differences in body composition between the treatment group versus 
control group. First, paired sample t-tests were used to assess change in body 
composition within each of the two groups separately, to investigate any change in body 
composition during the trial. In both groups, obese children gained significantly in 
weight and height. However when converted into SDS these differences were no longer 
significant. BMI SDS significantly reduced by an average of 0.1 SDS for both groups. 
Body volume, TBW and BMC were significantly greater at follow-up in the treatment 
and control groups. No significant differences in FM or % fat were observed, however 
children in both groups had significantly greater FFM (2.3 kg for treatment, 2.4 kg for 
control) at follow-up, changes which remained significant after adjusting for height. 
Second, independent sample t-tests were used to investigate whether change in body 
composition over time differed significantly between the groups. No significant 
differences were observed for any of the measurements except for FFM, whereby those 
in the treatment group gained 0.6 kg/m^ more FFMI compared to those in the control 
group (p = 0.02).
A further analysis was performed to investigate differences in change in body 
composition between those who received treatment, and then left as opposed to those 
that had to wait for 6 months before they received treatment. Body composition was 
assessed by the 3C model because children only had a bone scan for their first two 
visits; hence the 4C model was not used.
Those being first treated then left underwent measurements at time points A, B and C. 
Change in body composition was calculated as: change in body composition when 
being left -  change in body composition when being treated. This corresponds to (C -  
B) -  (B -  A), and would include everyone (both from treatment and control groups in 
the RCT) that had the corresponding measurements. These time points are shown in 
figure 6-3.
This group included a total of 26 children, 17 from the RCT treatment group and 9 from 
the RCT control group.
On the other hand, those that were being first wait-listed and then treated underwent 
measurements at time points D, A and B. Since only those from the control group RCT 
had measurement time point D, only those from the control group were included in this
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calculation (n = 13). Change in body composition was calculated as: change in body 
composition when being treated -  change in body composition when being left. This 
corresponds to (B -  A) -  (A -  D).
Table 6-6 illustrates relative change in body composition for both groups. The first 
group (being treated then left) reveal that being left resulted in an increase in all body 
composition parameters except FFMI. A significant relative increase in WT SDS, BMI 
SDS, MUAC, thigh circumference and FM was apparent when comparing change in 
body composition between being left versus being treated.
Analyses from the second group (being wait-listed then treated) reveal that relative to 
being left with no treatment, being treated improved body composition; results include a 
slight relative reduction in WT SDS and FM in addition to a reduction in MUAC, hip 
and calf circumferences. None of these differences however achieved statistical 
significance. One possible reason could be that the sample size used for this analysis 
was smaller (n = 13) compared to the other group: treated then left (n = 26). Hence this 
sample does show a trend but a larger sample size may be needed to achieve significant 
effects.
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Table 6-1 Baseline differences in background and body composition 
characteristics between treatment versus controls in the RCT
Treatm ent Controls
n m ean SD n m ean SD
Background
Age (years) 30 10.6 1.6 32 10.0 1.5
Gestation (weeks) 30 40.3 1.1 32 40.0 1.9
Birth weight (kg) 30 3.6 0.4 32 3.6 0.6
Paternal BMI (kg/m^) 23 2&2 8.9 27 28.9 4.3
Maternal BMI (kg/m^) 30 33.6 11.6 31 29.6 7.0
Physical activity (hours/wk) 30 5.1 5.6 32 5.3 4.9
Physical activity compared to peers (n,
%)
Much less & less active 
Same
More active 
Much more active
14 (46.7) 
12 (40.0) 
3 (10.0)
1 (3.3)
12 (37.6) 
15(46.9) 
4 (1 2 .5 )
1 (3.1)
Social Class (n, %)
Class 1 
Class 2 
Class 3
Class 4 or more
1 (3.3)
8 (26.7)
7 (23.3)
14 (46.7)
I (3.1)
II (34.4) 
4 (1 2 .5 )
16(50)
Pubertal status (n, %)
Pre-pubertal 
Early pubertal 
Late pubertal
5 (17.2)
18(62 .1)
6 (20.7)
4 (1 2 .5 )
23 (71.9) 
5 (15.6)
A nthropom etry
Weight SDS 30 3.0 0.9 32 3.1 0.8
Height SDS 30 1.4 1.2 32 1.3 1.1
BMI SDS 30 3.1 0.7 32 3.2 0.6
WC SDS 30 3.4 0.5 32 3.5 0.6
Body volume (1) 29 71.0 20.4 32 6%8 20.5
TBW (1) 29 29.4 7.0 32 2&8 7.8
BMC (kg) 29 1.8 0.5 32 1.8 0.6
3C data
FM (kg) 28 32.0 11.8 32 29.7 10.8
FMI (kg/m^) 28 13.7 4.0 32 13.8 3.8
FFM (kg) 28 3 9 J 9.1 32 37.9 10.4
FFMI (kg/m^) 28 16.9 2.3 32 17.3 2.5
4C data
FM (kg) 27 31.6 11.1 32 30.2 10.8
FMI (kg/m^) 27 13.7 3.9 32 13.8 3.8
FFM (kg) 27 37.7 7.6 32 37.3 10.3
FFMI (kg/m") 27 16.4 1.8 32 17.1 2.7
Abbreviations: SD=standard deviation; SD= standard deviation; SDS= SD score; WC= waist 
circumference; TBW = total body water; BMC== bone mineral content; FM= fat mass; FMI^ FM index; 
FFM= fat-free mass; FFMI= FFM index. No significant differences between groups.
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Table 6-2 Baseline differences in background and body composition characteristics
Drop-outs Trial
n m ean SD n m ean SD
Age (years) 21 10.0 1.4 41 10.4 1.7
Gestation (weeks) * 21 40.7 1.0 41 39.9 1.7
Birth weight (kg) * 21 3.8 0.6 41 3.5 0.5
Paternal BMI (kg/m^) 16 30.1 5.1 34 27.9 7.4
Maternal BMI (kg/m^) 21 31.0 8.7 40 31.9 10.2
Physical activity (hours/wk) 21 5.0 3.5 41 5.3 5.9
Physical activity compared to peers 
(n,T4)
Much less & less active 
Same
More active 
Much more active
6 (28.6) 
11 (52.4) 
3 (14.3)
1 (4.8)
20 (48.8) 
16(39 .0)  
4 (9.8)
1 (2.4)
Social Class (n, %)
Class 1 
Class 2 
Class 3
Class 4 or more
0 (0 )
9 (42.9) 
3 (14.3) 
9 (42.8)
2 ^ 9 )
10 (24.4) 
8 (19.5) 
21 (51.2)
Pubertal status (n, %)
Pre-pubertal 
Early pubertal 
Late pubertal
2 (9.5) 
17(81 .0)  
2 (9.5)
7 (1 7 .5 )  
24 (60) 
9 (22.5)
Anthropom etry
Weight SDS 21 2.8 0.8 41 3.2 0.9
Height SDS * 21 0.8 1.1 41 1.6 1.1
BMI SDS 21 3.1 0.5 41 3.2 0.7
WC SDS 21 3.3 0.5 41 3.5 0.6
Body volume (1) * 21 6Z 2 18.3 40 73.1 20.5
TBW (1) 21 26.2 7.0 40 30.5 7.2
BMC (kg) * 21 1.6 0.4 40 1.9 0.5
3C data
FM (kg) 21 27.5 9.9 39 3 2 5 11.6
FMI (kg/m^) 21 13.1 3.4 39 13.9 4.0
FFM (kg) * 21 34.3 8.9 39 40.7 9.6
FFMI (kg/m") 21 16.5 2.2 39 17.5 2.5
4C data
FM (kg) 21 32.4 11.2 38 28.1 9.9
FMI (kg/m") 21 13.4 3.6 38 13.9 3.9
FFM (kg) 21 3T a 8.7 38 39.5 8.7
FFMI (kg/m") 21 16.3 2.5 38 17.1 2.3
* Significant difference between groups at p < 0.05
Abbreviations: n= number per group; SD=standard deviation; BMI= body mass index; SDS= SD score; 
WC= waist circumference; TBW = total body water; BMC= bone mineral content; FM= fat mass; FMI= 
FM index; FFM=  ^ fat-free mass; FFMI= FFM index.
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Table 6-3 Background characteristics of final RCT sample: treatment versus controls
Treatment Controls
n mean SD n mean SD
Age (years) 23 10.7 1.7 18 10.0 1.5
Gestation (weeks) 23 40.3 1.2 18 393 2.0
Birth weight (kg) 23 3.6 0.4 18 3.4 0.5
Paternal BMI (kg/m^) 18 27.2 9.2 16 28.6 4.6
Maternal BMI (kg/m" )^ 23 35.1 12.1 17 27.6 4.5
Physical activity (hours/week) 23 5.1 6.0 18 5.6 5.9
Ethnicity (n, %)
White
Asian
Black
Other
12 (52.2) 
2(&7) 
5(21.7) 
4(17.3)
7 (38.9) 
6 (33.3) 
2(11.1) 
3 (16.7)
Physical activity compared to 
peers (n, %)
Much less & less active 
Same
More active 
Much more active
11 (47.8)
9(39ri)
2(8.7)
1 (4.3)
9(50)
7 (38.9) 
2(11.1) 
0(0)
Social Class (n, %)
Class 1 
Class 2 
Class 3
Class 4 or more
1 (4 J )  
6(26.1) 
6(26.1) 
10 (43.4)
1(5.6)
4 (22.2) 
2(11.1) 
11 (61.2)
Pubertal status (n, %)
Pre-pubertal 
Early pubertal 
Late pubertal
3(13.(% 
13(59.1) 
6 (27.3)
4 (22.2) 
11 (61.1) 
3 (1(5.7)
Abbreviations: n= number per group; SD= standard deviation; BMI= body mass index. 
No significant differences between groups.
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Table 6-4 Baseline body composition of the final sample in RCT : treatment versus 
controls
Treatment Controls
n mean SD n mean SD
Anthropometry
Weight (kg) 23 73.6 20.9 18 70.7 19.3
Height (cm) 23 152.5 9.8 18 148.8 10.3
BMI (kg/m^) 23 31.1 6.0 18 31.4 5.9
Weight SDS 23 3.2 1.0 18 3.3 0.8
Height SDS 23 1.6 1.2 18 1.6 0.9
BMI SDS 23 3.1 0.7 18 3.3 0.7
MUAC (cm) 23 34.0 4.7 18 328 4.2
Head C (cm) 23 56.1 2.0 18 55.5 1.9
WC (cm) 23 925 11.3 18 91.3 10.0
Hip C (cm) 23 103.2 12.4 18 101.6 12.5
Thigh C (cm) 23 62.2 8.0 18 61.4 8.8
Calf C (cm) 23 38.1 4.6 18 383 5.0
WC SDS 23 3.5 0.6 18 3.6 0.6
Body volume (1) 22 74.9 21.6 18 71.0 19.6
TBW (1) 22 31.1 7.1 18 29.8 7.5
BMC (kg) 22 2.0 0.5 18 1.9 0.6
3C data
FM (kg) 21 33.6 12.7 18 31.3 10.4
FMI (kg/m^) 21 13.9 4.3 18 13.9 3.9
FFM (kg) 21 41.8 9.0 18 393 10.4
FFMI (kg/m^) 21 17.5 2.3 18 17.5 2.7
% fat 21 43.5 5.7 18 43.8 5.3
HfTm(%) 21 75.4 1.6 18 75.9 2.0
DfTm(kg/l) 21 1.09 0.01 18 1.08 0.01
4C data
FM (kg) 20 334) 12.0 18 31.7 10.5
FMI (kg/m" )^ 20 13.8 4.1 18 14.1 3.8
FFM (kg) 20 40.1 7.3 18 384) 10.3
FFMI (kg/m^) 20 16.9 1.8 18 17.3 2.7
% fat 20 44.1 5.8 18 44.5 5.2
HfTm(%) 20 76.6 1.8 18 76.8 2.1
D ffm  (kg/1) 20 1.09 0.01 18 1.09 0.01
Protein mass (kg) 20 6.8 1.3 18 6.7 2.2
Mineral mass (kg) 20 2.6 0.6 18 2.4 0.8
Abbreviations: n= number per group; SD= standard deviation; SDS= SD score; BMI= body mass index; 
MUAC= mid-upper arm circumference; C= circumference; WC= waist circumference; TBW = total body 
water; BM C= bone mineral content; FM= fat mass; FFM= fat-free mass; FMI= FM index; FFMI= FFM 
index; Hffn,= hydration o f  FFM; Dom= density o f  FFM
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Table 6-5 Change in body composition: treatment versus controls
Treatm ent C ontrols
n D1 SD P n D2 SD P
Age (years) 23 0.6 0.1 <0.001 18 0.6 0.2 <0.001
A nthropom etry
Weight (kg) 23 3.0 3.9 0.001 18 3.5 3.8 0.001
Height (cm) 23 2.4 1.5 <0.001 18 3.0 1.5 <0.001
BMI (kg/m2) 23 0.3 1.4 0.3 18 0.3 1.6 0.5
Weight SDS 23 -0.06 0.2 0.2 18 -0.05 0.2 0.3
Height SDS 23 -0.1 0.2 0.001 18 -0.1 0.3 0.1
BMI SDS 23 -0.1 0.2 0.02 18 -0.1 0.2 0.04
MUAC (cm) 23 0.02 1.3 0.9 18 0.7 1.5 0.06
Head C (cm) 23 0.0 1.3 0.9 18 0.1 0.9 0.5
WC (cm) 23 0.8 3.9 0.3 18 0.5 4.1 0.6
Hip C (cm) 23 1.6 4.4 0.09 18 1.8 3.1 0.03
Thigh C (cm) 23 0.0 2.1 0.9 18 -0.5 2.7 0.4
Calf C (cm) 23 0.4 1.4 0.2 18 0.7 1.3 0.04
WC SDS 23 -0.1 0.2 0.3 18 -0.1 0.3 0.2
Body volume (1) 22 3.1 4.3 0.003 18 3.3 3.9 0.003
TBW (1) 19 2.0 1.2 <0.001 16 1.8 1.7 0.001
BMC (kg) 22 0.1 0.1 0.001 18 0.2 0.1 <0.001
3C data
FM (kg) 18 1.0 3.7 0.3 16 1.0 2.9 0.2
FMI (kg/m^) 18 1.0 0.6 0.2 16 -0.1 1.3 0.7
FFM (kg) 18 2.3 1.3 <0.001 16 2.4 2.1 <0.001
FFMI (kg/m") * 18 1.0 0.6 <0.001 16 0.4 0.8 0.06
% fat 18 -0.9 2.5 0.2 16 -0.9 2.4 0.2
Hflm (%) 18 0.7 1.4 0.07 16 -0.2 1.6 0.6
Dffi,,(kg/1) 18 0.003 0.006 0.06 16 0.001 0.006 0.7
4C data
FM (kg) 17 1.3 3.7 0.2 16 1.0 2.9 0.2
FMI (kg/m") 17 0.5 1.5 0.2 16 -0.1 1.3 0.7
FFM (kg) 17 2.3 1.3 <0.001 16 2.3 2.2 0.001
FFMI (kg/m") * 17 1.0 0.6 <0.001 16 0.4 0.8 0.09
% fat 17 -0.8 2.6 0.2 16 -0.8 2.3 0.2
Hffin (%) 17 0.8 1.7 0.06 16 -0.1 1.8 0.8
Dffin(kg/1) 17 -0.003 0.006 0.09 16 0.001 0.007 0.7
Protein mass (kg) 17 0.1 0.9 0.6 16 0.3 0.9 0.2
Mineral mass (kg) 17 0.1 0.2 0.004 16 0.2 0.1 <0.001
* significant difference between groups; p < 0.05
D 1 = differences between measurements made at time points B and A (B -  A)
D2 = differences between measurements made at time points A and D (A -  D)
Abbreviations: n= number per group; SD= standard deviation; SDS= standard deviation score; BMI= 
body mass index; M UAC= mid-upper arm circumference; C= circumference; WC= waist circumference; 
TBW= total body water; BM C= bone mineral content; FM= fat mass; FFM= fat-free mass; FMI= FM 
index; FFMI= FFM index; hydration o f  FFM; Dffm= density o f  FFM
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Table 6-6 Differences in change in body composition between those that were treated
then left versus those that were wait-listed then treated
Treated then left Wait-]listed then treated
n Al SD P n A2 SD P
Anthropometry
Weight (kg) 26 2.3 5.6 0.04 13 -1.4 5.6 0.4
Height (cm) 26 0.02 1.1 0.9 13 -0.5 1.6 0.3
BMI (kg/m-^) 26 0.9 2.2 0.04 13 -0.3 2.6 0.7
Weight SDS 26 0.2 0.4 0.02 13 -0.006 0.3 0.9
Height SDS 26 0.06 0.3 0.3 13 0.06 0.4 0.6
BMI SDS 26 0.1 0.3 0.04 13 0.01 0.3 0.9
MUAC (cm) 26 1.6 1.8 <0.001 13 -0.8 2.6 0.3
Head C (cm) 26 0.09 2.0 0.8 13 0.2 1.4 0.6
WC (cm) 26 2.2 6.1 0.08 13 0.05 7.0 1.0
Hip C (cm) 26 0.9 6.8 0.5 13 -0.6 4.9 0.7
Thigh C (cm) 26 1.8 3.9 0.03 13 1.7 3.7 0.1
Calf C (cm) 26 0.8 2.3 0.1 13 -0.3 1.6 0.5
Body volume (1) 25 2.4 6.1 0.06 13 -1.6 6.1 0.4
TBW (1) 26 0.02 3.2 1.0 13 -0.6 2.7 0.4
3C data
FM (kg) 25 2.1 4.4 0.02 13 -1.0 4.1 0.4
FMI (kg/m^) 25 0.06 2.1 0.9 13 0.2 1.9 0.7
FFM (kg) 25 0.07 2.9 0.9 13 -0.4 2.7 0.6
FFMI (kg/m^) 25 -1.1 1.3 <0.001 13 0.6 1.2 0.1
Al = differences calculated using data from the following time points: (C -  B) -  (B -  A): 
left - treated
A] = differences calculated using data from the following time points: (B -  A) -  (A -  D): 
wait-listed-treated
Abbreviations: n= number per group; SD=standard deviation; BMI^^body mass index; SDS=SD score; 
MUAC=mid-upper arm circumference; C= circumference; WC=waist circumference; FM=fat mass;
FMI= fat mass index; FFM=fat-free mass; FFMI= fat-free mass index
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6.2.10 Discussion
Weight-loss programmes have proven to be extremely difficult not only in obese adults 
but also in obese children and adolescents. Most previous studies used BMI and BMI 
SDS to assess the efficacy of family-based treatment programmes (McCallum et al. 
2007; Jiang et a l 2005; Bermudez de la Vega et al. 2007). BMI however does not give 
any indication of changes in fat or lean mass, or any information about the distribution 
of fat in the body. Therefore, accurate measurement of body composition is crucial 
when investigating the effectiveness of various treatment programs, especially those 
that incorporate physical activity.
The results from this study illustrate that obese children in both the treatment group and 
control group had a slight but significant reduction in BMI SDS at six-month follow-up 
(mean reduction = 0.1 SDS), but there were no significant differences in outcome 
between the groups. A similar finding was observed in the study of McCallum and 
colleagues in 2007, whereby nine months of treatment resulted in a reduction of 0.1 
BMI SDS in the treatment group, with no significant difference between being part of 
the treatment group or the control group (McCallum et al. 2007).
On the other hand several other studies reported a significant decrease in BMI SDS in 
the treatment versus control group (Johnston and Steele, 2007; Jiang et al. 2005; 
Bermudez de la Vega et a l 2007). Johnston and Steele (2007) reported that 10 weeks 
of treatment resulted in a significantly greater decrease in BMI SDS in the treatment 
group versus control group (Johnston and Steele, 2007). One possible reason for the 
different finding is the population used in the study; Johnston and Steele included 
overweight in addition to obese children, whereas my study only included obese 
children. Those with greater adiposity may find it more difficult to adhere to the 
treatment programme compared to those who are less obese.
Jiang and colleagues (2005) also reported a significant reduction in BMI SDS between 
treatment and control groups (mean difference in BMI SDS between treatment and 
control group = 1.3) (Jiang et al. 2005). Jiang’s sample consisted solely of obese 
Chinese children, whereas the population from my study consisted of a mix of ethnic 
groups (approximately 50% White and 50% other ethnic groups including Asian, Black 
and other). Since ethnic groups vary in their body composition and perhaps in the
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factors that increase their risk of weigh gain and response to treatment, the results 
obtained from Jiang’s study may not be comparable to those obtained from my study.
Bermundez de la Vega (2007) also showed that 6 months of treating obese children on 
the TLP resulted in a significant reduction in BMI SDS (average reduction = 0.6 SDS) 
(Bermudez de la Vega et al. 2007). Even though the sample size used in his study was 
large (n = 50), there were no controls. The effectiveness of the trial was therefore not 
confirmed.
This study is the first to measure body composition changes in obese children with the 
most accurate approach at present; using the multi-component model. No significant 
change in FM or % fat was observed between both the treatment and control group. 
There was however a significant increase in FFM (by 2.3 kg) in both the treatment and 
control groups at the end of the trial even after adjusting for change in height. Also, 
there was a significant difference between both groups whereby those in the treatment 
group had an average of 0.6 kg/m^ more FFMI compared to controls (p = 0.02). One 
possible reason for this is that the treatment group became more active at the end of the 
trial. There were no differences in the number of hours of physical activity or level of 
activity compared to peers between the treatment and control group at baseline. 
However, at follow-up, the treatment group were on average doing 1.5 hours of physical 
activity a week more than the control group. Also, 6% of those on the treatment group 
reported that they were more or much more active compared to their peers, as opposed 
to none on the control group. None of these differences in physical activity achieved 
statistical significance.
Only one study assessed the efficacy of the TLP by measuring body composition in a 
group of obese children (Savoye et a l 2007). They found a significant decrease in % 
fat in the treatment versus control group (mean difference at 6 months = 5.2 %). 
Savoye and colleagues used a foot-foot impedance machine to assess body composition. 
This method however relies on using in-built equations that rely on using constant 
hydration values (usually 73%). I have previously reported in chapter 5 that obese 
children have significantly greater Hffm compared to non obese children (average 
hydration = 77%; SD = 2). Therefore, results obtained from impedance equipment need 
to be interpreted with caution. Validation of BIA in obese children will be discussed in 
depth in the next chapter (chapter 7).
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Even though results from the RCT did not reveal differences in body composition 
between treatment and control groups, differences in change in body composition when 
being treated as opposed to being left resulted in positive findings. There was a trend in 
relative reduction in weight, BMI and fat in the period when they were treated, versus a 
relative increase in weight, BMI and fat in the period when they were left. This 
illustrates that even though no significant differences were observed between treatment 
and control groups, there was a relative positive group effect in being treated versus 
being left.
One reason behind differences observed between the two analyses is that the groups 
included in each of two analyses varied in body composition, i.e. those who were part of 
the control group performed better when they received treatment compared to those on 
the treatment group. Since the RCT analysis only compares change in body composition 
between pre-baseline and baseline measurements for the control group, how the control 
group then performs on treatment is not studied. Hence the efficacy of the treatment 
programme may be overlooked if the control group performed better than the treatment 
group. On the other hand when the second analysis was performed, whereby everyone 
who received treatment was included such that those who were part of the RCT control 
group were also added, a significant positive effect was observed. Figure 6-4 and Figure 
6-5 clearly illustrate that compared to those who were part of the RCT treatment group, 
most of those that were originally part of the RCT control group showed a greater 
reduction in FM (mean change = -1.5 ± 3.3 kg for the control group versus -0.6 ±3.1 kg 
for the treatment group), and a greater reduction in BMI SDS (mean change = -0.08 ± 
0.2 for the control group versus -0.05 ± 0.2 for the control group).
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Figure 6-4 Change in FM in the control group versus the treatm ent group
Change in FM was calculated as: change in FM when being treated - change in FM when being left 
Change in FM = (B - A) - (C - B)
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Figure 6-5 Change in BMI SDS in the control group versus the treatment group
Change in BMI SDS was calculated as: change in BMI SDS when being treated - 
change in BMI SDS when being left 
Change in BMI SDS = (B - A) - (C - B)
Each bar represents a subject
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When analysing the effectiveness of a programme it relies on the group changing in 
body composition. In reality however, some children lose weight, some remain the same 
whilst others gain weight. Therefore the program may be effective in some individuals 
but not so effective in others. Also, obese children on the program are very young 
(average age = 10 years) and are starting to pass through puberty. This age group was 
targeted for two main reasons: first the children are still growing, whereby obese 
children need to ‘grow into their height’ instead of losing weight to lose excess 
adiposity, and second parents or guardians still have some control over their children’s 
habits. Therefore it may be that the children learnt from the programme and will use this 
knowledge to aid them in losing weight when they get older. Also, the programme is 
designed to improve parent behaviour and attitudes towards food and physical activity, 
this change in behaviour may require more time than 6 months, and the effectiveness of 
the programme may become more evident after a few years. Hence, the TLP aims to re­
assess those who took part in the program after five years to investigate this 
phenomenon.
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6.2.11 Study limitations
Maternal BMI in the treatment group was on average 8 kg/m^ higher than those in the 
control group although mothers reported their weights and heights rather than being 
measured. Even though this was not statistically significant, this aspect may have 
affected results obtained from the RCT.
Even though the average time between measurements was not significantly different 
between the treatment and control arms (average difference = 7 months), it may be that 
individuals who were unable to attend the body composition appointment as soon as 
their treatment ended did change in BMI SDS, which may have an effect on evaluating 
the effectiveness of the trial. Unfortunately this issue was out of my control as families 
were contacted and appointments arranged at the time they agreed to be measured. 
Other obligations such as school exams, illnesses and holidays could not be avoided.
The trial consisted of different wave arms which started at different times of the year. 
Families treated in the same wave may be different to those treated in other waves. 
Having different waves in the TLP did not appear to have an effect on the findings of 
the study. This was checked by including a dummy variable for each child in the 
analyses depending on which wave they belonged to, and investigating if  being in a 
specific wave influenced response to treatment. Because the sample size remaining from 
each wave was very small the effects this might have on the results could not be 
addressed properly, however no indication of any wave effect was apparent.
The treatment programme consisted of obese children from White, Asian, Black and 
other ethnic groups. Different ethnic groups vary in their body composition. However, 
this phenomenon should not have a big effect on the results as there were no significant 
differences in ethnicity between the treatment and control groups.
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6.3 Metformin program
6.3.1 Rationale of the study
The second programme investigated was a pharmacological management programme 
using Metformin. A group of children and adolescents seen at the weight management 
clinics at GOSH and UCH have elevated levels of insulin in their blood, and they might 
also have a family history of type II diabetes. These children and adolescents were 
prescribed Metformin. Metformin, a biguanide, acts by suppression of glucose 
production in the liver, and therefore reducing the production of insulin from the 
pancreas; hence reducing appetite (Hundal and Inzucchi, 2003). It has been traditionally 
used for the treatment of type II diabetes in adults by improving hyper-insulinemia, 
hyper-glycemia and reducing weight. Similar effects have also been shown in non­
diabetic adults (Fontbonne et al. 1996; Paolisso et al. 1998).
The effects of Metformin on different measures of body composition have not been 
adequately studied (refer to Table 6-7). In adolescents, only two RCTs have 
investigated the effectiveness of Metformin (Kay et al. 2001; Freemark and Bursey, 
2001). Kay and colleagues (2001) showed that obese hyper-insulinemic adolescents 
who took Metformin for 8 weeks had a significant reduction in their body weight and 
fat levels compared to those who did not take Metformin (Kay et al. 2001). A similar 
positive finding of taking Metformin for 6 months was reported by Freemark & Bursey 
(2001) (Freemark and Bursey, 2001). They showed that BMI significantly decreased (- 
0.12 SDS) in the Metformin group but increased (+ 0.9 SDS) in the placebo group. A 
recent pilot study which evaluated the effects of taking Metformin for 3 months in a 
group of Chinese obese adolescents also reported a signifieant reduction in BMI in 
those who took the medication (Fu et al. 2006). Body composition was not a primary 
outcome in the two latter trials, so reported changes in BMI do not reveal the effects of 
Metformin on different body components such as body fat or lean mass. The first study 
did look at body composition in more detail, however bioelectrical impedance analysis 
(BIA) was used as the assessment tool. Hence, due to the methodology used in all three 
trials, results arising from the studies should be interpreted with caution.
153
Table 6-7 A summary o f the different studies looking at the effects o f Metformin in adolescents
Study reference Study Population Type of trial Duration of 
treatment
Measures Findings
treatment versus controls
(Kayetal. 2001) 24 hyper-insulinaemic obese 
13-17 years
RCT 8 weeks WT(kg)
FM (BIA) (kg) 
FFM (BIA) (kg)
-6.1 ± 0.8 versus -3.2 ± 0.2 kg* 
-6.0 ± 0.62 versus -2.7 ± 0.5 kg** 
-1.6 ± 0.6 versus -1.8 ± 0.3 kg
(Freemark and 
Bursey, 2001)
29 obese hyper-insulinaemic
12-19 years
BMI > 30 kg/m^
family history of type II 
diabetes
RCT 6 months BMI SDS -0.1 versus +0.2*
(Fu et al. 2006) 20 obese 
10-16 years 
metabolic syndrome
pilot study 3 months BMI (kg/m^) 30.6 ± 3.6 versus 27.5 ±4.1 kg/m^|
Abbreviations: R C T - randomised controlled trial; WT= weight; BIA= bio-electrical impedance analysis; FM= fat mass; FFM= fat-free mass; BMI= body mass index; SDS= 
standard deviation score
* Significantly different; Metformin versus placebo group, p < 0.02
** Significantly different: Metformin versus placebo group, p < 0.001 
f  Significantly different: before versus after Metformin, p < 0.001
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6.3.2 Hypothesis
Six months and one year o f  taking Metformin significantly alters body composition in a 
group o f obese children and adolescents.
6.3.3 Study design
This section describes a pilot study looking at body composition changes after taking 
Metformin for 6 months and for 1 year in a group of children and adolescents. There 
were no controls at this stage and subjects acted as their own controls; their second body 
composition measurements were compared to their first, and their final body 
composition measurements at 1 year were also compared to their first. Obese children 
included in this study may have started taking Metformin before taking part in the 
study.
6.3.4 Recruitment
Children and adolescents were recruited from weight management clinics at GOSH and 
UCH.
6.3.5 Inclusion and exclusion criteria
To be eligible subjects had BMI-SDS > 95^ percentile based on the 1990 UK reference 
cut-off point (Cole et al. 1995). Subjects also had insulin resistance tested by the 
paediatrician (Dr. R Viner) in clinic by an oral glucose tolerance test, or showed signs 
of acanthosis nigricans. Subjects on other weight loss programmes were excluded from 
taking part in this study.
6.3.6 Sample size
The formula used to calculate sample size for the Metformin part of the study is the 
same one used for aim 1 (refer to chapter 5):
n = 8 (SDVD^) Equation 6-1
32 subjects will detect a difference of 0.5 SDS. A total of 36 obese children and 
adolescents were recruited to take part in the study, however only 22 completed the
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trial. 12 had complete 4C measurements and 17 had completed 3C measurements; 
enabling detection of a difference of 0.8 and 0.7 SDS respectively.
6.3.7 Methods
Body composition was estimated using the 4C model (details described in chapter 4). 
For those who could not be scanned on the DXA (weight >115 kg), the 3C model was 
used instead to estimate their body composition. Regional body composition was 
determined by DXA. DXA was assessed at baseline and at six months. Therefore the 4C 
model and regional body composition was not assessed at one year, and only the 3C 
model was used at that stage.
6.3.8 Statistical analysis
SPSS was used to analyse all the data. Paired sample t-tests were used to compare body 
composition differences between follow-up (6 months and 1 year) and baseline 
measurements.
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6.3.9 Results
6.3.9.1 Characteristics of the sample
A total of 36 obese children and adolescents were recruited for the Metformin trial. The 
entire sample had baseline body composition measurements, however 9 did not take 
Metformin and 5 did not attend the 6-month follow-up appointment, bringing the 
sample size down to 22 (9 males, 13 females). Figure 6-6 is a flow-chart describing the 
Metformin trial.
Table 6-8 describes baseline characteristics of the Metformin group including those that 
were prescribed the drug but did not take it, those that dropped-out of the trial, and 
finally those that continued in the program. The three groups did not significantly differ 
in age, weight or BMI. The average age was 14 years and average BMI SDS was 3.5. 
Also, there were no significant differences in any of the circumferences, whole body 
composition or regional body composition measurements between the three groups. 
Hence, no significant physical or measured baseline differences were found between 
those that remained in the trial and those that did not end up in the trial.
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Table 6-8 Baseline characteristics of the Metformin group including those that: did not 
take Metformin, dropped out, and remained in the trial
Elid not take
Dropped o 
6-mont
ut at
hs
Remained in the 
trial
n mean sd If mean sd If mean sd
Age (years) 9 13.9 2.9 5 14.4 0.9 22 14.5 3.5
weight-SDS 9 3.6 1.0 5 4.2 0.5 21 3.7 0.8
height-SDS 9 1.3 1.9 5 0.7 1.0 22 0.7 1.3
BMI SDS 9 3.4 0.7 5 3.7 0.3 21 3.5 0.6
BMI (kg/m' )^ 9 37.7 7.9 5 41.5 5.5 21 38.0 7.6
Circumferences
(cm)
MUAC 9 39.3 6.3 5 40.7 2.9 22 39.2 5.5
WC 9 107.9 18.7 5 115.2 7.8 22 109.2 16.4
HipC 9 121.0 16.0 5 125.3 7.6 21 118.4 13.7
Thigh C 9 71.7 9.4 5 74.2 7.2 21 69J 7.8
CalfC 9 44.1 4.9 5 4&8 4.8 22 43.3 4.3
Whole body 
composition (kg/m^)
FMI-3C 9 18.1 5.8 4 2&5 5.3 21 17.6 5.4
FFMI-3C 9 19.6 2.7 4 20L6 2.2 21 20.5 3.6
FMI-4C 1 16.5 4.4 3 18.6 3.7 16 16.5 4.6
FFMI-4C 1 18.0 1.0 3 19.9 2.7 16 8.0 1.9
Regional body 
composition by DXA 
(kg/m^)
Trunk-FMI 1 7.6 1.8 4 10.0 1.7 16 8.1 1.8
Trunk-FFMI 1 7.8 0.5 4 8.9 0.7 16 8.7 1.7
Limbs-FMI 1 8.5 2.5 4 9.7 1.8 16 8.0 1.9
Limbs-FFMI 1 7.4 0.8 4 8.3 0.5 16 7.9 1.3
Abbreviations: n= number per group; SDS= standard deviation score, M UAC= mid upper arm 
circumference, WC== waist circumference, C= circumference, FMI= fat-mass index, FFMI= fat-ffee mass 
index, DX A= dual x-ray absorptiometry
No significant differences between groups
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Table 6-9 Physical characteristics of Metformin group: at baseline, at 6 month follow- 
up and at 1 -year follow-up
B aseline 6- m onth follow-up 1- year follow-up
n m ean SD n mean SD n m ean SD
Age (years) 22 14.5 3.5 22 15.1 3.5 12 14.6 3.7
weight-SDS 21 3.7 0.8 21 3.7 0.8 12 3.6 1.0
height-SDS 22 0.7 1.3 22 0.6 1.4 12 0.4 1.4
BMI SDS 21 3.5 0.6 21 3.5 0.6 12 3.5 0.6
BMI (kg/m") 21 38.0 7.6 21 3&2 7.9 12 38.0 7.9
C ircum ferences (cm) 15 3.8 0.8 15 3.8 0.8 8 3.6 0.9
MUAC 22 39.2 5.5 22 39.0 5.1 12 38.1 6.0
WC 22 109.2 16.4 22 108.6 16.8 12 107.4 17.5
W C-SDS 15 3.8 0.8 15 3.8 0.8 8 3.6 0.9
H ipC 21 118.4 13.7 22 120.1 14.2 12 116.7 14.6
Thigh C 21 69.3 7.8 21 6&9 6.5 12 66.7 7.4
C alfC 22 43.3 4.3 22 43.5 4.7 12 42.6 4.7
W hole body  
com position (kg/m")
FMI-3C 21 17.6 5.4 17 18.1 5.2 8 15.8 5.6
FFMI-3C 21 20.5 3.6 17 20.7 4.1 8 19.9 3.6
FMI-4C 16 16.5 4.6 12 17.5 4.6 -
FFMI-4C 16 18.0 1.9 12 18.9 2.3 -
R egional body  
com position by D X A  
(kg/m")
Trunk-FMI 16 8.1 1.8 15 8.1 2.3 -
Trunk-FFMI 16 8.7 1.7 15 8.2 0.9 -
Limbs-FMI 16 8.0 1.9 15 7.9 1.8 -
Limbs-FFMI 16 7.9 1.3 15 7.7 0.9 -
A bbreviations: n= number per group; SDS= standard deviation score, M UAC= mid upper arm 
circumference, W C= waist circumference, C= circumference, FMI= fat-mass index, FFMI= fat-free mass 
index, D X A= dual x-ray absorptiometry
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Figure 6-6 Flowchart o f the Metformin trial
Total Recruited
Took Metformin
Did not take Metformin
Dropped out
6-month follow-up
Dropped out
1-year follow-up
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Table 6-10 Differences in body composition between baseline and 6-month follow-up, and between baseline and 1 year fol
A 6 month follow-up - baseline A1 year fol [ow-up - baseline
n mean SD p-value n mean SD p-value
WT-SDS 21 -0.03 0.3 0.7 12 -0.07 0.4 0.6
HT-SDS 22 -0.03 0.4 0.7 12 -0.2 0.3 (103
BMI SDS 21 -0.07 0.2 0.1 12 -0.1 0.3 0.2
BMI (kg/m") 21 0.07 1.8 0.9 12 -0.2 2.4 0.8
Circumferences (cm)
MUAC 22 -0.2 1.9 0.6 12 -0.03 2.0 1.0
WC 22 -0.6 5.9 0.6 12 -0.1 4.2 0.9
WC-SDS 15 -0.07 0.3 0.4 8 -0.02 0.2 0.8
HipC 21 1.2 4.6 0.3 12 0.1 4.9 0.9
Thigh C 21 -0.4 4.0 0.6 12 -1.3 4.3 0.3
CalfC 22 0.2 1.4 0.6 12 -0.09 1.6 0.2
Whole body composition (kg/m")
FMI-3C 17 -0.04 1.6 0.9 8 3.5 5.2 0.1
FFMI-3C 17 0.46 1.1 0.1 8 -1.3 7.5 0.6
FMI-4C 12 1.3 2.0 0.04
FFMI-4C 12 0.51 2.3 0.4
Regional body composition by DXA (kg/m")
Trunk-FMI 15 0.2 1.0 0.6
Trunk-FFMI 15 -0.2 0.7 0.3
Limbs-FMI 15 -0.01 0.8 1.0
Limbs-FFMI 15 0.03 0.3 0.7
ow-up
A: differences obtained by paired sample t-test.
Difference at 6 months = 6 month follow-up visit -  baseline visit, and difference at 1 year = 1 year follow-up visit -  baseline visit 
Abbreviations: n= number per group; SD= standard deviation; SDS= SD score; WT= weight; HT= height; BMI= body mass index; MUAC= mid 
upper arm circumference, WC= waist circumference, C= circumference, FMI= fat-mass index, FFMI= fat-free mass index, DXA= dual X-ray 
absorptiometry
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Figure 6-7 Relationship between FMI at baseline and change in FMI over 6 months by 
the 3C model (top) and 4C model (bottom)
FMI-3C: r = 0.37; p= 0.2 
FMI-4C: r = 0.12; p = 0.7
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Figure 6-8 Relationship between FMI at baseline and FMI at 6 months by the 3C (top) 
and 4C (bottom) models. FMI-3C: r=0.96; p<0.001; FMI-4C: r=0.9I; p<0.001
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Figure 6-9 Relationship between baseline measurements of FMI calculated by the 3C 
model and FMI calculated by the 4C model r = 0.99; p < 0.001
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Table 6-9 illustrates the characteristics o f the Metformin trial at baseline, at 6-months 
and at 1-year. DXA measurements were only performed at baseline and at six month 
follow-up; therefore the one year follow-ups did not have any 4C data or regional body 
composition measurements.
Paired sample t-tests were used to test for body composition differences by comparing 
measurements at baseline and six months, or by comparing measurements at baseline 
and one year. The differences were calculated by subtracting data obtained from six 
months and baseline, or by subtracting data from one year follow-ups and baseline 
(refer to Table 6-10 for details).
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6.3.9.2 6-month follow-up
After six months of taking Metformin, there was a 0.03 decrease in both weight and 
height SDS, and a 0.07 decrease in BMI SDS; however these decreases were not 
significant. In terms o f body circumferences, following intervention the children lost an 
average of 0.2 cm off their arm, 0.6 cm off their waist, and 0.4 cm off their thigh, but 
gained an average of 1.2 cm on their hips and 0.2 cm on their calves. None of these 
gains or losses achieved any statistical significance. Only 17 and 12 children had 
baseline and follow-up whole body composition measurements for the 3C and 4C 
models respectively. Children lost an average of 0.04 kg/m^ FMI and gained 0.5 kg/m^ 
FFMI calculated by the 3C model; these were not significant. However, FMI calculated 
using the 4C model showed that children significantly gained 1.3 kg/m^ (p = 0.04).
Because there were differences in outcome between the 3C and 4C models, I then did a 
scatter plot of FMI at baseline versus FMI at 6 months for both the 3C and 4C models 
(refer to Figure 6-8). The graph for the 3C model shows that most of the points lie close 
to the line of identity, indicating that there is no systematic trend to gain or loss of fat 
after six months. However, the graph for the 4C model shows that the majority of the 
points lie on top o f the line of identity, indicating that obese children gained fat after six 
months of treatment.
In order to test whether there was a difference in the sample investigated between the 
3C and 4C models, a paired sample t-test was used only on the 12 that had data for both 
the 3C and 4C models at baseline and at six months. Similar to the findings obtained 
when the entire sample was included, the 4C model showed that subjects significantly 
increased in fat after treatment (p = 0.04) however no significant change was observed 
when the 3C model was used (p = 0.5).
A total of 15 children had regional body composition assessed by DXA. Comparing 
body composition at six months to that at baseline, children gained 0.2 kg/m^ fat mass 
in the trunk area and lost 0.01 kg/m^ in the limbs area, and gained 0.03 kg/m^ FFM in 
the limbs area and lost 0.2 kg/m^ FFM in the trunks area. None of the regional data 
comparisons achieved statistical significance.
Because some of the sample included in the above analyses included those who were 
already taking Metformin before taking part in the study; baseline body composition 
data before starting treatment was not available. Therefore a further analysis
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investigating change in BMI SDS during the first six months of taking Metformin was 
conducted. Weight and height measurements of the 22 obese subjects was obtained 
from their out-patient clinic notes at UCH and GOSH. Results reveal that six months of 
taking Metformin resulted in an average loss of 0.05 ± 0.04 BMI SDS; this difference 
however was not statistically significant (p = 0.3).
6.3.9.3 1 year follow-up
A total of 12 children attended one year follow-up appointments, and of those only 8 
had whole body composition measurements analysed. After one year of taking 
Metformin, children had a reduction of 0.07 and 0.1 weight and BMI SDS respectively; 
these reductions were not significant. The sample had a significant reduction in height 
SDS of 0.2 (p = 0.03). In addition, the sample lost an average of 0.03 cm off the arm, 
0.1 cm off the waist, 1.3 cm off the thigh and 0.09 cm off the calf, whereas they gained 
0.1 cm on the hip. None of the changes in circumferences were significant. In terms of 
whole body composition, assessed using the 3C model, children after one year of taking 
Metformin had an average increase o f 3.5 kg/m^ FMI and a reduction of 1.3 kg/m^ 
FFMI; neither of changes was significant.
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6.3.10 Discussion
Very few studies have investigated the effect of Metformin on body composition in a 
group of obese children and adolescents. This is the first study to measure body 
composition using a multi-component model approach instead of using the conventional 
approach, measuring weight, height and BMI.
My study showed that six months of taking Metformin did not significantly change BMI 
or BMI SDS; BMI changed from 38 kg/m^ to 38.2 kg/m^, and BMI SDS decreased by 
0.07 SDS.
A pilot study found that obese adolescents who took Metformin for three months lost an 
average BMI o f 3.1 kg/m^ (Fu et al. 2006). A possible reason behind the differences 
obtained between my study and Fu’s study is that the obese children that were part of 
my trial were much larger than those on Fu’s study; mean BMI = 38 kg/m^ versus BMI 
= 27.5 kg/m^ respectively. Therefore, it is possible that those fatter at baseline find it 
more difficult to lose weight compared to the thinner ones.
Freemark and Bursey (2001) performed a RCT investigating the effect of Metformin on 
a group of obese adolescents, and after six months of being on the trial, those on the 
medication lost an average of 0.12 BMI SDS whereas those on placebo gained 0.23 
BMI SDS (Freemark and Bursey, 2001). Even though my results were not significant, it 
could be that this slight loss or maintenance of BMI and BMI SDS is actually a 
significant outcome. According to Freemark and Bursey’s study, those that do not take 
the medication increased in BMI SDS over time. Hence, the fact that Metformin halted 
this gain might be viewed as a positive accomplishment.
Taking Metformin for six months and for one year did not significantly improve body 
composition outcomes; fat and lean did not significantly differ at the end of the trial. 
Contrary to my findings, Kay and colleagues (2001) found that obese adolescents on 
Metformin lost an average of 6 kg o f fat over a period of 2 months, whilst those that 
took placebo only lost 2.7 kg (Kay et al. 2001). There are several reasons that could 
explain the differences between these findings. First, the duration of treatment was 
substantially longer in my study compared to Kay’s study; six months-one year, versus 
two months. Second, Kay’s study was an RCT whereas my study was a pilot study; 
therefore I had no controls to compare to. Third, body composition was assessed using
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the multi-component approach in my study, whereas Kay’s study used BIA to estimate 
fat and lean. The latter technique is less accurate in assessing body composition. BIA 
assumes constant properties of FFM which have been previously demonstrated not to be 
constant in obese children (refer to Chapter 5). Therefore, the findings obtained from 
Kay’s study should be interpreted with caution. Hence due to the many differences 
between the trials, comparing results from these studies is not very robust.
In this study, both the 3C and 4C models were used to assess body composition changes 
in obese children. The 3C model showed that there were no significant changes in body 
composition after six months of taking Metformin; however the 4C model showed that 
children significantly increased in fat after six months of treatment. This difference in 
outcome observed between the two models might be due to three reasons. First the 
sample size used in the 3C model was larger than that used in the 4C model; 17 versus 
12. Second, the difference might be due to the methodology. Third, there might be a 
bias in the sample investigated, whereby those that gained weight after six months of 
treatment were studied. Therefore, analysis from the sample that had data from both the 
3C and 4C models (i.e. in the 12) were performed, and results show that the difference 
between models remained; indicating that the 4C model shows a bigger weight gain 
compared to the 3C model. Change in FMI (by 3C model) in the 17 was -0.04 ± 1.60 
kg/m“ whereas change in FMI (by 3C model) on the 12 was 0.26 ±1 .17  kg/m^. This 
indicates that there was a sample bias where those analysed by the 4C model tended to 
be those gaining more weight.
Data from the RCT of the behavioural program illustrated that controls significantly lost 
approximately 0.1 BMI SDS in six months. The controls from the traffic light program 
however are not suitable to use as controls for the Metformin program. Those on the 
Metformin trial were older and were substantially larger; average age = 14.5 versus 10 
years and average BMI SDS = 3.5 versus 3.0.
A previous study showed that girls with higher baseline fat levels tend to gain more fat 
compared to the leaner ones (Goulding et al. 2003). My study however showed no 
correlation between baseline fat levels and subsequent change in FM over 6 months 
(refer to Figure 6-7). One possible reason might be that Goulding’s sample were much 
younger than my sample (mean age = 4.5 years versus 15.5 years). Another reason may 
be that my sample all had very high baseline fat levels, and were all well above the
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obesity cut-off level (mean BMI SDS = 3.5) whereas those from Gouding’s study 
included a variety o f children including many with lower fat levels.
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6.3.11 Study limitations
This was a pilot study investigating how six months and one year of taking Metformin 
changes body composition. Since there were no controls, I cannot be absolutely 
confident that any differences in body composition measurements obtained were due to 
the intervention rather than other factors. Therefore, the next step is to do an RCT 
investigating the effectiveness o f Metformin, and to try to control for other factors such 
as dietary intake.
Another limitation of the study is that not all subjects were assessed before starting the 
medication. Therefore baseline measurements included those that had already been on 
the medication for a year or so. Hence, even though there was no change in BMI SDS 
during the first 6 moths of taking Metformin, it may be that Metformin did significantly 
alter body composition during the first few months when it was prescribed, but then the 
different body components such as fat stabilized rather than continued to decrease.
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Chapter 7: Bio-electrical impedance analysis for 
measuring body composition in obese children and 
adolescents
7.1 Introduction
There is no simple and accurate tool that can assess childhood body composition in 
clinics; hence proxy techniques such as BMI are currently being used. However BMI is 
a poor indicator of body adiposity and the disadvantages with using such a technique 
have been described in detail previously in chapter 3. Therefore validating a simple 
technique, such as BIA using the new TANITA machine (BC-4I8 MA), and producing 
a specific equation that can be used to predict body composition in obese children and 
adolescents would be very useful to use in routine clinics not only to assess body 
composition, but also to look at the effectiveness of the different weight loss strategies 
that are being implemented.
7-2 Hypothesis
A new BIA machine, TANITA BC-418 MA, can accurately measure body composition in 
obese children and adolescents compared to a reference method.
This hypothesis can be divided into two parts:
• To validate BIA using the TANITA machine (BC-418 MA) as a method for 
measuring body composition in obese children and adolescents against the 3C 
and 4C models
• To assess the success of evaluating absolute body composition and change of 
body composition over time using the TANITA machine (manufacturer 
equations versus my prediction equations) compared to the 3C model
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7.3 Study design
This is a validation study investigating the accuracy and reliability of a BIA machine in 
estimating body composition in obese children and adolescents compared to a reference 
method. The reference method for estimating TBW is D2 O, and for estimating FM and 
FFM is the 3C or 4C model.
7.4 Recruitment
Obese children and adolescents were recruited from weight management clinics at 
GOSH and UCH in London, the LEAF clinic in Chichester, and from an ongoing body 
composition research project measuring healthy children and adolescents at 
ICH/GOSH.
7.5 inclusion and exclusion criteria
Obese children and adolescents with BMI > 95^ percentile; equivalent to BMI-SDS > 
1.64 defined by the 1990 UK reference cut-offs (Cole et al. 1995) were eligible to take 
part in the study. It was previously described that different ethnic groups vary in their 
body composition (Deurenberg et al. 1998) therefore only those from White ethnic 
backgrounds were included, and children from other ethnic backgrounds were excluded 
from this part o f the study. In addition, this study only included obese children and 
adolescents that were not on any pharmacological treatment; hence those on Metformin 
for example were not included.
For the first part o f the hypothesis, only baseline measurements of body composition (or 
one of the measurements if the first measurement was not successful) were used for 
participants who were assessed more than once. Those with successful measurements 
from both the 3C and 4C models (FFM), D2 O (TBW) and the TANITA machine (R) 
were included in the analyses; whereas participants who had either one of the 
measurements missing were excluded from the study.
173
For the second part o f the hypothesis, eligible participants were required to have two 
complete follow-up body composition measurements from the D2 O, 3C model and 
TANITA machine. Participants did not have a DXA scan on their third visit, hence only 
the 3C model was used to estimate their FM and FFM. In addition, subjects used for 
part one analyses were not included in part two analyses to make sure that the two 
analyses (validation versus evaluation) were independent.
7.6 Sample size
It was difficult to decide on the appropriate sample size for the validation study. This is 
because there is not enough information on the relationship between impedance (HT^/R) 
and TBW or FFM. We also do not know what the standard error of the estimate (SEE) 
for TBW or FFM in individuals: which is the level of predictive inaccuracy; and this 
varies according to the population. Therefore we could not predict the appropriate 
number of subjects required for the study. Most previous validation studies have used 
approximately 30 to 50 subjects, i.e. 15 to 25 subjects from each gender across a wide 
age range and with very few subjects within the obese population (Lazzer et al. 2003; 
Andreoli et al. 2002; Bell et al. 1998). However, such sample sizes are considered to 
be relatively small because, as mentioned before, body composition varies substantially 
between individuals even in obesity, and so we need to ensure that the sample size is 
large enough to include a wide range of age and body composition in each gender. 
Hence the aim was to recruit a total o f 100 subjects; 50 males and 50 females, which 
should be sufficient to incorporate a wide range of body composition in obese children 
and adolescents within the age range measured.
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7.7 Methods
TBW was measured using D 2 O, and the 3C and 4C models were used to estimate FM 
and PPM by combining measurements from different methodologies (BODPOD and 
DXA). The TANITA machine (BC-418 MA model) was used to obtain R (details of 
these techniques and measurements can be found in chapter 4).
The main principle of the BIA method is that the opposition to electrical flow of a 
geometrical conductor (in this case the human body) is related to its length (or height) 
and inversely related to its cross-sectional area (Schoeller, 2000; Kushner, 1992). 
Therefore, it is assumed that the body is a conductor of uniform length and cross 
sectional area. The equations representing this are described in chapter 3.
7.8 Statistical analysis
All statistical analyses were performed using SPSS software.
Paired sample t-tests were used to compare measured (by D2 O, 3C and 4C models) 
versus predicted (from T A N I T A m a n u f a c t u r e r )  differences in body composition.
Linear regression analyses were used to investigate the relationship between HT^/R 
(from TANITA TBP-418 MA) and TBW (from D2 O) or PPM (from 3C and 4C 
models). The independent variable was assigned as HT^/R and the dependent variable 
was assigned as TBW or PPM. Prediction equations for estimating TBW and PPM from 
HT‘/R were then produced for my obese sample.
Independent sample t-tests were used to investigate gender differences in age and other 
body composition parameters; gender was assigned as an independent variable.
Confounding variables such as pubertal status and gender were tested by including them 
in the regression analysis. The regressions were conducted in a step-wise manner, using 
the independent variables o f sex (dummy code: male = 1 and female = 2), pubertal stage 
and pubertal hair development, and HT^/R; the dependant variable was TBW or PPM.
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Paired sample t-tests were used to compare predicted longitudinal change in TBW, FM 
or PPM obtained from the TANITA (manufacturer and prediction equations) versus 
actual change in TBW (from D2 O), or actual change in PM and PPM (from the 3C 
model).
Bland and Altman analyses were used to plot differences between the methods 
(T AN IT A-equation or manufacturer- versus D2 O, 3C or 4C) against their mean to 
investigate the relationship between the measurement error and true value (Bland and 
Altman, 1986). Agreement between methods can be described by calculating bias 
(difference between measurements) and standard deviation of the difference (SD). 
Limits of agreement between measurements would be ± 2 SD from the mean. The 
standard error (SE) was also used to report how precise estimates of body composition 
from TANITA versus multi-component model were. Correlations between magnitude of 
the bias and mean o f the bias were used to report whether the bias changes if the child 
get smaller or bigger.
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7.9 Results
7.9.1 Hypothesis 1
A total of 164 obese children and adolescents were measured. However, 86 had to be 
excluded because they did not fulfil the inclusion criteria described above. Table 7-1 
shows the sample size excluded and the reason why they had to be excluded from this 
part of the study.
Table 7-1 Sample size and reason why subjects were excluded
Number excluded Reason excluded
58 non-White
13 no impedance measurements
13 unknown ethnic background
2 Hffm outside acceptable range; defined as 
68 -84%
The final sample size included in the analyses consisted of a total of 78 obese children 
and adolescents; 30 males and 48 females age ranging between 4.6 and 21.7 years. 
Table 7-2 provides a breakdown o f the number of subjects that took part in the study 
and where they were recruited from.
Table 7-2 A breakdown of where the final sample was recruited from
Number included Recruitment
42 Reference study
26 “Traffic Light Program” at GOSH
4 LEAF clinic in Chichester
3 UGH weight-management clinic
3 GOSH weight-management clinic
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Table 7-3 The range, mean and standard deviation o f some o f  the physical characteristics o f  the obese subjects measured
Males (n = 30) Females (n = 48)
min max mean SD min max mean SD
Age (years) 5.0 20.0 12.0 3.4 4.6 21.7 11.3 3.5
Weight (kg) 28.2 110.5 65.1 20.6 21.9 90.8 60.1 16.3
HT (cm) 112.9 182.0 152.4 16.7 108.9 169.0 148.0 13.7
BMI (kg/m^) 21.3 40.6 27.4 4.8 18.4 38.9 26.8 4.2
WT SDS 1.1 4.8 2.4 0.9 1.2 3.7 2.4 0.7
HT SDS -2.2 3.1 0.6 1.2 -0.8 2.7 0.8 0.8
BMI SDS 1.7 4.7 2.7 0.8 1.6 3.9 2.5 0.7
TBW (D2 O)* 14.5 49.7 31.2 10.4 12.2 39.5 26.6 6.7
HT^/R* 20.3 60.7 39.1 12.4 16.9 48.3 33.3 7.6
FM (4C) 9.4 58.6 24.8 10.7 5.76 49.5 25.2 9.0
FFM (4C) 18.8 68.6 40.3 13.7 16.1 52.3 35.0 8.9
% FAT (4C) 19.0 53.0 37.9 7.99 26.3 55.4 41.1 6.2
H(Tm (4C) 71.5 83.9 77.1 2.48 73.1 81.3 76.3 1.7
Dffm (4C)* 1.05 1.11 1.08 0.01 1.07 1.11 1.09 0.01
Abbreviations: n= number per group; WT= weight; HT= height; SD= standard deviation; SDS= SD score; TBW= total body water; DzO^ deuterium 
oxide; R= resistance; FM= fat mass; FFM= fat-free mass; Hffm= hydration of FFM; Dffm= density of FFM
* Significant difference between males and females at p < 0.05
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Table 7-3 shows a description of the characteristics of the obese sample included, 
separated by sex. The average age of the sample measured was 12.0 and 11.3 years for 
males and females respectively, with an average difference of 0.7 years. This difference 
however was not statistically significant (p = 0.4). The mean BMI S D S  was 2.7 and 2.5 
for boys and girls respectively. There were no significant gender differences in WT 
S D S ,  HT S D S ,  BMI S D S ,  FM (4C), FFM (4C), % fat (4C) and H f f m  (4C). However, on 
average boys had significantly greater TBW (measured by D2 O) compared to girls 
(mean difference = 4.6, S E  = 2.1 litres; p = 0.04), and boys had significantly lower D f f m  
compared to girls (mean difference = 0.006, S E  = 0.002 litres; p = 0.01).
Table 7-4 illustrates differences in body composition values between those obtained 
from T A N I T A  (manufacturer) versus those that were measured (by D2 O, 3C and 4C 
models). The results reveal that in obese children and adolescents, T A N I T A m a n u f a c t u r e r  
overestimates TBW by 0.4 and 0.8 litres for males and females respectively; only the 
latter achieving statistical significance. T A N I T A m a n u f a c t u r e r  was also found to 
significantly underestimate FM by approximately 4 kg and to overestimate FFM by 
approximately 2.5 kg in both sexes.
Correlations between the difference (calculated as T A N I T A  - 4C) and mean (calculated 
as average of T A N I T A  + 4C) for FM and FFM were then performed to establish 
whether the error in estimating body composition in obese children and adolescents 
using T A N I T A m a n u f a c t u r e r  Compared to the 4C model varied across the range of body 
composition (refer to Figure 7-1). The results reveal that there was a borderline 
significant positive correlation between the amount and magnitude of the error in 
estimating FFM from T A N I T A m a n u f a c t u r e r  compared to the 4C model (r = 0.22; p = 0.06). 
There was also a significant negative correlation between the amount and magnitude of 
the error in estimating FM (r = -0.26; p = 0.03).
Compared to the 4C model, the T A N I T A  system therefore systematically overestimates 
FFM with slightly higher overestimation in children with higher FFM, and 
underestimates FM with greater underestimation in those with the lowest FM levels. 
Because in-built T A N I T A  equations ( T A N I T A m a n u f a c t u r e r )  were found to be inaccurate at 
predicting body composition in obese children and adolescents, the next step was to 
predict body composition from impedance (the only direct outcome measured by
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TANITA using data from the multi-component model to develop equations for 
predicting body composition in obese children and adolescents.
Table 7-4: Differences in body composition in obese children: measurements versus 
prediction from T A N I T A m a n u f a c t u r e r
Difference Males Females
n D SD p-value n D SD p-value
TBW 30 0.4 2.2 0.4 48 0.8 1.2 <0.001
FM (3C) 30 -3.5 2.4 <0.001 47 -3.6 1.8 <0.001
FM (4C) 30 -4.0 2.4 <0.001 47 -4.1 1.9 <0.001
FFM (3C) 30 2.2 2.4 <0.001 47 2.1 1.8 <0.001
FFM (4C) 30 2.7 2.4 <0.001 47 2.6 1.8 <0.001
D = T A N I T A m a n u f a c t u r e r  “ actual mcasurcd value
Abbreviations: n= number per group; D= difference; SD= standard deviation; TBW= 
total body water; FM= fat mass; FFM= fat-free mass; 3C= 3 component model; 4C= 4 
component model
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Figure 7-1 : Bland-Altman plots showing the agreement between the differences 
( T A N I T A m a n u f a c t u r e r  ValueS -  4C Values) and mean ( T A N I T A m a n u f a c t u r e r  + 4C) of (a) FFM 
(r = 0.22; p = 0.06), and (b) FM (r = -0.26; p = 0.3)
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Figure 7-2 Relationship between HT^/R and TBW by D2 O in obese males and females 
(r = 0.98; p<0.001)
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Figure 7-3 Relationship between HT^/R and FFM by 4C model in obese males and 
females (r = 0.98; p<0.001)
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Figure 7-4 Relationship between HT^/R and FFM by 3C in obese males and females (r 
= 0.98;p<0.001)
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Figure 7-2, Figure 7-3 and Figure 7-4 show the scatter plots relating TBW (measured by 
D2 O) to HT^/R (obtained from the TANITA TBF-418 MA machine), or FFM (calculated 
by the 3C or 4C model) to HT^/R. There was a highly significant correlation between 
HT^/R and each of TBW (r=  0.98; p < 0.001), FFM-3C (r=  0.98; p < 0.001) and FFM- 
4C (r = 0.98; p < 0.001), indicating that HT^/R is a very good predictor of TBW and 
FFM.
Three different analyses were then conducted where HT^/R was regressed against TBW: 
first the entire sample was included, second only males were analysed, and third only 
females were included in the analysis. The results are shown in Table 7-5. In all three 
cases there was a strong and highly significant correlation between the two variables (r  ^
= 0.96; p < 0.001). At this point, either a gender specific equation can be constructed 
whereby TBW can be calculated from impedance using the values obtained for males 
and females separately, or one equation can he constructed that can be used for both 
males and females. An important factor one needs to consider before deciding on which 
equation to use is the SEE i.e. the scatter of the points on the graph around the 
regression line. When the entire sample is included in the analysis the SEE is 1.72 litres 
whereas when males are only used the SEE is 2.22 litres; hence the equation with the 
entire sample included would be more reliable because the SEE is smaller in the former 
analysis. On the other hand the female SEE is 1.35 litres which is slightly lower than the 
SEE when the entire sample is included. This means that when calculating TBW in a 
female sample, using a female equation might he more reliable. This means that girls 
have less scatter on the graph whereas boys are grouped less tightly and are more 
scattered. The greater SEE found in males compared to females may he due to their 
smaller sample size (n = 30 for males versus n = 48 for females).
A further analysis was then performed where gender was incorporated into the analysis 
along with HT^/R as the independent variable (refer to Table 7-6). A difference of 0.24 
litres extra TBW was found for being a male. This difference was very small and did 
not achieve significance (p = 0.6).
Moreover, pubertal status, including stage of development and hair development, were 
also incorporated in the regression analysis to establish whether pubertal stage has an 
effect on the association between HT2/R and TBW (refer to Table 7-6).
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Pubertal stage development made a significant contribution to the model (mean 
difference = 0.69 litres; p = 0.002). However, when both pubertal stage and hair 
development were incorporated in the model, the association was no longer significant 
(p = 0.09 and p = 0.3 respectively). The average difference of either including or not 
incorporating puberty into the analysis is approximately 0.7 litres of TBW, making a 
calculation error of approximately 0.95 kg of FFM.
A similar analysis was then performed where HT2/R was regressed against FFM 
(calculated by both the 3C and the 4C model) when the entire sample was included, 
when only males were included and when only females were included in the analysis 
(refer to Table 7-7 and Table 7-9). Similar to the results obtained when TBW was used, 
the SEE was lower when only females were included versus the whole sample. 
However an equation with the entire sample included was preferred because differences 
between SEE were not large.
Again, a further analysis was performed including sex, and pubertal stage in the 
equation to establish whether if  they have any effects on the association between HT^/R 
and FFM (calculated by the 3C and 4C models) (refer to Table 7-8 and Table 7-10). A 
difference of 0.78 kg or 0.85 kg o f FFM calculated by the 4C and 3C respectively was 
found for being a male; this did not achieve statistical significance. Even though 
pubertal stage did have a significant effect on the association between HT^/R and FFM 
when incorporated into the model (p < 0.001), it only improved SEE of FFM by 0.2 kg 
(3C) and 0.3 kg (4C).
As mentioned earlier, pubertal status was self-assessed by selecting pictures that closely 
resembled the subjects’ appearance at the time of the measurement. Even though 
pubertal development showed a significant effect in the analyses, the method of 
collecting the data may be difficult and problematic, and the final error for calculating 
body composition if  it were not included is small and not clinically significant. 
Therefore, pubertal status was not taken into account when constructing the final 
regression equations for calculating TBW and FFM from HT^/R.
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Table 7-5 A regression analysis o f  HT /R against TBW (by D2O) in the entire sample versus males only versus females only
Sample SEE Y-intercept (SE) HT"/R coefficient (SE) t-value ( HT^/R) p-value
1. All included 0.96 1.72 -1.302 (0.722) 0.834 (0.026) 42.6 <0.001
2. Males only 0.96 2.22 -0.976(1.361) 0.822 (0.033) 24.7 <0.001
3. Females only 0.96 1.35 -2.158(0.889) 0.862 (0.026) 33.1 <0.001
Table 7-6 Step-wise regression analysis of HT^/R against TBW (by D2 O) incorporating sex, stage and pubertal development in the analysis
Regression model SEE Y-intercept (SE) Coefficient (SE) t-value p-value
h t Vr 0.96 1.72 -1.302 (0.722) 0.834 (0.02) 42.6 <0.001
HT^/R 0.96 1.73 -1.798 (1.142) 0.837 (0.02) 40.9 <0.001
Sex 0.236 (0.420) 0.6 0.6
HT^/R 0.96 1.66 -0.996(1.276) 0.777 (0.03) 26.1 <0.001
Sex -0.044 (0.456) 0.1 0.9
stage development 0.690 (0.219) 3.2 0.002
h t Vr 0.96 1.70 -0.508 (1.36) 0.759 (0.034) 22.2 <0.001
Sex -0.063 (0.46) -0.1 0.9
stage development 0.490 (0.284) 1.7 0.09
hair development 0.335 (0.301) 1.1 0.3
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Table 7-7 A regression analysis o f  HT^/R against FFM (by 4C) in the entire sample versus males only versus females only
Sample SEE Y-intercept (SE) HT^/R coefficient (SE) t-value (HT^/R) p-value
1. All included 0.96 2.23 -2.032 (0.946) 1.096 (0.026) 42.6 <0.001
2. Males only 0.96 2.22 -0.976(1.361) 0.822 (0.033) 24.7 <0.001
3. Females only 0.96 1.35 -2.158(0.889) 0.862 (0.026) 33.1 <0.001
Table 7-8 Step-wise regression analysis of HTVr against FFM (by 4C) incorporating sex, stage and pubertal development in the analysis
Regression model R^ SEE Y-intercept (SE) coefficient (SE) t-value p-value
h t Vr 0.96 2.23 -2.032 (0.946) 1.096 (0.026) 42.9 <0.001
HT^/R 0.96 2.22 -3.649(1.464) 1.106 (0.026) 42.0 <0.001
Sex 0.776 (0.539) 1.4 0.2
HT^/R 0.97 1.99 -1.923 (1.544) 1.001 (0.036) 27.8 <0.001
Sex 0.047 (0.554) 0.08 0.9
stage development 1.197 (0.267) 4.5 <0.001
HT*/R 0.97 1.96 -0.827 (1.605) 0.961 (0.04) 23.9 <0.001
Sex 0.006 (0.544) 0.01 1.0
stage development 0.739 (0.338) 2.2 0.03
hair development 0.76 (0.356) 2.1 0.04
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Table 7-9 A regression analysis o f HT /R against FFM (by 3C) in the entire sample versus males only versus females only
Case SEE Y-intercept (SE) HT'/R coefficient (SE) t-value ( HT^/R) p-value
1. All included 0.96 2.31 -2.211 (0.980) 1.115 (0.260) 26.7 <0.001
2. Males only 0.96 2.75 -1.929(1.682) 1.095 (0.041) 26.7 <0.001
3. Females only 0.96 1.92 -4.050(1.292) 1.179 (0.038) 31.3 <0.001
Table 7-10 Step-wise regression analysis of H I /R against FFM (by 3C) incorporating sex, stage and pubertal development in the analysis
Regression model SEE Y-intercept (SE) coefficient (SE) t-value p-value
HT^R 0.96 2.31 -2.211 (0.980) 1.115 (0.260) 26.7 <0.001
HT^/R 0.96 2.3 -3.980 (1.514) 1.126 (0.027) 41.3 <0.001
Sex 0.848 (0.557) 1.5 0.1
HT^/R 0.97 2.02 -2.110(1.562) 1.011 (0.036) 27.8 <0.001
Sex 0.069 (0.561) 0.1 0.9
stage development 1.311 (0.270) 4.9 <0.001
HT^/R 0.97 1.98 -0.959 (1.620) 0.969 (0.041) 23.8 <0.001
Sex 0.028 (0.549) 0.05 1.0
stage development 0.833 (0.341) 2.4 0.02
hair development 0.794 (0.341) 2.2 0.03
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Therefore, because there were no significant sex differences and the SEE differences 
between the genders was small, one equation can be constructed that can be used for 
White obese individuals within the age group measured. Using the slope and y-intercept 
obtained from the regression analyses shown in the above tables, the equations for 
calculating TBW and FFM (from 3C and 4C models) from whole body impedance 
measurement (R) are:
TBW = -1.302 + 0.834 (HTVR) Equation 7-1
FFM (4C) = -2.032 + 1.096 (HT^/R) Equation 7-2
FFM (3C) = -2.211 + 1.115 (HT^/R) Equation 7-3
FM can then be calculated as: WT -  FFM Equation 7-4
In a sub-analysis where different ethnic groups, largely Asian (n = 21) and Black (n = 
17), were included in the regression equation, ethnicity was found to significantly alter 
the prediction of TBW (p < 0.001). This confirms that people from different ethnic 
groups differ in the relationship between impedance and body composition, and should 
therefore be analysed separately. The sample size for other ethnic groups was not large 
enough to derive ethnic specific equations for estimating body composition. Also, 
because my sample was largely from a White background, I restricted my longitudinal 
analyses to White children and adolescents.
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7.9.2 Hypothesis 2
The second part of the study is a longitudinal investigation of the accuracy of the 
TANITA machine in assessing change in body composition in obese children over six 
months. The reliability o f the equation in estimating body composition in this group of 
obese children was also tested.
A total of 47 obese children and adolescents had longitudinal body composition 
measurements; however 29 had to be excluded from the analysis because they did not 
fulfil the inclusion criteria. Table 7-11 shows a list of subjects excluded from this part 
of the analysis and the reason for excluding them. Therefore, the final sample included a 
total of 18 subjects; 5 boys and 13 girls who had complete measurements of TANITA 
and TBW (by D2 O) for both visits (2 and 3). One girl did not have a body volume 
measurement (by BODPOD) and therefore did not have any 30 data; her TBW data 
however was used in the analysis.
TBW and FFM (30) were calculated from TANITA using the equations constructed 
from the above cross-sectional analysis:
TBW = -1.302 + 0.834 (HT^/R) Equation 7-5
FFM (3C) = -2.211 + 1.115 (HT^/R) Equation 7-6
FM was then calculated by subtracting FFM from total body weight.
As mentioned earlier, FFM from the 40  model was not calculated for this sample 
because subjects did not have a DXA scan during their third visit. Therefore, 40  data 
were not available and only the 30  equation was used to estimate FFM.
Table 7-12 shows the characteristic o f the final sample included. Visit 2 obese children 
were between 8.9 and 13.4 years, and had an average BMI SDS of 2.8. Approximately 
six months after being either treated or on the waiting list of the traffic-light 
programme, the children’s average BMI SDS increased by approximately 0.1 SDS.
As mentioned earlier, TBW was measured directly using D2 O or estimated using either
TANITA’S in-built manufacturer equations ( T A N I T A m a n u f a c t u r e r )  or using the new
equations constructed from T A N I T A  ( T A N I T A e q u n ) .  Similarly, FM and FFM were
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estimated by using either the 3C model or using T A N I T A m a n u f a c t i r e r  or using 
T A N I T A e q u n -  Differences in body composition over time using measured versus 
equations are shown in Table 7-13. Compared to D2 O, both T A N I T A m a n u f a c t u r e r  and 
TANITAequn Overestimated the difference in TBW by 0.3 litres and 0.05 litres 
respectively but not significantly. Also compared to the 3C model, the T A N I T A e q u n  
overestimated the difference in FFM and underestimated the difference in FM by 0.2 
kg; this however did not achieve statistical significance (p = 0.7). Similarly, 
T A N I T A m a n u f a c t i r e r  Overestimated FFM and underestimated FM by 0.1 kg; this difference 
however was not statistically significant (p = 0.4).
Scatter-plots illustrating the relationship between the differences in FM and FFM using 
T A N I T A e q u n  versus actual measurements (by the 3 C  model) are shown in Figure 7 - 5 .  
Differences in FM (r = 0 . 7 6 ;  p < 0 . 0 0 1 )  and FFM (r = 0 . 7 4 ;  p = 0 . 0 0 1 )  using my 
prediction equations were found to be significantly correlated with those obtained from 
the 3 C  model; indicating that the T A N I T A e q u n  can predict approximately 6 4 %  and 5 0 %  
of the variance in differences in FM and FFM respectively from the 3C model.
A Bland and Altman plot was performed to test whether the accuracy of predicting body 
composition change using prediction TANITAequn was dependant on the amount of FM or 
FFM the child gained or lost while they were on the treatment programme (refer to 
Figure 7-6). Results indicate that there were no significant differences in change of fat 
or lean, and magnitude o f the error in estimating body composition from using these 
equations.
The same analyses were performed to test the accuracy of using T A N I T A m a n u f a c t u r e r  to 
predict change in body composition in obese children and adolescents. Similar to results 
obtained from using the constructed equations, compared to the 3C model 
T A N I T A m a n u f a c t u r e r  was able to predict 50% of the variance in differences in FM and 
FFM. No significant bias was found between the change in body composition and error 
from estimating change in body composition when using T A N I T A m a n u f a c t u r e r  versus the 
3C model (refer to Figure 7-7 and Figure 7-8).
A  further analysis was performed to investigate how well B M I  can predict change in 
FM compared to the T A N I T A e q u n -  First, an equation was constructed from the cross- 
sectional study where B M I  was regressed against % fat (calculated by the 3C); taking
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into account age. Gender was not included because I have previously demonstrated in 
Chapter 5 that obese boys and girls did not differ in FM and FFM. The equation 
obtained was:
% fat (3C) = 17.48 + (1.51*BMI) -  (0.817 *age) 
FM (3C) = (% fat/100)*WT
Equation 7-7 
Equation 7-8
FM was then calculated and changes in FM obtained by the 3C model were compared to 
those obtained from the above equation. Results show that change in FM calculated by 
the 3C model was significantly correlated with predicted change in FM from BMI (r  ^= 
0.43; p = 0.003; SEE = 1.92). Predicting change in FM from my TANITA equation 
compared to the 3C model resulted in a 14% stronger correlation and lower SEE (r  ^= 
0.57; p < 0.001; SEE = 1.71). This indicated that my prediction equation constructed 
from TANITA is better than BMI in predicting change in body composition in obese 
children and adolescents.
Table 7-11 A list of sample excluded from the longitudinal TANITA analysis
Number excluded Reason
8 Treated with Metformin
7 Asian
6 Black
8 other non-White ethnic groups
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Table 7-12: Characteristics o f the obese sample for visits 2 and 3
Visit 2 Visit 3
N minimum maximum mean SD minimum maximum mean SD
Age (years) 18 8.9 13.4 11.0 1.5 9.5 14.0 11.4 1.5
WT (kg) 18 45.1 101.7 67.2 17.9 50.6 110.1 71.0 17.4
HT (cm) 18 129.3 177.6 151.2 11.3 132.2 181.3 154.2 11.2
BMI (kg/m') 18 24.1 41.4 28.9 4.9 23.7 39.0 29.5 4.5
WT SDS 18 1.5 4.0 2.7 0.9 1.6 3.9 2.8 0.8
HT SDS 18 -2.0 3.1 1.1 1.3 -0.7 3.1 1.2 1.1
BMI SDS 18 1.8 4.0 2.8 0.6 1.5 3.7 2.9 0.6
TBW (DzO) 18 18.4 42.4 28.6 6.7 21.3 46.9 30.6 7.0
TBW (from equation) 18 17.5 41.3 28.6 6.4 20.8 48.2 30.8 7.2
TBW (TANITA) 18 19.6 43.4 29.4 6.2 21.4 49.1 31.5 7.0
h t '/r 18 22.5 51.0 35.8 7.6 26.5 59.3 38.5 8.6
FM (3C) (kg) 17 18.8 53.8 30.0 10.6 18.7 51.0 30.7 10.6
FM (3C) (from equation) 17 17.7 58.1 29.4 11.6 18.7 54.1 30.0 10.7
FM (TANITA) 18 14.0 55.5 25.7 11.3 15.6 50.5 26.7 10.0
FFM (3C) (kg) 17 23.6 55.1 37.9 8.6 27.3 61.8 40.8 9.2
FFM (3C)( from equation) 17 22.9 54.7 38.3 8.4 27.4 63.9 41.4 9.4
FFM (TANITA) 18 26.8 59.2 40.1 8.5 29.2 67.1 43.0 9.5
Abbreviations: N= sample size; WT= weight; HT= height; BMI= body mass index; SDS= standard deviation score; TBW- total body water; 0:0= 
deuterium dilution; R= resistance; FM= fat mass; FFM: fat-free mass
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Table 7-13: Differences in body composition between visits 2 and 3 using measured (3C) versus TANITAequn and TANITAmanufacturer
Difference
(measured)
Difference
( T A N I T A e q u n )
Difference
( T  A N I T  A m a n u fa c tu r e r )
mean SD mean SD mean SD
TBW (1) 2.0 2.6 2.3 1.7 2.1 1.3
FFM (kg) 2.9 2.6 3.1 1.7 2.9 1.8
FM (kg) 0.7 2.5 0.5 2.6 1.1 3.0
Abbreviations: SD= standard deviation; TBW= total body water; FFM= fat-free mass; FM= fat mass; SD= standard deviation 
Difference = visit 3 -  visit 2
Table 7-14: Bland-Altman analysis reporting difference in change in body composition: in-built TANITA equations and prediction equations versus 
the 3C model
D ifference (TANITAequn - measured) D ifference ( T A N I T A m a n u f a c t u r e r  - measured)
mean SD p-value r p-value mean SD p-value r p-value
TBW  (1) 0.3 2.0 0.6 -0.49 0.04 0.1 2.1 0.9 -0.70 0.001
FFM  (kg) 0.2 1.8 0.7 -0.16 0.5 0.1 1.8 0.8 -0.48 0.05
FM  (kg) -0.2 1.8 0.7 0.05 0.8 -0.1 1.9 0.4 0.06 0.8
Abbreviations: SD= standard deviation; TBW= total body water; FFM= fat-free mass; FM= fat mass; SD= standard deviation; 
correlation coefficient
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Figure 7-5: A scatter-plot of difference in change of (a) FM (r = 0.76; p<0.001), (b) 
FFM (r = 0.74; p=0.001) by using measured (3C) versus TANITAequn
195
(a) FM
4.00”
"S
200 -
3g. 0 00-
- 2 ,00 -
Sü_
-4.00“
O o
— 1—  
-4.00
(b) FFM
4.00”
•O
3  2.00- 
:
c0
19" 0,00-
•0 c
2
1
- 2 .00-
-4.00-
—,— 
-2 00
—I— 
- 2.00
—I— 
0.00 2.00 4.00
—T" 
6.00
mean FM difference (kg)
o o
o o
o o
— I—  
0.00
— I—
2.00
—r~
4.00 6.00
Mean FFM difference (kg)
Figure 7-6: Bland and Altman plot showing the agreement between mean of the change 
in the difference of (a) FM (r = 0.05; p=0.8), (b) FFM (r=-0.16; p = 0.5) using measured 
(by 3 C  model) versus T A N I T A e q u n
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Figure 7-7 A scatter-plot of the difference in change of (a) FM (r = 0.74; p=0.001), (b) 
FFM (r = 0.73; p = 0.001) by using measured (3C) versus T A N I T A m a n u f a c t u r e r
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Figure 7-8 Bland-Altman plot showing the agreement between the difference in change 
in F M  ( T A N I T A m a n u f a c t u r e r  - 3 C )  and mean of change in F M  ( T A N I T A m a n u f a c t u r e r  + 3 C )  (r =
0.06; p = 0.8)
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Figure 7-9 Bland-Altman plot showing the agreement between difference in change in 
F F M  ( T A N I T A m a n u f a c t u r e r  "3C) and mean of change in F F M  ( T A N I T A m a n u f a c t u r e r  ■i"3C) (r — 
-0.48; p = 0.05)
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7.10 Discussion
Measuring body composition accurately in obese children and adolescents is extremely 
important, particularly when looking at the effectiveness of various treatment strategies. 
BIA offers a rapid, simple, non-invasive and cheap way of predicting body composition. 
However, there has been very limited information on the validity of this technology in 
obese children and adolescents. This study compares the TANITA (BC-418 MA) 
machine against the most accurate techniques for calculating body composition: D2 O 
and multi-component models (3C and 4C models).
Results from this study show that raw predictions directly obtained from the T A N I T A  
machine ( T A N I T A m a n u f a c t u r e r )  should be interpreted with extreme caution when assessing 
this particular group. In obese children and adolescents, compared to the multi- 
component model, T A N I T A m a n u f a c t u r e r  significantly underestimated FM (by 
approximately 4 kg; p < 0.001) and overestimated FFM (by approximately 2.7 kg; p < 
0.001). Previous studies evaluating the accuracy of B I A  have been inconsistent.
There have been a limited number of studies evaluating impedance in assessing body 
composition in obese children, most relying on DXA as the reference method. DXA 
however has been shown to be unreliable for use in longitudinal studies especially when 
subjects undergo change in nutritional status, because the bias in estimating fat and lean 
mass was found to be inconsistent and dependant on subject’s size and level of 
adiposity (Williams et al, 2006).
Similar results to mine were reported by Lazzer and colleagues (2003) when validating 
foot-foot impedance in 53, 13-16 year old overweight and obese adolescents against 
DXA (Lazzer et al. 2003). In addition, Frisard and colleagues (2005) reported that in 
overweight adults, foot-foot impedance overestimated FFM and underestimate FM 
compared to DXA (Frisard et al. 2005).
One possible reason for this finding is that impedance machines make assumptions 
concerning the Hnm. I have previously demonstrated in chapter 5 that obese children and 
adolescents have significantly greater hydration levels compared to those non-obese; 
average Hffm is approximately 76 - 77% in this group. Therefore FFM is over-estimated
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and FM is underestimated in those with Hffm > 73% (the hydration constant used in 
impedance machines).
On the other hand, Prins and colleagues (2007) validated a whole body impedance 
machine (TANITA BC-418 MA) in a group of 5 - 17 year old children from The 
Gambia against D2 O, and found that TANITA underestimated FFM and overestimated 
% fat with a greater overestimation in thinner individuals (Prins et al. 2007). 
Differences in my results may be due to the ethnicity of subjects that took part in the 
study; Prins’s subjects were African whereas my subjects came from a White 
background. Also, my study consisted of only obese children and adolescents whereas 
Prins’s study population were not obese. Hence, differences subject characteristics 
between the studies may account for differences in outcomes obtained.
Another study by Jebb and colleagues (2000) evaluated a foot-foot impedance machine 
in 16-78 year olds against the 4C model (Jebb et a l 2000). They found that the 
impedance machine over-estimated FM by approximately 0.8 kg. A possible reason for 
this finding is that the body build of obese subjects is different from that of lean 
subjects; especially those with abdominal obesity. The trunk contains about 50% of 
body mass but contributes only about 10-20% of total body impedance (Deurenberg, 
1996). Obese subjects with more abdominal mass will have more water (or FFM) 
located in the trunk, but the effect o f that part o f the body on total impedance will be 
low. This is because the trunk is relatively short and has a large diameter, and 
impedance is proportional to height but inversely proportional to area. Hence FFM and 
TBW in this body region may be underestimated.
This study also demonstrated that the error in estimating F M  and F F M  from 
TANITAmanufacturer was inconsistent across the range of body composition. Compared to 
the 4 C  model, T ANITAm anufacturer under-estimated F M  more in children with the highest 
F M  and overestimated F F M  more in those with the highest F F M . This phenomenon 
should not be overlooked when this technique is being used to assess body composition 
in obese children particularly when assessing changes in body composition during a 
weight loss programme. Ideally, specific equations should be constructed when 
assessing body composition in patients that may differ from the norm such as obese 
children and adolescents.
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Equations constructed from T A N I T A  (T A N IT A e q u n ) were found to estimate changes in 
body composition accurately in obese children enrolled in a 6-month weight-loss 
programme; underestimating a change in FM and overestimating a change in FFM by 
approximately 0.2 kg each when compared against the 3C model; this bias is negligible. 
In addition, the accuracy of the machine was not affected by the amount of fat and lean 
mass children lost or gained while they were on the treatment programme. This 
indicates that compared to the multi-component model, prediction equations constructed 
from T A N I T A  (T A N IT A e q u n ) can provide reliable assessments of body composition 
changes in White obese children. This is extremely useful for weight-management 
clinics because TA N I T A  is inexpensive, easy to use and provides more information 
than traditional weight and height measurements.
It has been reported that the magnitude of the weight loss may influence the accuracy of 
impedance machines in assessing change in body composition (Frisard et a l 2005). In 
obese populations, some studies reported that the Hffm decreases following weight loss 
(Ritz et a l 2007), whilst others did not report such a change in Hffm (Marken 
Lichtenbelt and Fogelholm, 1999; Leone et a l 2000). Therefore body composition 
measurements obtained using methods which rely on a fixed Hffm, such as BIA, may not 
be accurate. In this population, the magnitude of change in FM and FFM did not 
significantly impact the accuracy of the TANITA machine. The current study 
population however comprised a small homogenous sample of White obese children. 
Consequently, the acceptability o f this finding may be limited to populations specific to 
that examined.
In spite of the good assessment of change in body composition using T A N I T A 's 
manufacturer’s in-built equations (TANITAmanufacturer), it cannot be recommended for 
assessment of body composition in obese children and adolescents because of the large 
errors of individual estimates. Instead, equations predicted from impedance using the 
multi-component model as the reference (TANITAequn) are recommended when 
assessing body composition in White obese children and adolescents because they 
provide a more accurate estimate of body composition.
Moreover, the accuracy of TANITA was examined against a common conventional 
measure of adiposity: BMI. Both methods were significantly correlated in predicting 
change in body composition over time; however prediction equations constructed from
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T A N IT A  (TA N ITA equn) provided a 14% stronger correlation and 0.2 kg less error in 
predicting change in FM. Therefore, my T A N IT A  equations can provide more accurate 
assessment of change in body composition than the approach traditionally used to assess 
body composition.
Further research looking at the different ethnic groups and constructing gender specific 
equations for obese children and adolescents would be extremely valuable. The 
equations above should only be used for White obese children or adolescents, because 
body composition differs significantly between different ethnic groups. For example 
Blacks have higher lean mass compared to Whites whereas Asians have higher FM 
(Deurenberg et al. 1998; Dudeja et al. 2001). Therefore, constants and equations 
derived from analysing data on White children may not be applicable in other ethnic 
groups.
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7.11 Study limitations
Although R measurements can be reliably obtained from impedance machines such as 
the one used in this study, several factors may affect their accuracy. These include 
hydration status, food intake and exercise. The impedance measurement was the last 
measurement performed at the 1.5 hour appointment. Therefore, subjects had nothing to 
eat and no exercise at least one hour before the measurement was taken. In addition, the 
touching of limbs while the measurement is being taken may short-circuit the electric 
pathway and reduce impedance, thus over estimating TBW. Subjects were measured 
with trousers on, to avoid such inaccuracies and were also asked to void before the 
measurement
The TANITA (BC-418 MA) impedance machine used in this study uses a low 
frequency o f 50 KHz, which flows mainly through ECW due to the high capacitance of 
the cell membrane (Kushner, 1992). At higher frequencies (> 200 KHz), the cell 
membrane is crossed by the electrical current and both the ECW and ICW 
compartments are measured. Multi-frequency BIA machines which provide resistance at 
multiple frequencies may be a better technique; however TBW, ICW, ECW and FFM 
are highly correlated among themselves (Schoeller, 2000). Thus, multi-frequency BIA 
may not provide a better prediction o f ECW or TBW than single-frequency BIA. More 
research however is needed to confirm this hypothesis.
The reference method used for the longitudinal assessment of the accuracy of TANITA 
in estimating body composition in obese children and adolescents over time, was the 3C 
instead of the 4C model. For ethical reasons, obese children had a bone scan only for 
their first two visits but not their third; hence body composition was not estimated using 
the ‘gold standard’ 4C model and only the 3C model was used. However, I have 
demonstrated previously in Chapter 5 that body composition estimated from the 3C 
versus 4C models was not significantly different in obese children. Hence, the accuracy 
of the TANITA machine in predicting change in body composition using 3C prediction 
equations instead o f 4C equations would have not been affected.
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Chapter 8: Conclusion
This chapter will outline a summary of the findings derived from this thesis, and 
describe areas where further research may be beneficial.
8.1 Summary o f findings
In chapter 5, I tested my first hypothesis by comparing the body composition of obese 
children with that of non-obese children and adolescents matched for age and sex. I 
found that obese children, especially girls, were taller than non-obese children. This 
confirms the need to adjust for body size when comparing body composition (including 
FM and FFM) in groups o f children even after adjusting for age and sex differences. I 
also found the properties of FFM were not constant between children of the same age 
and sex; obese children and adolescents have increased Hffm and reduced Dffm compared 
to non-obese children. This has important implications when assessing body 
composition in obese children using techniques that assume constant properties of FFM. 
These techniques include DXA scanners and BIA, which have been widely used in 
many research studies and clinical work. To date, there is not enough information on the 
potential implications o f this excess hydration. Regional body composition analyses 
using DXA further showed that obese children had increased FM especially in the 
abdominal region; which is correlated with increased risk of metabolic complications. 
Given that obesity is associated with so many body composition outcomes, 
investigations of the effect o f treatment should ideally incorporate body composition 
measurements.
In chapter 6, I tested the effectiveness of two weight loss programmes on body 
composition in obese children and adolescents.
The first programme tested was an RCT evaluating the effectiveness of the TLP in a 
group of obese children and adolescents. Children were randomised to a treatment 
group and a control group, the former group received treatment immediately whereas 
the latter group had to wait for 6 months before receiving treatment. Results reveal that 
even though there was a slight reduction in BMI SDS in both the treatment and control 
groups; the groups did not significantly differ for any of the body composition
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measurements, indicating that the TLP was not very successful. This was when the RCT 
was analysed; i.e. when treatment group were compared to controls (the period when 
they received no treatment). However, when a further analysis was performed whereby 
change in body composition between being treated then left versus being wait-listed 
then treated, the TLP was found to be successful. This analysis included all the children 
that received treatment, i.e. the controls when they were treated outside the RCT, and 
investigated change in body composition at different time-points. Those that were 
treated as opposed to being left showed a significant loss of FM and BMI SDS, and a 
significant increase in FFM, indicating the treatment programme was actually effective 
in improving body composition. Differences between the RCT analysis and the second 
analysis resulted because controls on the RCT performed better on the treatment 
programme compared to those who were part of the treatment group; thus when the 
controls who received treatment were included in the second analyses the TLP was 
found to be effective.
The second programme tested was a pilot study evaluating the effectiveness of 
Metformin on change in body composition in a group of obese children and adolescents. 
Results obtained from this study illustrated that 6 months and 1 years of taking 
Metformin resulted in a slight reduction in BMI SDS which was not significant. This 
programme was not an RCT, therefore the results obtained need to be confirmed using a 
larger sample size and using controls. Also, the programme included some that had 
already been taking Metformin, and so baseline body composition data before they 
started treatment was not available. Even though there was no change in BMI SDS 
between baseline (before Metformin was prescribed) and 6 months after taking 
Metformin (data obtained from clinic notes); it may be that there was a slight change in 
body composition.
Because childhood obesity has proven to be very difficult to treat, and weight loss 
programmes for obese children and adolescents are not very effective, it may be best to 
direct most effort to preventing the onset of obesity using public health programmes. 
Even though schools have been promoting healthy eating and physical activity the 
results are not especially successful, and it may be that this prevention should start at an 
even younger age.
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Also treatment programmes in children may not be drastic enough; whereby some of the 
programmes for young children recommend weight maintenance instead of weight loss. 
This might work for overweight or slightly obese children who might ‘grow into their 
weight’. However some o f the children that were included in my treatment programmes 
were very obese (BMI SDS o f approximately 3.5, which is well above the cut-off for 
childhood obesity), and therefore will need to decrease in weight rather than simply 
maintain it.
In chapter 7, a simple tool ( T A N I T A  BC-418 MA) for assessing body composition was 
validated against multi-component models to investigate the accuracy of using this 
machine to estimate body composition in White obese children and adolescents. 
Compared to the 3C and 4C models, TANITAmanufacturer significantly underestimated FM 
and overestimated FFM; the bias was not consistent across the range of body 
composition. This indicates that in-built T A N I T A  equations are not very accurate, and 
may be particularly inaccurate when assessing change in body composition during 
weight-loss programmes. Equations from impedance were then derived using multi- 
component models (3C and 4C models) as the reference methods that can be used to 
estimate body composition. The equation from the 3C model was then tested on a 
sample that had longitudinal body composition measurements. Results show that the 
equation was unbiased in predicting change in body composition. Hence, these 
equations are recommended when using impedance ( T A N I T A  BC-418 MA) to assess 
body composition in weight-management clinics. These equations (from impedance) are 
more accurate to use compared to traditional measurements that rely on weight and 
height, and are more practical and cost effective than imaging techniques such as DXA 
and MRI. However with a SEE of 2.2 kg, they are less accurate than MRI or DXA and 
are best considered a useful guide to body composition and its change over time rather 
than a definitive measure.
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8.2 Future research
Based on my findings, I suggest several areas where further research may be beneficial.
Increased Hffm was observed in obese children and adolescents, but the reason behind 
this is unclear. This phenomenon could be further examined by directly measuring 
ECW by sodium bromide dilution, and calculating ICW as the difference between TBW 
and ECW. It would then be possible to determine whether significant weight loss 
reduces this over-hydration.
The effectiveness o f the TLP was only investigated 6 months after treatment ended. 
Therefore, a long-term follow-up into adulthood, investigating the effectiveness of TLP 
on body composition and health outcomes may be beneficial. This is planned by those 
running the programme.
The Metformin programme I evaluated was a pilot study, there were no controls and the 
sample included anyone who was taking Metformin. An RCT is therefore required for 
investigating the effect of Metformin on body composition in obese children and 
adolescents, assessing whole body composition by using the multi-component model to 
obtain accurate change in total body fat and lean mass, in addition to using MRI to 
examine changes in visceral fat. Even though there might not be significant changes in 
total fat, it may be that there are changes in visceral fat, which provides a more accurate 
marker for insulin sensitivity.
In chapter 7 ,1 have shown in a sub-sample that TANITA equations developed for White 
obese children were not applicable to use in other ethnic groups. However, I did not 
have a large enough sample to develop ethnic-specific equations. Therefore a study 
evaluating BIA against the multi-components models in obese children and adolescents 
from other ethnic groups is recommended.
Age and sex-specific cut-offs for defining obesity and overweight in children and 
adolescents age 5 - 1 8  years have been proposed by McCarthy and Colleagues in 2006, 
using a BIA machine: TANITA model BC-418 MA (McCarthy et al. 2006). Given I 
have demonstrated in chapter 7 that TANITA (BC-418 MA) compared to the 4C model 
did not describe body composition accurately, it may be beneficial that these cut-offs
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are revised or confirmed using a more accurate technique such as the multi-component 
model.
Behavioural programmes are generally used in young obese children, typically aged 
between 8 and 13 years, whereas pharmacological programmes tend to be used in older 
obese children and adolescents. Family based behavioural programmes have advantages 
in that the programme teaches the family to adopt a healthier lifestyle; hence targeting 
the family as a whole rather than concentrating on the individual obese child. 
Pharmacological programmes however tend to be used when all other options have 
failed; children on this programme are now older and more obese than those on 
behavioural programmes. Findings from my PhD illustrate that treating childhood 
obesity is challenging and generally not very successful in either age groups; and it may 
be that programmes working on preventing childhood obesity in the first place are more 
beneficial. There are very few public health programmes preventing childhood obesity, 
and very little research evaluating body composition and longitudinal effects of these 
programmes. Therefore, more research on the effectiveness of sueh programmes is 
needed.
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Copy to: Institute of Child Health/ Great Ormond Street Hospital R&D Department
An advisory committee to  North Central London Strategic Health Authority
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NHS
Great Ormond Street Hospital 
for Children NHS Trust / The 
Instiüite of Child Health 
Local Research Ethics Committee
Institute of Child Health 
30 Guilford Street 
London 
WC1N 1EH
Tel: 020 7905 2620 
Fax: 020 7905 2201 
Email: l.howe@ich,ud,8C.uk
3"^  October 2003
Jonathan Wells
Nutrition
ICH
Dear Dr Wells,
Title: Body Cwnposltlon and Bone Mineralisation In Patients
At GOSH
R&D registration number; 02Nnr01
Protocol num ber/version: N/A
Thank you for your email dated 22""^  September 2003. The Chairman of the Research 
Ethics Committee, Dr Victor Larcher, has on behalf of the Committee, approved the 
following amendments to the above project:
•  Carrying out the measurements before and after clinical interventions. This 
amendment relates to all patient groups in this study. You must ensure that this is 
made clear to patients in the information provided to them.
•  The recruitment of obese children from Chichester and The London Hospitals, 
providing appropriate agreement from the responsible clinicians and Research Ethics 
Committees is obtained.
The decision will be ratified at the full Committee meeting that will take place on 
VNfednesday Novemt)er 2003 (Please note that you will not receive a letter confirming the 
above ratification).
Yours sincerely 
Laura Howe
R esearch  Ethics Coordinator
CO. Mary Fewtrell, Margaret Lawson
An advisory committee to  North Central London Strategic Health Authority
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Appendix 2: information sheets for parents and children
(a) Parent information sheet
The
child
first
and
Parent information sheet
MRC Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street always
London W C1N 1 EH 
Tel 020 7905 2747
Title o f  project
Body composition changes during weight-loss 
The aim o f  the study
To measure the changes in body composition that occurs during weight loss in children. 
Why is the study being done?
Many children are now being treated for excess body weight. However, it is not yet 
known exactly how weight loss treatment influences the different components of 
weight, including muscle mass, bone mass and fat mass. Our study aims to make 
measurements to provide information on body composition during weight loss. This 
will help refine weight loss programmes for children in the future.
How is the study to be done?
We are recruiting children who are on programmes for weight loss. If you are willing to 
take part in the study, we will arrange an appointment at a time which is convenient for 
you to come up to the Hospital for Sick Children, Great Ormond Street, where our 
equipment is kept. We will reimburse any travelling expenses. The measurements will 
be made at the start o f treatment, and again after 6 months on the weight loss 
programme.
At the appointment, we will
weigh your child and record his/her height.
perform three scans using our DXA (Dual X-ray Absorptiometer) scanner -  one of the 
hip, one o f the spine and one of the whole skeleton. The scans take a maximum of 5 
minutes each, and are performed whilst wearing light indoor clothing (such as shorts 
and a t-shirt) and lying on a bed, keeping as still as possible. These scans give a 
measurement o f the size and amount o f mineral in the bones, as well as the proportions 
of fat and muscle. If there is any possibility that the person to be scanned is pregnant, 
the scan will not be performed.
perform a measurement of the strength of the bone in the wrist and lower leg, using an 
ultrasound machine. These measurements are painless, take a few minutes each and do 
not use X-rays.
measure the amount of water in the body. This measurement involves drinking some 
water containing heavy hydrogen molecules. These molecules are not radioactive, they 
simply weigh more than most hydrogen molecules and they occur naturally in all of us. 
Before and after the drink your child will be asked to provide a saliva sample using an 
absorbent cotton wool swab.
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measure the volume o f the body. This measurement involves your child sitting still 
inside a chamber called a BodPod for about 45 seconds while room air is gently blown 
around them. Two such measurements will be made. The test is performed with the 
child wearing a close fitting swimming costume (not swim shorts), 
perform a measurement of bioelectrical impedance using a low level of electrical 
current (that is undetectable), passed between electrodes placed on the hand and foot. 
The test is harmless and painless and gives a measure of body water, 
ask some questions about your child’s general health, including any medicines being 
taken, illnesses such as asthma and broken bones, and use a short questionnaire to 
measure his or her calcium intake and activity level. For older children (above 9 years 
of age) we also need to know if  any pubertal development has taken place as this affects 
the growth and mineral content of bones. To avoid any undressing, we will show your 
child some photos of the different stages of pubertal development and ask him or her to 
pick the one which is closest to them.
Measure your child’s blood pressure with an electronic monitor. This measurement 
involves briefly inflating a cuff around the arm while the machine makes a 
measurement.
The whole appointment should last about 60 minutes.
Are there risks and discomforts?
All of the tests are painless and will not harm your child. DXA scans involve a tiny 
amount of radiation, which is less than half of a day’s background radiation in the 
United Kingdom (to which we are all exposed), and less than one tenth of the radiation 
from a flight across the Atlantic. However, if  there is any possibility that the person to 
be scanned is pregnant the scan will not be performed. During the blood pressure 
measurement, the cuff acts like a balloon being inflated while wrapped round the arm; it 
might feel a bit tight but it won’t hurt.
What are the potential benefits?
The measurements provide more specific information than body weight about the level 
of body fat, which is what the weight loss programme is trying to reduce. The 
measurements o f body composition will therefore provide accurate information about 
how much fat has been lost during the 6 months of treatment, while also showing any 
changes in lean mass. Most children also find the tests interesting and educational and 
each child will be given a printout o f his/her skeleton to take home.
Who will have access to the research records?
Only the researchers and a representative of the Research Ethics Committee will have 
access to the data collected during this study. Each child will be given a study number, 
and names and addresses will not be computerised. The computerised information 
(weight, height, age and test results but no names or addresses) will be made into a 
reference database of children. This may then be used by other doctors wishing to 
compare results between children.
Do I  have to take part in this study?
No. If you decide, now or at a later stage, that you do not wish to take part in the study, 
that is entirely your right.
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Who do I  speak to i f  problems arise?
If you have any complaints about the way in which this research project has been, or is 
being conducted, please, in the first instance, discuss them with the researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London WCIN 1ER, 
or, if urgent, by telephone on 020 7905 2620, and the Committee administration will put 
you in contact with him.
What are the arrangements fo r  compensation?
This project has been approved by an independent research ethics committee who 
believe that it is of minimal risk. However, research can carry unforeseen risks and we 
want you to be informed of your rights in the unlikely event that any harm should occur 
as a result o f taking part in this project.
This research is covered by a no-fault compensation scheme which may apply in the 
event of any significant harm resulting to your child from involvement in the project. 
Under this scheme it would not be necessary for you to prove fault. You also have the 
right to claim damages in a court o f law. This would require you to prove fault on the 
part of the Hospital/Institute and/or any manufacturer involved.
Details o f  how to contact the researchers:
MRC Childhood Nutrition Research Centre 
Dalia Haroun
Tel: , email d.haroun@ich.ucl.ac.uk 
Dr Jonathan Wells
Tel:  email i.wells@ich.ucl.ac.uk
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(b) Participant information sheet
The
child
first
and
Subject information sheet for children
MRC Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street 
London WC1N 1 EH always
Tel 
Title o f  project
Body composition changes during weight loss 
The aim o f  the study
To measure the changes in body composition that occur during weight loss in children. 
Why is the study being done?
Many children are now being treated for excess body weight. However, it is not yet 
known exactly how weight loss treatment influences the different components of 
weight, including muscle mass, bone mass and fat mass. Our study will tell us which 
components of weight actually change during the programme, and will tell you how 
much fat you have lost.
How is the study to be done?
We are recruiting children aged who are on programmes for weight loss. If you are 
willing to take part in the study, we will arrange an appointment at a time which is 
convenient for you to come up to the Hospital for Sick Children, Great Ormond Street, 
where our equipment is kept. We will reimburse any travelling expenses. The 
measurements will be made at the start of treatment, and again after 6 months on the 
weight loss programme.
At the appointment, we will; 
weigh you and record your height.
perform three scans using our DXA (Dual X-ray Absorptiometer) scanner -  one of the 
hip, one of the spine and one o f the whole skeleton. The scans take a maximum of 5 
minutes each, and are performed with you wearing light indoor clothing (such as shorts 
and a t-shirt) and lying on a bed, keeping as still as possible. These scans give a 
measurement o f the size and amount of mineral in the bones, as well as the amount of 
fat and muscle. If there is any possibility that you may be pregnant the scans will 
not be performed.
perform a measurement o f the strength of the bone in the wrist and lower leg, using an 
ultrasound machine. These measurements are painless, take a few minutes each and do 
not use X-rays.
measure the amount of water in your body. This measurement involves drinking some 
water containing heavy hydrogen molecules. These molecules are not radioactive, they 
simply weigh more than most hydrogen molecules and they occur naturally in all of us. 
Before and after the drink you will be asked to provide a saliva sample using an 
absorbent cotton wool swab.
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measure the volume of the body. This measurement involves you sitting still inside a 
chamber called a BodPod for about 45 seconds while room air is gently blown around 
you. The measurement is then repeated. The test is performed with you wearing a close 
fitting swimming costume (not shorts).
perform a measurement of bioelectrical impedance using a low level of electrical 
current (that is undetectable), passed between electrodes placed on the hand and foot. 
The test is harmless and painless and gives a measure of body water, 
ask some questions about your health, including any medicines being taken, illnesses 
such as asthma and broken bones, and use a short questionnaire to measure your 
calcium intake and activity level. We also need to know if any pubertal development 
has taken place as this affects the growth and mineral content of bones. To avoid any 
undressing, we will show you some photos of the different stages of pubertal 
development and ask you to pick the one which looks closest to you.
Measure your blood pressure with an electronic monitor. This measurement involves 
briefly inflating a cuff around your arm while the machine makes a measurement.
The whole appointment should last about 60 minutes.
Are there risks and discomforts?
None of the tests will hurt you. DXA scans involve a tiny amount of radiation, which is 
less than half o f a day’s background radiation in the United Kingdom (to which we are 
all exposed), and less than one tenth of the radiation from a flight across the Atlantic. 
However, if  there is any possibility that you may be pregnant the scans will not be 
performed. During the blood pressure measurement, the cuff will feel as if  you were 
having a balloon inflated while wrapped round your arm; it might feel a bit tight but it 
won’t hurt.
What are the potential benefits?
Taking part in the study will show you how much fat you have lost while taking part in 
the weight loss programme. Also, most people find the scan pictures interesting and 
educational and you will be given a printout of your skeleton to take home.
Who will have access to the research records?
Only the researchers and a representative of the Research Ethics Committee will have 
access to the data collected during this study. Each child will be given a study number, 
and names and addresses will not be computerised. The computerised information 
(weight, height, age and test results but no names or addresses) will be made into a 
reference database o f normal children. This may then be used by other doctors wishing 
to compare results from sick children with those from normal children.
Do I  have to take part in this study?
No. If you decide, now or at a later stage, that you do not wish to take part in the study, 
that is entirely your right.
Who do I  speak to i f  problems arise?
If you have any complaints about the way in which this research project has been, or is 
being conducted, please, in the first instance, discuss them with the researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London WCIN lEH, 
or, if urgent, by telephone on , and the Committee administration will put 
you in contact with him.
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What are the arrangements fo r  compensation?
This project has been approved by an independent research ethics committee who 
believe that it is o f minimal risk. However, research can carry unforeseen risks and we 
want you to be informed of your rights in the unlikely event that any harm should occur 
as a result o f taking part in this project.
This research is covered by a no-fault compensation scheme which may apply in the 
event of any significant harm resulting to your child from involvement in the project. 
Under this scheme it would not be necessary for you to prove fault. You also have the 
right to claim damages in a court o f law. This would require you to prove fault on the 
part of the Hospital/Institute and/or any manufacturer involved.
Details o f  how to contact the researchers:
MRC Childhood Nutrition Research Centre
MRC Childhood Nutrition Research Centre 
Dalia Haroun
Tel: , email d.haroun@ich.ucl.ac.uk 
Dr Jonathan Wells
Tel:  email j .wells@ich.ucl.ac.uk
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Appendix 3: appointment ietter
UCL INSTITUTE OF CHILD HEALTH 
Parent/Guardian of XXX
Date:
Appointment fo r  body composition study o n ...............................a t ............
Thank you fo r  taking part in this research project.
I f  you enter the main entrance o f  the hospital in Great Ormond Street, make your
way to the X-RA V RECEPTION and ask to have a bone scan. Either call me or tell the 
reception to call me on the Extension: 2309 or 2747.
If you have any problems attending this appointment, please call and leave me 
a message Tel: and I will organise another date.
In order to do an accurate measurement of body volume in the BODPOD, it is 
necessary to wear a close fitting swimming costume. Loose fitting shorts will 
affect the measurement and are not acceptable, but tight fitting shorts are 
acceptable. If you think you may have a problem let me know before the 
appointment.
The nearest underground is Russell Square 
Please call me if you have any questions at all.
I look forward to meeting you all.
Yours sincerely.
Dalia Haroun
Tel: 
Emailid.haroun@ich.ucl.ac.uk
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Appendix 4: consent form for parents and participants, and assent 
form for children
(a) Consent form for parents
Great Ormond Street Hospital for Children NHS Trust and Institute o f  Child Health Research Ethics 
Committee
Consent Form for PARENTS OR GUARDIANS 
of Children Participating in Research Studies
Title: Body Composition changes during weight loss
NOTES FOR PARENTS OR GUARDIANS
1. Your child has been asked to take part in a research study. The person organising that study is 
responsible for explaining the project to you before you give consent.
2. Please ask the researcher any questions you may have about this project, before you decide whether 
you wish to participate.
3. If  you decide, now or at any other stage, that you do not wish your child to participate in the research 
project, that is entirely your right, and if  your child is a patient it will not in any way prejudice any present or 
future treatment.
4. You will be given an information sheet which describes the research project. This information sheet 
is for you to keep and refer to. P lease read  it carefully.
5. I f you have any complaints about the way in which this research project has been or is being 
conducted, please, in the first instance, discuss them with the researcher. If the problems are not resolved, or 
you wish to comment in any other way, please contact the Chairman o f  the Research Ethics Committee, by 
post via The Research and Development Office, Institute o f  Child Health, 30 Guilford Street, London W CIN  
lEH or if  urgent, by telephone on 020 7905 2620 and the committee administration will put you in contact 
with him.
CONSENT
I/W e__________________________________ , being the parent(s)/guardian(s) o f
__________________________________ agree that the Research Project named above has been explained to me
to my/our satisfaction, and I/We give permission for our child to take part in this study. I/We have read both 
the notes written above and the Information Sheet provided, and understand what the research study involves.
SIGNED (Parent (s)/Guardian (s) ) PRINTED DATE
SIGNED (Researcher) PRINTED DATE
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(b) Assent form for children
Great Ormond Street Hospital for Children N HS Trust and Institute o f  Child Health Research Ethics 
Committee
Assent Form for CHILDREN Participating in Research Studies 
Title: Body Composition changes during weight loss
NOTES FOR CHILDREN
1. You have been asked to take part in some research. The person organising that study must explain 
the project to you before you agree to take part.
2. Please ask the researcher any questions you like about this project, before you decide whether to join  
in.
3. If you decide, now or at any other time, that you do not wish to be involved in the research project, 
just tell us and we w ill stop the research. If you are a patient your treatment will carry on as it would 
normally.
4. You w ill be given an information sheet which describes the research. This information is for you to 
keep and refer to at any time. P lease read  it carejully.
5. If  you have any conplaints about the research project, discuss them with the researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the Chairman o f  the 
Research Ethics Committee, by post via The Research and Development Office, Institute o f  Child Health, 30 
Guilford Street, London W C IN  lE H  or i f  urgent, by telephone on 020 7905 2620 and the committee 
administration w ill put you in contact with him.
ASSENT
I ________________________________________________ agree that the Research Project named
above has been explained to me to m y satisfaction, and I agree to take part in this study.
I have read both the notes written above and the Information Sheet about the project, and 
understand what the research study involves.
SIGNED PRINTED DATE
SIGNED (Researcher) PRINTED DATE
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(c) Consent form for participants
Great Ormond Street Hospital for Children N HS Trust and Institute o f  Child Health Research Ethics 
Committee
Consent Form for PARTICIPANTS in Research Studies 
Title: B ody com p osition  changes d uring  w eigh  loss 
N O TES FO R  PA R T IC IPA N T S
1. You have been asked to take part in some research. The person organising that study must explain 
the project to you before you agree to take part.
2. Please ask the researcher any questions you like about this project, before you decide whether to join  
in.
3. If you decide, now or at any other time, that you do not wish to be involved in the research project, 
just tell us and we w ill stop the research. If  you are a patient your treatment will carry on as normal.
4. You will be given an information sheet which describes the research. This information is for you to 
keep and refer to at any time. Please read  it carefully.
5. If  you have any complaints about the research project, discuss them with the researcher. If 
the problems are not resolved, or you w ish to comment in any other way, please contact the [named 
representative o f  the sponsor, with address details] or if  urgent, by telephone on [phone number] and the 
committee administration w ill put you in contact with him.
C O N SE N T
I ________________________________________________ agree that the Research Project named
above has been explained to me to my satisfaction, and I agree to take part in this study.
I have read both the notes written above and the Information Sheet about the project, and 
understand what the research study involves.
SIG NED P R IN T E D  DATE
SIG NED (R esearcher) P R IN T E D  DATE
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Appendix 5: questionnaires
24396 Îd
WEIGHT LOSS STUDY
0 B /
Date of birth
□ j ' Œ I '
Subject's surnam e 
Subject's first name
Mother's surnam e 
Address
Post code 
Home telephone number (+code)
Work telephone number (+code)
GP's nam e
Address
Date of interview 
/
initials
Tel (+code)
225
I I I - I - ]
30276
BODY COMPOSITION: REFERENCE DATA id 
Social Data
Today's date
0 B /
/ 2 0
Number of people in homo (inci subject)
Number of rooms in home (Incl dining, living + bedrooms, excl kitchen + bathroom)
Is home own or rented? O Owned 
o  Rented
If home is rented, is it from; O Private landlord 
O Council
O Housing association 
O Not rented 
O irrelevant
Mother's dale of birth / m 9
Mother's educational attainments (highest completed) 
Mother's highest qualification
Mother's occupation
How many months employed In the last year?
Page 1.1
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BODY COMPOSITION: REFERENCE DATA id 
Social Data contd
Father's date of birth I I
0 B /
/ I  9
j^SDeàÿéÿNlSflf
Father's educational attainments (highest completed) 
Father's highest qualification
I L
Father's occupation
1
! 1
How many months employed in the last year? I
Who is the primary earner for the family? O Father
O Mother 
O Grandparent 
O Both parents 
O missing
Social class (use primary earner's occupation) Social code as below
Page 1.2
227
■ H D3(»7e
BODY COMPOSITION: REFERENCE DATA
S ocial Data con td
id 0 B /
Ethnic origin
Please tick the box that you think best 
describes your ethnic origin
White P
Black-Caribbean O
Black-African o
Black-other o
Indian o
Pakistani o
Bangladeshi 0
Chinese o
Asian-other o
Other o
Refused o
Page 1.3
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BODY COMPOSITION STUDY: REFERENCE DATA 
Fractures
Has child ever had a  fracture? I I
I— I yes=1, n o-2  if no, turn to
B
next section
First accident, bones fractured
Other
other
fracture 1 
fracture 2 
fracture 3
which side 
which side 
which side
rights 1 .k)(t=2 n/a=3
Cause of first accident
ÏÎ
cause fracture 1 
cause fracture 2 
cause fracture 3
other
other
other
Place where first accident happened
fracture 1 
fracture 2 
fracture 3
other
other
other
Page 2.1
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BODY COMPOSITION STUDY: REFERENCE DATA B
Fractures continued
Second accident, bones fractured
s'
m
fracture 1 
fracture 2 
fracture 3
which side 
which side 
which side
other
other
other
right» 1,lelt=2 n/a»3
Cause of second accident
cause fracture 1 
cause fracture 2 
cause fracture 3
Place where second accident happened
fracture 1 
fracture 2 
fracture 3
other
other
other
Page 2.2
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BODY COMPOSITION STUDY: REFERENCE DATA B
Fractures continued
Third accident, bones fractured
fracture 1 
fracture 2
fracture 3
n
which side 
which side 
which side
other
other
other
ight= 1,len=2 n/a=3 
C ause of third accident
cause fracture 1 
cause fracture 2 
cause fracture 3
other
other
other
Place where third accident happened
fracture 1 
fracture 2 
fracture 3
other
other
other
P a g e  2 .3
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BODY COMPOSITION STUDY: REFERENCE DATA B
Medical Details
Has child had a significant illness during childhood yes=1, no=2
if no, continue to next section
Type of illness
illness 1 type 
illness 2 type 
illness 3 type
3# #
duration (yrs) 
duration (yrs) 
duration (yrs)
if other illness please state 
illness 1
illness 2 
illness 3
Has child been on long term medication/or currently taking medication ! I
Type of medication (y e s .1 .n o .2  if no. turn to next section) i — I
drug 1
type
nam e
doseage units
date started date stopped
/
time on medication mths
still taking medication o  yes 
o n o  
Page 2.4
fre q u e n c y n
'------1 2= twicc/day
3= three/day
4= four/day  
5= > four/day  
6= alternate days 
7= less than alternate dayi jjjjjj[| 
8= missing, N/A
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BODY COMPOSITION STUDY: REFERENCE DATA
Type of medication
B
«'f 4 «
type
name
doseage units
1
1— 111 r
date commenced 
/ /
date stopped 
/ [
time on medication mttis frequency
still taking medication o  yes 
o n o
oncc/day  
2= twicc/day  
3= thrcc/day  
4= four/day  
5= >  four/day  
6= alternate days 
7 s  less than alternate days 
8=n/a, missing
type
name
doseage | | units
1
date started date stopped 
/
time on medication mths frequency! | Frequency
I___ I 1= once/da
Still taking medication o  yes 
o  no
Page 2.5
once/day 
2= twice/day 
3= throe/day  
4= four/day  
5= > four/day 
6= alternate days 
7 s  less than alternate days  
8=n/a
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BODY COMPOSITION: REFERENCE DATA B
Vitamin and mineral supplements
In the past year has the child taken daily supplements o  yes
O  no continue to 
next section
Calcium supplem ents o  yes 
o  no
name of calcium supplem ent
date started
D / D
date stopped
no capsules/day
still taking calcium supplem ents 
o y e s  
o  no
Calcium intake (mg)/day derived from Calquest analysis
Multivitamins o  yes 
Ono
nam e of multivitamin
date started 
/
no capsules/day
still taking multivitamins 
o y e s  
o  no
date stopped
m /m /
Page 2.6
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BODY COMPOSITION: REFERENCE DATA
Family history of other disease:
With respect to subject (not parent), code 0 for no disease:
1 - mother 2 - father
3 - brother 4 - sister
5 - maternal grandmother 6 - maternal grandfather
7 - paternal grandmother 8 - paternal grandfather
High Cholesterol 
Heart disease
Osteporosis 
Hypertension 
Diabetes - non-insulin dependant 
Diabetes - insulin dependant
Has your child ever required surgery for any of the following: 
(1 = yes. 2= no)
lung heart Gl tract liver kidney
Please give details of any surgery in childhood
Has your child ever required medical treatment for any of the following: 
(1 = yes, 2= no)
lung heart GI tract liver kidney
Please give details of any medical treatment in childhood
Page 2,7
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BODY COMPOSITION STUDY: id 0 B|.
Children's Exercise Questionnaire
How many PE lessons do you have per week
How long is each PE lesson, in minutes
How many hours per week do you spend watching 
TV and videos, plus playing on the computer and 
video gam es (school nights only)
How many hours per week do you spend 
watching TV and videos, plus playing on the 
computer and video gam es (weekend)
How many hours per week do you spend on each of these 
activities outside PE classes:
Running
Football
Aerobics/dancing
Gymnastics
Walking
Other, please specify
Riding bike j | | |
Swimming | | |
Tennis 
Netball 
Hockey 
Basketball 
Rugby 
Skating 
Other sport
□
□
□
□
Page 3.1
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30DY COMPOSITION STUDY: REFERENCE DATA id O B
Pamnt s opinion of the child's physical 
activity levels
Total hours child spents in vigorous activity per week
Level of child's activity compared to peers
Pubertal Development (if 9 or above)
data to transfer from confidential data sheet
Breast/genital development stage (1-5) 
Pubic hair development (1-5) 
Age periods commenced (months)
Have periods started yes d
no o
not applicable o
Oral contraceptive or implant? Yes= 1 
No = 2
Date of first day of last menstrual period
Number of days in whole menstrual cycle
F o r  e x a m p l e :  5  d a y s  m e n s t r u a t i o n  t h e n  2 5  d a y s  t o  n e x t  
m e n s t r u a t i o n  -  3 0  d a y  c y c l e .
Page 3.2
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JODY COMPOSITION STUDY: REFERENCE DATA Id O B
Gestation ^  Birth Weight (g)
Mother's reported weight Mother's reported height .|
Father's reported weight Father's reported height l-D
Anthropometry
MUAC (cm) Head circum (cm)
Waist circum (cm) Hips (cm) □
Thigh circum (cm) Calf circum (cm)
Page 4.1
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b o d y  c o m p o s it io n  STUDY: REFERENCE DATA id B
BODPOD
Date / / [
Time Temp
Final Test System
s d [ I I
Test Data
Raw Volume 
Test One
Mean Volume
!
Bost Mean
% Fat
Raw Density 
(weight/volume)
Weight
Com m ents
Test Two
Pressure
Test Three 
1 ] .
Height . 2 ]  Lung Volume | | ] ,
L 1
L I
1 1 1 1 1 1 1 1
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b o d y  c o m p o s it io n  STUDY: REFERENCE DATA 'd B
DEUTERIUM DILUTION
Full bottle of diluted deuterium (g) Post dosing bottle weight (g)
Post dose fluid intake (mis) Time post dose saliva sample taken
cn[
BIOELECTRICAL IMPEDANCE
Log no. distance (cm)
Whole arm
Upper arm 
Trunk
Upper leg 
Whole leg 
Whole body 
Whole body
Blood Pressure
Systolic Diastolic
[ m
Cuff Size
A; Adult
AL; Large Adult
XAL; Extra Large Adult
Page 4.3
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Appendix 6: pubertal status questionnaire
For boys:
Study Sublect No: Pt»aso look at the Pania and 
Scrotum floly In these lectures. 
Please put a tick In the box that looks 
most like you now.
Scrotum and Panto 
same size as when you 
were youngsr.
The Scrotum has
The Penis to kmgsr 
and wider the Scrotum 
Is darker and trigger 
ttian before
theScrotumto
larger.
towered a  oa
and the Penis
to aiw e larger.
‘ Please look at the Pubic Hair only In 
these pictures.
Please put a tick In the tx>x that looks 
most like you now.
Very ïUle hair Ouhs a lot ol hair
The hair has not
spread over the
S e l f  A s s e s s m e n t
The hair has sptssd 
over Ihe thighs
S e l f  A s s e s s m e n t
For girls:
Study Subjoct No:
•  Please put a  tick In the  
box that looks m ost like 
you now....
The Breasts form smalt mounds.
Ntppte
Areots
The n'opte arrd the surrounding part 
(The ytreofs; make up a mound that 
sticks up above the braeet
self Assessment
The Breasts are flat
The breasts form larger mounds than In Z
Only the nipple slicks out beyond the breast
P lea se  put a  tick In the 
box th a t looks most like
T
The hair has not
spread over the
you now...,
3.
Quite a let of hair
The hair has spread 
over the inigha
S  e  I f Î A 's s  e  8 s  m e  p |
241
Appendix 7: instruction sheet for taking saiiva sampie
INSTRUCTIONS FOR TAKING SALIVA SAMPLE 
Study No. 
Date
We need you to take a sample of saliva after you get home and post it back to 
us in the envelope provided.
 hours after your special drink a t  we would like you to do another
saliva sample in the same way you did the first. Do not eat, drink or clean 
your teeth for 30 minutes before taking the sample. Move the swab around 
your mouth until it is very wet without chewing on it.
It is very important that you take the sample at this time but if it is not possible 
it is better that you tell us the time it was taken.
Record time sample taken here...............
We also need to know how much you drank in the period between the special 
drink and the saliva sample you have done at home.
Record the amount of drink you have had:.................. cups (125ml)
.................. mugs (150ml)
.................. small glasses (150)
.................. large glasses (200)
.................. cans (330ml)
.................. bottles (500ml)
Place the cotton swab in the tube and replace the lid firmly. Put the tube in the 
plastic bag and seal carefully.
Please return this sheet and the sample in the envelope provided as soon as 
possible.
THANK YOU FOR TAKING PART IN THIS STUDY
□alia Haroun 
Research Assistant
MRC Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street, London WC1N 1EH 
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